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Abstract 
Mesenchymal stem cells (MSCs) are a multipotent cell population which have been described to 
exert renoprotective and regenerative effects in experimental models of kidney injury. In 
addition, it was recently shown that human MSCs are able to contribute to the development of 
both renal tubules and glomeruli. These results suggest that MSCs might be potential candidates 
for stem cell-based de novo renal tissue generation. The current study was aimed at re-evaluating 
the renogenic capacity of mouse and human bone marrow-derived MSCs. In order to elucidate 
the renogenic potential of MSCs, a novel method of embryonic kidney culture was used that is 
based on disaggregation of mouse kidney rudiments and their subsequent re-aggregation in the 
presence of cells from different origins to form kidney chimeras. Initially, MSCs did show 
expression of some genes involved in renal development; however, neither mouse nor human 
cells expressed important renal development genes, such as Wt1 and Pax2. Accordingly, MSCs 
were demonstrated to have low renogenic potential in the chimeric kidney model as they did not 
engraft into ureteric buds, the precursors of collecting duct system, and were only occasionally 
found in the condensing metanephric mesenchyme, which gives rise to nephrons. In addition, the 
incorporation of MSCs into embryonic kidneys had some detrimental effect on metanephric 
development. This effect was mediated through a paracrine action of the cells, as conditioned 
medium derived from mouse MSCs was demonstrate to reduce ureteric bud branching in in vitro 
kidney rudiment culture. On the contrary, mouse neonatal kidney cells did engraft into the 
condensing mesenchyme of chimeric kidneys and were subsequently found in some developing 
nephron-like structures. Regarding the potential of mouse embryonic stem cells to contribute to 
renal development in the re-aggregated kidney chimeras, the cells were found to some extent in 
both the condensing mesenchyme and the laminin-positive tubular compartment of chimeric 
 xiii 
kidneys, possibly the ureteric buds. No negative effect on kidney development was observed 
using the neonatal kidney cells as well as the embryonic stem cells. Ultimately it has been shown 
that the pre-conditioning of mouse MSCs with medium derived from mouse neonatal kidney cells 
facilitated the engraftment of MSCs into condensing mesenchyme of chimeric kidneys. It also 
prevented the negative action of MSCs on kidney development confirmed in the in vitro kidney 
rudiment culture. MSCs were demonstrated to up-regulate GDNF expression upon the pre-
conditioning which is important factor for outgrowth and branching of ureteric buds. In 
conclusion, although pre-conditioning of the MSCs with medium derived from kidney cells was 
able to improve considerably the renogenic potential of the cells in the chimeric kidney, MSCs 
demonstrate a relatively low renogenic potential and for this reason are not good candidates for 
regenerative approaches aimed at recapitulation of nephrogenesis. 
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Chapter 1: Introduction 
1.1. Overview of the anatomy and function of the adult kidney 
Kidneys remove waste products from blood. They also produce hormones, like erythropoietin 
and maintain homeostasis by regulating fluid balance, acid-base balance and blood pressure. The 
nephron is the structural and functional unit of the kidney. It consists of renal tubules, including 
the proximal tubule, limbs of the loop of Henle and the distal tubule, as well as the renal 
corpuscle formed by the Bowman’s capsule and the glomerulus. The role of the glomerulus is to 
produce an ultrafiltrate, in the process called glomerular filtration, which becomes urine once it is 
concentrated by the renal tubules, while the collecting duct system of the kidney is connecting the 
nephrons to the ureters. The kidneys, together with ureters, bladder and urethra, form the urinary 
system (Figure 1.1a) (Vize Peter 2003). 
A kidney contains a cortex and a medulla, as demonstrated in the Figure 1.1b. In the renal cortex, 
glomeruli, proximal and distal tubules, loops of Henle and collecting ducts are found (Figure 
1.1b). The medulla is divided into outer medulla, containing the proximal and distal tubules, the 
loops of Henle and the collecting ducts, while the inner medulla harbours the loops of Henle and 
large collecting ducts that empty into the minor calyces (Figure 1.1b). The renal interstitium is 
present in both the renal cortex and medulla and contains fibroblasts, lymphocyte-like cells, 
pericytes and the extracellular matrix (Vize Peter 2003; Cullen-McEwen et al. 2005). Fibroblasts 
are the most abundant cell population producing the extracellular matrix (Vize Peter 2003). In 
addition, the medulla can be organized into several renal pyramids connecting to the minor 
calyces and renal columns which are formed between the pyramids by cortical tissue. 
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Accordingly, the urine flows from the medulla into the minor calyces, which open into the major 
calyces and subsequently into the renal pelvis. The renal pelvis is connected to the ureters and the 
urine flows into the bladder (Figure 1.1a) (Vize Peter 2003). 
As mentioned earlier, the role of the glomerulus is to perform filtration. The blood enters the 
kidney though the renal arteries, which divide subsequently into arterioles that enter and exit the 
Bowman’s capsule at the vascular pole (Figure 1.2a). In the Bowman’s capsule the glomerular 
arterioles branch into glomerular capillaries. Mesangial cells found between glomerular 
capillaries maintain the structural integrity of the glomerulus. Later, the blood from the 
glomerular arteriole is transported to the peritubular capillaries which recover water, salts and 
other compounds reabsorbed by the tubular epithelium. The glomerular filtration proceeds 
through a filtration barrier consisting of glomerular capillaries with many fenestrations, the 
glomerular basement membrane and the podocytes. The filtration barrier allows separation of 
blood cells and large macromolecules from the ultrafiltrate. Podocytes are specialized cells of the 
Bowman’s capsule which wrap around the glomerular capillaries using foot processes. The 
filtration proceeds through slits in the foot processes and subsequently the ultrafiltrate is collected 
in the Bowman’s space. Figure 1.2b shows a schematic representation of the filtration barrier. 
The glomerular filtration is regulated by vasoconstriction and dilation of afferent and efferent 
arterioles, which together with the distal tubule, form the juxtaglomerular apparatus at the 
vascular pole of the renal corpuscle (Vize Peter 2003). 
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Figure 1.1 Schematic representation of the urinary system and kidney parenchyma. (a) The urinary 
system, including the minor and major calyx and renal pelvis. (b) The components of renal parenchyma, 
the cortex and medulla, with two types of nephron found in the kidneys.  
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Figure 1.2 A schematic representation of the renal corpuscle (a) and the filtration barrier found in the 
glomerulus (b). 
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From the Bowman’s space, the ultrafiltrate enters the proximal tubule at the urinary pole (Figure 
1.2a). The proximal tubule consists of a convoluted and a straight part. In the proximal tubules, 
reabsorption of water as well as amino acids, glucose, creatinine, bicarbonate, phosphate, 
potassium, calcium, sodium and chloride occurs. The epithelial cells of proximal tubules have a 
brush border of microvilli which enhance the reabsorption. They also express many proteins 
related to transport, such as aquaporin-1, a water channel protein responsible for water transport 
across the tubule. The proximal tubule is also the site of secretion of uric acid and the site of 
ammonia production (Vize Peter 2003). 
The ultrafiltrate from the proximal tubule passes next through the loops of Henle which consist of 
the thin descending limb, permeable to water and ions, the thin ascending limb, permeable to 
salts but less permeable to water, and the thick ascending limb, impermeable to water but able to 
actively transport salts. The thick ascending limb is the largest site of sodium and chloride 
reabsorption after the proximal tubule. The loop of Henle is also the regulatory site of magnesium 
excretion. In addition there are two main populations of nephrons in the kidney depending on the 
length of the loop of Henle. Cortical nephrons have shorter loops in comparison to 
juxtamedullary nephrons (Vize Peter 2003). 
Subsequently, the ultrafiltrate reaches the distal tubule which is impermeable to water but 
reabsorbs salts. The distal tubule is divided into the straight and convoluted portion. At the point 
where the ascending straight part of the distal tubule reaches the glomerulus, the macula densa is 
formed, which is a component of the juxtaglomerular apparatus. The distal tubule is also the 
regulatory site for calcium extraction. The intermediate zone between the distal convoluted tubule 
and the collecting duct is called the connecting segment and contains cells that have the 
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characteristics of both distal tubule cells as well the collecting duct cells (Vize Peter 2003). 
The collecting duct is divided into the following segments: cortical, outer medullar and inner 
medullary and papillary. These segments increase in size towards the papilla where the medulla 
empties urine into the minor calyx. The principal and intercalated cells are two cell types that are 
distinguished in the collecting duct. The principal cells, expressing aquaporin-2, are specialized 
in water transport, while the intercalated cells play a role in maintaining the acid-base balance by 
secreting bicarbonate into the collecting duct. In the medullary segment of the collecting duct, the 
reabsorption of  sodium, chloride and water occurs (Vize Peter 2003). 
1.2. Kidney development 
The urinary system is derived during embryogenesis from the intermediate mesoderm (IM) which 
is located between the somitic and lateral plate mesoderm. Figure 1.3a demonstrates the 
localization of the IM in a developing mouse embryo before the nephric duct is formed at 
embryonic day (E) 8. Kidney development is characterized by the sequential appearance of three 
excretory organs, namely the pronephros, mesonephros, and finally the metanephros, which is the 
permanent kidney in amniotes. A central role in nephrogenesis is played by the nephric duct, 
which is responsible for the formation of the collecting duct system. The pronephros develops in 
the anterior part of the duct whereas the mesonephros is located more caudally. Ultimately, the 
metanephros arises caudal to the mesonephros (Saxen 1987; Vize Peter 2003). Figure 1.3b 
demonstrates the sequential development of the mouse pronephros, mesonephros and 
metanephros. 
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Figure 1.3 Schematic representation of kidney development in amniotes. (a) Localization of intermediate 
mesoderm within a mouse embryo before E8. (b) Sequential appearance of the pronephros, mesonephros 
and the metanephros in a mouse embryo. 
1.2.1. Pronephros 
The pronephric kidney (pronephros) is the most primitive kidney and contains a single nephron 
which filters blood. However, as there is no Bowman’s space, the filtrate from the glomus 
(glomerulus) is collected from an open cavity by ciliated tubules called nephrostomes which are 
connected to pronephric tubules. Pronephric tubules contain a proximal segment which resorbes 
solute, and a distal segment which resorbes water. Subsequently the urine passes through the 
nephric duct, also called the pronephric duct, to the cloaca. Pronephroi are present during the 
urinary tract development in mammals but they are rudimentary and undergo early degeneration 
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in comparison with well-developed pronephroi found in fish and amphibians. In mice, the 
pronephros appears around E8. Accordingly, the pronephros functions as an excretory organ in 
the larval stages of lower vertebrates. In adult fish the pronephros becomes a lymphoid organ, 
similar as in the amphibians, where it becomes the site of hematopoiesis (Saxen 1987; Vize Peter 
2003). 
1.2.2. Mesonephros 
The mesonephric kidney (mesonephros) is a temporary organ that precedes the development of 
the permanent kidney in mammals. However, it is the definitive excretory organ in adult 
amphibians and some fish, such as the zebrafish. The mesonephros is characterized by a linear 
series of nephrons that are linked to the nephric duct, called at this stage of development, the 
Wolffian duct. The mesonephric nephron consists of a glomerulus, proximal and distal tubule. 
Some important differences exist between the nephrons found in the mesonephric kidneys and the 
nephrons of a permanent kidney. Accordingly, mesonephric nephrons have poor fenestration of 
the capillaries and they lack the juxtaglomerular apparatus. The mesonephros emerges in mice at 
E9.5. The mesonephros undergoes degeneration during embryogenesis in mammals. The 
degradation is partial in males and the remaining mesonephric tubules form parts of the ducts in 
the gonads. The role of the Wolffian duct during mesonephric kidney development is not only 
restricted to its function as a urinary drain. The Wolffian duct plays an important part in the 
induction of mesonephric devolvement, possibly utilizing the same molecular mechanisms found 
during the development of the  permanent kidney (Saxen 1987; Vize Peter 2003). 
 9 
1.2.3. Metanephros 
The metanephric kidney (metanephros) becomes the permanent kidney in mammals. It is the 
most complex kidney, and unlike the mesonephros, has a branched structure. The metanephros 
starts to develop in mice at E11 and its development continues postnatally for approximately 1 
week. The development of the adult kidney starts with the invasion of the ureteric bud (UB) into 
the surrounding metanephric mesenchyme (MM). UB is an epithelial outgrowth of the posterior 
end of the Wolffian duct and is a precursor of the collecting duct system, while MM is involved 
in nephron formation. Aspects of metanephric development, which include the formation of the 
collecting duct, nephron and stroma in the metanephros, are discussed in the following sections. 
1.2.3.1. Collecting duct system development 
The collecting ducts develop from the UB, which is the derivative of the nephric duct. The 
outgrowth of the UB is induced by the MM and starts with the formation of an epithelial bud 
from the Wolffian duct. In mouse, the UB forms at E10, and at E11, invades the MM. Further 
interaction between the UB and MM triggers the UB to branch dichotomously. By E11.5, the UB 
forms a T-shaped tubule. At the same time, the UB induces the MM to form nephrons and further 
branching morphogenesis occurs. Later during development, the UB branches less and several 
nephrons start to form at the same level, joining to the same collecting duct. Figure 1.4 
demonstrates the branching morphogenesis of a UB during mouse metanephric kidney 
development. Ultimately, the UB develops into the collecting ducts, calyces, renal pelvis and the 
ureter (Vize Peter 2003; Dressler 2006). 
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Figure 1.4 The branching morphogenesis of the UB. 
1.2.3.2. Nephron development 
The interaction between UB and MM stimulates the uninduced MM to condense in the proximity 
of the UB tips and subsequently form nephrons. In the mouse, the MM starts to condense in the 
proximity of the UB tips around E11. Accordingly, the condensing MM undergoes epithelial 
conversion, generating renal vesicles. This transition is characterised by important changes in the 
expression of extracellular matrix proteins. The uninduced MM expresses collagen type I and III, 
as well as fibronectin, which are not found in condensing MM. Conversely, the condensation of 
MM is accompanied by expression of laminin, a component of the epithelial basement membrane 
(Horster et al. 1999; Dressler 2006). Furthermore it has been described that α1 chain of laminin-1 
is highly expressed during early epithelial development and it is also the major chain found in 
adult kidneys (Ekblom et al. 2003). Subsequently, renal vesicles are converted into comma (C)-
shaped bodies. At this stage the developing nephrons start to fuse with the UBs. Next, the C-
shaped bodies develop into the S-shaped bodies (Horster et al. 1999; Dressler 2006). The 
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formation of the early nephron, including the renal vesicle, C-shaped and S-shaped body stage, is 
depicted in Figure 1.5a. The proximal end of the S-shaped body forms the renal corpuscle, 
whereas the distal end fused with UB epithelium forms the renal tubule. Around the vascular cleft 
found in the proximal end of the S-shaped body the Bowman’s capsule is formed. Accordingly, 
the outer cell layer of the proximal end of the S-shaped body develops into the Bowman’s 
capsule epithelium whereas the internal cell layer becomes the podocytes (1.5b) (Horster et al. 
1999; Vize Peter 2003; Dressler 2006). The glomerular basement membrane is derived from both 
the extracellular matrix of the forming capillary endothelium and the podocytes (Vize Peter 
2003). Subsequently, the endothelial precursors invade the forming nephron at the vascular cleft 
to form the glomerular capillary loops (Figure 1.5b). The glomerular endothelial and mesangial 
cells are most likely of extrarenal origin. However, there is also some evidence that the MM 
contains endothelial progenitors (Vize Peter 2003). Ultimately, the S-shaped body also forms the 
proximal tubule, the loop of Henle, distal tubule and the connecting segment. However there is 
not much data on the pattering of the emerging renal tubules (Vize Peter 2003). 
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Figure 1.5 Schematic representation of early nephron development. (a) Formation of the renal vesicle, C-
shaped and S-shaped body (in orange). The ureteric bud is shown in blue. (b) A developing the S-shaped 
body. As demonstrated, the proximal end of the S-shaped body will develop into renal corpuscle and the 
distal into different renal tubules. 
1.2.3.3. Development of the renal stroma 
An important compartment in the developing metanephros, which is implicated in regulation of 
UB branching and mesenchymal-to-epithelial transition of the MM, is the renal stroma. The 
localization of the stromal compartment in a mouse metanephros is depicted in Figure 1.6. After 
the UB has invaded the MM and induced MM to condense around its tips, formation of two 
mesenchymal compartments can be determined in the metanephros. Accordingly, the condensing 
MM closely surrounding the bud tip will form the nephrons, and the peripheral cells will become 
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the stromal cells (Figure 1.6). Later, the stromal cells are found surrounding the UB branches and 
forming nephrons (Figure 1.6). These cells are called the primary renal interstitium. As renal 
tubules develop, a secondary interstitium is formed; the cortical stroma and the medullary stroma 
(Cullen-McEwen et al. 2005). Earlier it has been proposed that renal stromal cells could be neural 
crest derivates, as the stromal cells were found to express neurofilaments (Sainio et al. 1994). 
However, recent results in chicken, presented by Guillaume et al., showed that the renal stroma 
mainly originates from paraxial mesoderm (Guillaume et al. 2009).  
 
Figure 1.6 Localisation of stroma in developing mouse metanephros at the onset of metanephric 
development at E11 and later at E12.5. 
1.2.3.4. Genes important during metanephric development 
A number of genes are implicated in the development of the metanephric kidney (Dressler 2009). 
In order to ensure that the metanephros develops in the correct location at the posterior end of 
IM, metanephric development requires a tight regulation of key transcription factors along the 
mediolateral and anteroposterior axis (Dressler 2009). For example Eya1 (Sajithlal et al. 2005) 
and Hox11 paralogs (Mugford et al. 2008) play a crucial role in determining the region of IM that 
will become MM. Hox11 proteins, together with Eya1 and Pax2, form a transcriptional complex 
which activates expression of genes such as glial cell line-derived neurotrophic factor (Gdnf) in 
the posterior intermediate mesoderm, thus triggering the start of metanephric development 
UB 
MM 
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forming nephrons 
E11                            E12.5 
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(Gong et al. 2007). Other genes that positively regulate expression of Gdnf include Six2 and Sall1 
(Saavedra et al. 2008). Metanephric development is initiated with the interaction between the UB 
and MM. Gdnf plays a crucial role in this interaction as the binding of Gdnf to the tyrosine kinase 
receptor, Ret, is responsible for UB outgrowth and branching (Vega et al. 1996; Sainio et al. 
1997). Furthermore, some genes have been demonstrated to take part in later metanephric 
development. For instance, it has been shown that Notch2 signalling plays role in nephron 
patterning. Accordingly, kidneys of Notch2-deficient kidneys do not develop proximal tubules, 
although they form distal tubules (Cheng et al. 2007). Finally, it is important to note that some 
genes involved in metanephric development are not exclusively found in the metanephros. Genes 
such as Pax2 were also demonstrated to be expressed during  development of the pronephros and 
mesonephros (Dressler et al. 1990). An overview of several important signalling pathways and 
genes involved in metanephric development is presented below. 
Gdnf signalling  
The initial outgrowth and subsequent branching of the UB is induced by the glial cell line-derived 
neurotrophic factor (Gdnf) that is expressed by MM adjacent to the UB. Gdnf is a member of the 
transforming growth factor-β (TGF-β) superfamily and was identified by its ability to promote 
the survival of dopaminergic neurons (Saavedra et al. 2008). During metanephric development, 
Gdnf binds to the tyrosine kinase receptor, Ret, which is found at the tips of the UB and 
stimulates UB branching (Vega et al. 1996; Sainio et al. 1997). Ret activates various signalling 
pathways, such as p38 mitogen activated protein kinase (MAPK) and c-Jun N-terminal kinase 
(JNK) pathways (Takahashi 2001). Another receptor taking part in the interaction is the 
glycosylphosphatidylinositol (GPI)-anchored Gdnf receptor-α (GFR-α) which is expressed in 
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both UB and MM (Sainio et al. 1997). Gdnf-null mice do not develop a UB. The uninduced MM 
undergoes apoptosis, consequently leading to complete renal agenesis at birth (Sanchez et al. 
1996). Similarly, in the Ret-deficient mice, the kidneys were also absent. However, occasionally 
some rudimentary dysplastic kidneys with large areas of undifferentiated mesenchyme were 
observed in the mutant animals (Schuchardt et al. 1994). The phenotype of GFR-α null mouse 
was consistent with Ret knockout, demonstrating lack of kidneys or renal dysgenesis (Enomoto et 
al. 1998). 
Sall1 
Similarly to Gdnf, the transcription factor, Sall1, a homologue of the Drosophila region-specific 
homeotic gene spalt, is important for regulating the initial interactions between MM and UB 
during UB outgrowth (Nishinakamura et al. 2001). Sall1 expression starts at E10.5 in mice. At 
E11.5 Sall1 is expressed in mesonephric tubules, Wolffian ducts, and in the metanephric 
mesenchyme but not in the UBs. Later, Sall1 expression is observed in the condensing MM 
around the UBs and in comma-shaped bodies. Sall1-null mice display kidney agenesis, or severe 
dysgenesis, characterized by a disorganized renal structure, shrunken glomeruli, necrotic 
proximal tubules and multiple cysts. The ureteric bud in the Sall1-null animals either does not 
invade the MM or does not induce MM condensation. Impaired branching is observed in mutant 
mice (Nishinakamura et al. 2001). Mutations of SALL1 in humans cause the Townes-Brocks 
syndrome, an autosomal dominant disease characterized by dysplastic ears, preaxial polydactyly, 
imperforate anus, and kidney and heart anomalies (Kohlhase et al. 1998). 
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Lim1 
Another essential gene in renal development is the LIM-class homeobox gene, Lim 1. Lim1 
displays a broad expression profile during nephrogenesis. Its expression starts in the IM and is 
subsequently restricted to the nephric duct and UB. Lim1 expression is also present at different 
stages of nephron formation, including pretubular aggregates, comma-shaped and S-shaped 
bodies. Subsequently, postnatal Lim1 expression is found in collecting ducts and cortical tubules 
but remains downregulated in mature glomeruli (Karavanov et al. 1998; Kobayashi et al. 2005). 
Lim-/- mice lack head structures and die at E10. However, some stillborn Lim1-/- pups were 
shown to not have developed kidneys (Shawlot and Behringer 1995). In addition, in E9.5 Lim1-
null mice, the expression of Pax2, an important transcription factor during nephrogenesis, is only 
found in the posterior region of the IM in comparison with wild type mice where Pax2 expression 
was demonstrated along the entire length of the IM (Tsang et al. 2000). 
Wnt signalling 
During metanephric development, Wnt signalling is observed at different stages of MM 
development and in ureteric buds (Maretto et al. 2003; Iglesias et al. 2007). Experiments in mice 
demonstrated that Wnt signalling can be observed in the nephric duct. However, by E16.5, it 
becomes restricted to the UB tips of branching UBs and the distal part of the S-shaped body. It 
has been demonstrated that in UB cells, the inactivation of β-catenin, which mediates Wnt 
signalling, impairs UB branching during nephrogenesis, and consequently, leads to lower 
numbers of nephrons and collecting ducts in kidneys of new born mice (Bridgewater et al. 2008). 
Wnt4 is a member of the Wnt gene family. During metanephric development it is expressed in 
condensed MM. Its expression persists in vesicles, C- and S-shaped bodies. Wnt4-deficient mice 
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develop small kidneys which are composed of undifferentiated MM and branches of collecting 
duct. Initial condensation of MM occurs in the Wnt4-deficient mice. However, no C-shaped and 
S-shaped bodies are detected in the E15 kidneys, while branching morphogenesis is preserved 
(Stark et al. 1994). The forced expression of Wnt4 in the NIH3T3 mouse embryonic fibroblast 
line was sufficient to elicit tubulogenesis in co-cultured MM. Accordingly, it has been shown that 
Wnt4 expression induces MM to condense, form epithelial structures and finally display 
glomeruli, similar as the induction with the spinal cord (Kispert et al. 1998). Another member of 
the Wnt family is Wnt9b, inactivation of which leads to renal agenesis in mice. Wnt9b is 
expressed in collecting ducts. Further studies on Wnt9b mutant mice demonstrated that Wnt9b is 
important for establishing planar cell polarity in the renal tubules (Karner et al. 2009). 
Pax2 
Pax2, a pair box gene, is expressed in the UB, condensing mesenchyme and developing nephrons 
(Dressler et al. 1990; Dressler and Douglass 1992). Experiments in mice showed that Pax2 can be 
detected also in adult kidney in the collecting duct cells. In addition, some cells in the inner 
medulla and thin descending limb of loop of Henle were also demonstrated to express Pax2 (Cai 
et al. 2005). Pax2-null mice lack kidneys. Accordingly, no Wolffian duct elongation is found at 
E10.5 and the parts of the Wolffian duct that form initially, subsequently degenerate in Pax2-
deficient mice at E12.5. In addition, no mesonephric tubules are detected in mutant embryos. 
Pax-2+/- mice develop hypoplastic kidneys with smaller calyces and a decreased number of 
developing nephrons (Torres et al. 1995). Pax2-deficient mutants do not express Gdnf (Brophy et 
al. 2001). 
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Wt1 
The Wilms' tumor gene, Wt1, encodes a transcription factor that plays a number of crucial roles 
throughout nephrogenesis, and ablation of Wt1 leads to renal agenesis (Kreidberg et al. 1993). 
Expression of Wt1 has been associated with both condensing mesenchyme and developing 
nephrons (Armstrong et al. 1993; Mundlos et al. 1993). Some Wt1 expression can be observed 
prior to the onset of nephrogenesis, both  in the IM and uninduced MM (Armstrong et al. 1993). 
During kidney development, Wt1 expression becomes restricted to the precursors of podocytes in 
the S-shaped bodies in both the metanephros and mesonephros. Wt1 expression persists in the 
podocytes throughout adulthood (Mundlos et al. 1993). In Wt1-deficient mice, fewer 
mesonephric tubules are detected. Further, at E11.5, the UB is absent in the mutant mice and the 
MM is undergoing apoptosis. Ultimately, at E12, the MM is completely degenerated (Kreidberg 
et al. 1993). Pax2, Six2 and Gdnf are however expressed in the MM of mutant embryos, 
suggesting that Wt1-deficient MM acquired already features of the nephrogenic lineage and 
possibly for this initial process, Wt1 is not required. Nevertheless, Wt1-deficient MM could not 
be induced by UB to undergo tubulogenesis in vitro (Donovan et al. 1999). 
Six2 
Six2 expression is found in the MM before UB invasion as well as the induced MM surrounding 
the UB. However, its expression is downregulated in cells undergoing subsequent mesenchymal-
to-epithelial transition. Inactivation of Six2 expression in mice leads at E11.5 to formation of 
premature renal vesicles surrounding the UB. Also, Six2-/- kidneys do not demonstrate branching 
of the UB (Self et al. 2006). Six2 regulates the expression of Gdnf in the MM (Brodbeck et al. 
2004). Ultimately, the Six2 expressing cells were shown to gives rise to all nephron-specific cell 
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types within the metanephros (Kobayashi et al. 2008).  
Osr1 
Osr1 is odd-skipped related 1 gene encoding a transcriptional regulator. The Osr1-expressing 
precursor population in the IM was shown to gives rise to most cells found within the developing 
metanephros, including the collecting duct epithelium, nephrons and interstitial mesenchyme, 
mesangial and smooth muscle cells. Still, it was demonstrated that Osr1-expressing precursors 
for nephron and interstitial mesenchyme separate before the start of metanephric development 
(Mugford et al. 2008). In E9.5 mice, Osr1 expression is present in intermediate and lateral plate 
mesoderm. Its expression is also found in undifferentiated mesonephric mesenchyme and tubules. 
At the onset of metanephric development, Osr1 is expressed in the MM but is absent in the UB. 
Later it is expressed in the condensing mesenchyme that surrounds the branching UB, but is 
down-regulated in pre-tubular aggregates, C-shaped and S-shaped bodies (James et al. 2006). 
Osr1-null mice lack kidneys as no MM and UB development occurs in the embryos (Wang et al. 
2005). No expression of Six2, Eya1, Gdnf, Pax2 and Sall1 was found in the metanephric region in 
the mutant mice (James et al. 2006).  
Eya1 
Eya1 is a homologue of the Drosophila eyes absent gene. Eya1 expression is first observed at 
around E8.5 in the intermediate mesoderm and subsequently becomes restricted to a region where 
the UB forms. During the early stage of metanephric development, Eya1 is expressed in both 
uninduced and induced MM but not in UB (Sajithlal et al. 2005). Eya1+/− mice were 
demonstrated to have renal defects, such as renal hypoplasia and unilateral agenesis, while 
Eya1−/− mice completely lacked kidneys and ureters (Xu et al. 1999). In the Eya1-deficient 
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mouse embryos, Ret expression is observed in the Wolffian duct but no UB outgrowth occurs 
(Sajithlal et al. 2005). Subsequently, in the absence of the UB, the MM undergoes apoptosis. 
Complete degeneration of the MM is observed by E12.5 (Xu et al. 1999). 
Hox11 paralogs 
Hox genes encode transcription factors that play an essential role in patterning of the body axes 
during embryonic development. As Hox11 paralogous genes are redundant, the knockouts of 
Hox11 result in incompletely penetrant phenotypes. Accordingly, Hoxa11/Hoxd11-deficient mice 
display hypoplastic kidneys, whereas Hoxa11/Hoxc11/Hoxd11-deficient mice completely lack 
kidneys. Accordingly, no UB formation is observed in triple mutants. This is accompanied by the 
lack of Six2 and Gdnf expression in the MM (Wellik et al. 2002). Hox11 paralogous proteins 
were demonstrated to form a complex with Pax2 and Eya1, which activates the expression of 
Six2 and Gdnf in the MM (Gong et al. 2007). 
Notch2 signalling 
Notch genes encode single-transmembrane receptors. It has been demonstrated that disruption of 
Notch2 receptor expression in the metanephric mesenchyme disrupts nephrogenesis. 
Accordingly, Notch2-deficient mice at birth displayed smaller kidneys with no glomeruli or 
proximal tubules. The mutant mice demonstrated normal condensation of MM and subsequent 
transition to epithelium, however no segmentation of the nephron into proximal and distal tubules 
occurred in the kidneys (Cheng et al. 2007). 
Bmp4 
Like Gdnf, bone morphogenetic protein 4 (Bmp4) is a member of the TGF-β superfamily. At 
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E12.5 Bmp4is expressed in the stromal mesenchymal cells. In addition, at E14.5, expression is 
seen in the S-shaped bodies. The Bmp receptor gene, Alk3, is ubiquitously expressed during 
kidney development, while Alk6 is expressed in the Wolffian duct and in UBs. Bmp4+/- mice 
display renal abnormalities similar to human congenital anomalies of the kidney and urinary tract 
(CAKUT), categorized as dysplastic kidneys, hydronephrosis or duplex kidney with bifid ureters 
(Miyazaki et al. 2000). In vitro it was demonstrated that Bmp4 promotes growth and elongation 
of UBs, but also inhibits condensation of MM and promotes expansion of the peripheral stromal 
compartment (Miyazaki et al. 2000; Raatikainen-Ahokas et al. 2000; Miyazaki et al. 2003).  
Bf2 
Brain factor 2, Bf2, (Foxd1) encodes a transcription factor expressed in stromal cells that in 
mouse kidneys at E11.5 form a ring of stromal mesenchyme around the Pax2 positive 
nephrogenic mesenchyme. Later, Bf2 expression is found in cells surrounding the condensing 
MM and at the periphery of the kidney rudiment. Mice carrying a Bf2-null mutation show 
abnormalities in development of both the collecting duct system and nephrons. The number of 
nephrons is reduced, as large amounts of condensing mesenchyme are still present in the kidneys 
at birth. Further, the number of UB branches is diminished. The expression of Ret in mutant 
kidneys is not restricted to UB tips in the cortex, as it is in wild type E14.5 kidneys, but is found 
along the branches in both cortical and medullary regions (Hatini et al. 1996).  
Rarβ2 
Retinoid acid receptor β 2 (Rarβ2) expression is found in mouse metanephroi as early as E11. 
Rarβ2 is associated with stromal cells surrounding the UB and MM, where its expression co-
localizes with the other stromal marker, Bf-2. During the later stages of nephrogenesis, Rarβ2 is 
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expressed in stromal cells found in the developing cortex and medulla. It is also expressed in the 
subcapsular region, again co-localizing with Bf2 (Mendelsohn et al. 1999). In mice lacking Rarβ2 
along with other retinoid acid receptors, Rarα1 and Rarα2, the kidneys at birth display 
diminished numbers of nephrons and UB branches (Mendelsohn et al. 1994). It has been 
demonstrated that in these mutant kidneys, starting from E12, Ret expression in the UB tips is 
downregulated, leading to reduced UB branching. Furthermore, the stromal cells are abnormally 
distributed, forming a thick peripheral stromal layer in the E14 mutant kidneys (Mendelsohn et 
al. 1999). 
1.2.3.5. Metanephric kidney as a model for in vitro nephrogenesis 
Metanephric kidney is good model for studying in vitro nephrogenesis. For in vitro culture, 
metanephric kidneys can be obtained from mouse embryos at E10.5 when the UB has just 
invaded the MM, or at E11.5 when the UB has branched once. Following isolation, the kidney 
rudiments are cultured at the gas/medium interface. For this reason, the embryonic kidneys are 
placed on a filter supported by a metal grid which is submerged in growth medium (Davies 
2010). After 4 to 5 days, the in vitro cultured E11.5 rudiment reaches a similar development stage 
as the E14 metanephros (Vize Peter 2003). The rudiments can be also cultured on a glass surface 
in the presence of a low volume of medium. One of the advantages of this culture method is the 
fact that the metanephroi develop a clear anatomical cortico-medullary zonation with extended 
loops of Henle (Sebinger et al. 2010). In addition, it is possible to trigger in vitro the development 
of MM into nephrons in the absence of the UB. It has been shown that spinal cord induces MM 
development similar to UB (Davies 2010). 
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1.3. Mesenchymal stem cells and their role in kidney repair and regeneration 
1.3.1. Characteristics of mesenchymal stem cells 
Mesenchymal stem cells (MSCs) are described as an adult stem cell population that possesses the 
capability to highly proliferate in vitro and differentiate into multiple lineages. They were 
initially isolated by Friedenstein (Friedenstein et al. 1974) who has shown that bone marrow 
contains an adherent heterogeneous fraction of cells with the ability to rapidly multiply and 
differentiate (Prockop 1997). Although MSCs have been demonstrated to primarily give rise to 
fat, bone and cartilage (Pittenger et al. 1999; Peister et al. 2004), there exist reports describing a 
much broader differentiation potential of the cells, such as myogenic (Dezawa et al. 2005), 
neuronal (Woodbury et al. 2000) and pancreatic lineages (Xie et al. 2009). Furthermore, the 
plasticity of MSCs is accompanied by immunosuppressive properties of the cells (Le Blanc and 
Ringden 2007). The following characteristics have been proposed as the minimal criteria for 
identification of human MSCs: plastic adherence, expression of surface markers such as CD105, 
CD73 and CD90, as well as adipogenic, osteogenic and chondrogenic differentiation potential 
(Dominici et al. 2006). In addition, since bone marrow-derived MSCs are commonly isolated by 
their ability to adhere to plastic culture dishes, the presence of contaminating hematopoietic cells 
in such cultures has been documented (Phinney et al. 1999). For this reason, negative selection 
using immunodepletion of cells expressing hematopoietic markers, such as CD45, is employed in 
order to enrich the cultures for MSCs (Baddoo et al. 2003). Although bone marrow is commonly 
described as a niche for MSCs, it is possible to establish MSC cultures from various other tissues 
and organs, like lung or kidney. These cells share common MSC features although their 
differentiation capabilities may differ depending on the source of isolation (da Silva Meirelles et 
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al. 2006; Kern et al. 2006). Recently, it was shown that MSCs could be obtained from different 
foetal tissues. Accordingly, it was possible to establish human MSCs from foetal bone marrow, 
lung or liver (Campagnoli et al. 2001; in 't Anker et al. 2003). 
It is important to note that for both mouse and human bone marrow-derived MSCs, 
subpopulations with higher plasticity have been isolated (Kucia et al. 2006; Anjos-Afonso and 
Bonnet 2007). Mouse bone marrow-derived MSCs capable of differentiation into all three germ-
layer lineages are named very small embryonic-like (VSEL) stem cells. These cells resemble 
embryonic stem cells in their morphology and express embryonic stem cell markers, such as 
Oct4, SSEA-1 and Nanog (Kucia et al. 2006). A similar subpopulation of cells has been 
described by Anjos-Afonso and Bonnet, who called these cells the most primitive mesenchymal 
progenitors in the adult murine bone marrow compartment (Anjos-Afonso and Bonnet 2007). In 
humans, bone marrow-derived MSCs that maintain the ability to proliferate rapidly and 
differentiate into a wide range of lineages, among them neurons and pancreatic islet cells, have 
been named marrow-isolated adult multilineage inducible cells (MIAMI) (D'Ippolito et al. 2004).  
1.3.2. Mesenchymal stem cells in kidney disease 
In the literature, there are a number of reports showing the existence of extra-renal cells within 
the kidney (Ito et al. 2001; Poulsom et al. 2001; Gupta et al. 2002). The presence of male 
extrarenal cells in male patients receiving transplantation of female kidneys was established by 
some authors (Poulsom et al. 2001; Gupta et al. 2002). Subsequent results demonstrated that 
these cells could originate from the bone marrow. Accordingly, experiments in mice showed that 
the kidneys of female recipients of male bone marrow contained male cells within the renal 
tubules and glomeruli (Poulsom et al. 2001). A similar experiment was performed in rats: 
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labelled rat bone marrow was transplanted into irradiated recipient rats, and following, the 
induction of glomerulonephritis, the labelled bone marrow-derived cells were found in the 
glomeruli of injured rats and were described to provide structural support for glomerular 
capillaries (Ito et al. 2001). Others showed that wild type bone marrow cells injected into 
collagen type IV α3 knockout mice with progressive glomerulonephritis (a model of Alport 
syndrome), resulted in improved renal histology and function (Prodromidi et al. 2006). From this 
study, as well as from other studies, it was not entirely clear which bone marrow-derived 
population, i.e., the MSCs or the hematopoietic stem cells (HSCs), was responsible for the 
positive outcome. Subsequently, many authors concentrated on evaluating the contribution of 
bone marrow-derived MSCs to renal regeneration and it was demonstrated that MSCs can indeed 
protect mice from tubular damage and renal function deterioration in various experimental 
models of acute renal injury (Herrera et al. 2004; Morigi et al. 2004; Togel et al. 2005; Bi et al. 
2007; Semedo et al. 2007; Togel et al. 2007; Qian et al. 2008; Li et al. 2010). Some of the data 
suggested also that MSCs are able, at least to some extent, to engraft into damaged kidneys and 
differentiate towards tubular cells (Herrera et al. 2004; Morigi et al. 2004; Qian et al. 2008; Li et 
al. 2010).  
As demonstrated by Morigi et al., mouse bone morrow-derived MSCs injected into mice 24h 
after induction of acute renal injury following subcutaneous injection of cisplatin, improved renal 
function, as well as prevented tubular damage at the peak of cisplatin injury at day 4. In addition, 
MSC administration was demonstrated to induce proliferation of tubular cells in cisplatin-treated 
mice. Furthermore, injected MSC were found in the proximal and distal tubules kidneys of 
cisplatin-treated animals. The MSCs engrafted among tubular cells and accordingly, stained with 
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Lens culinaris lectin, which binds to the brush border of the tubular epithelium. Even 29 days 
after the injury, the cells were still detected within the tubular epithelium. In the same study it 
was also demonstrated that administration of HSCs does not protect mice from renal function and 
tissue damage in the cisplatin-induced injury model. Nevertheless, occasional engraftment of 
HSCs into injured tubules was observed (Morigi et al. 2004). More recently, Morigi and the co-
workers demonstrated the effectiveness of human cord blood-derived MSCs in ameliorating 
cisplatin-induced kidney injury. MSCs were injected into severe combined immunodeficiency 
(SCID) mice following cisplatin treatment. At the peak of injury the tubular damage was reduced 
in the kidneys of animals receiving MSCs. Importantly, the injection of the cells was able to 
improve the survival of cisplatin-treated mice. Consequently, MSCs were demonstrated to inhibit 
cisplatin-induced damage by reducing oxidative damage and apoptosis in the kidneys of 
cisplatin-treated animals. The injured kidneys receiving MSCs also demonstrated an increase in 
tubular cell proliferation, as well as having a high number of tubules positive for the 
serine/threonine protein kinase Akt, which mediates anti-apoptotic effects. Additionally, the 
injured kidneys treated with MSCs showed up-regulation in expression of hepatocyte growth 
factor, a factor responsible for anti-apoptotic effects during kidney injury. Nevertheless, 
regarding the engraftment and differentiation potential of human MSCs in the injured renal 
tissue, the cells were mainly found in the peritubular areas and only rarely engrafted in the 
tubules or glomeruli (Morigi et al. 2010). 
The data obtained in cisplatin-induced injury were confirmed in the model of glycerol-induced 
acute renal failure, where enhanced functional and structural recovery was accompanied with 
engraftment of MSCs into the injured tubules (Herrera et al. 2004; Qian et al. 2008). 
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Accordingly, Herrera et al. investigated the effect of administration of mouse bone morrow-
derived MSCs in acute injury induced by intramuscular injection of glycerol in the mice. 
Similarly as in the cisplatin model, MSCs were demonstrated to increase tubular cell 
proliferation. Furthermore, MSCs were detected in the tubular epithelium of glycerol injured 
kidneys expressing cytokeratin, suggesting that some of the MSCs were possibly differentiating 
into tubular epithelial cells (Herrera et al. 2004). Others demonstrated that human foetal bone 
marrow-derived MSCs administrated into rats with glycerol-induced acute renal failure enhanced 
tubular cell proliferation, which was accompanied by engraftment of MSCs into injured tubules. 
Consequently, the integrated cells acquired expression of aquaporin-1 and parathyroid hormone 
receptor 1 as well as stained positively for cytokeratin, suggesting epithelial differentiation of 
engrafted MSCs (Qian et al. 2008).  
Interestingly, it has been observed that following intravenous injection, MSCs homed to the 
kidney of mice with induced renal injury; however, they failed to localize to the kidneys of 
uninjured mice (Herrera et al. 2004). Subsequently, efforts have been made to elucidate the 
mechanism underlying homing of MSCs into injured kidneys. Some results suggest that the 
homing to injured tissues depends on chemotactic factors. MSCs migrate in vitro in response to 
some growth factors, such as platelet-derived growth factor (PDGF)-AB and insulin-like growth 
factor-1. In addition, pre-treatment with inflammatory cytokines, such as the tumor necrosis 
factor-α (TNF-α), enhances MSC migration. Also, an increase in migration of the cells towards 
chemokines, like stromal-derived factor-1, upon stimulation with TNF-α has been described 
(Ponte et al. 2007). In the model of glycerol-induced acute renal failure it was shown that the 
interaction between CD44, expressed on MSCs, and its ligand, hyaluronic acid, is responsible for 
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localization of the cells to the injury site. Accordingly, CD44-positive MSCs were detected in the 
peritubular capillaries and interstitium in kidneys of glycerol-treated mice, whereas only rarely, 
CD44-negative MSCs were found in the renal tissue of injured animals (Herrera et al. 2007). In 
the same study it was demonstrated that CD44-positive MSCs were also present to some extent in 
glomeruli and within the tubular epithelium (Herrera et al. 2007). 
Other reports have shown renoprotective effects of MSC administration in the ischemia-
reperfusion model of acute kidney injury (Togel et al. 2005; Semedo et al. 2007; Togel et al. 
2007; Li et al. 2010). For instance, Togel and co-workers demonstrated that injection of rat bone 
marrow-derived MSCs into the carotid artery in the ischemia-reperfusion model in rats improves 
renal function. In addition, the injured kidneys of animals receiving MSCs showed higher tubular 
cell proliferation and less apoptosis in comparison with injured kidneys of animals receiving no 
MSCs. After administration of rat MSCs, the injured kidneys also showed reduced  expression of 
the pro-inflammatory cytokines, TNF-α and interleukin-1β, and an increase in expression of the 
anti-inflammatory molecule, interleukin-10. Furthermore, no MSCs were identified in the injured 
kidneys after 3 days from administration of the cells, strongly suggesting a differentiation-
independent mechanism of MSC action (Togel et al. 2005).  
MSCs were demonstrated to also have some renoprotective action in the experimental model of 
glomerulonephritis. Accordingly, rat bone marrow-derived MSCs were injected into the renal 
artery of rats with mesangioproliferative anti-Thy1.1 glomerulonephritis. Following injection, the 
cells were detected in glomeruli. Accordingly, MSC administration led to a reduction of 
mesangiolysis and increased intra-glomerular and glomerular cell proliferation. Most of the 
MSCs found in the glomeruli, however, did not express the endothelial marker, JG12, or the 
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mesangial marker, α-smooth muscle actin (α-SMA). In addition, MSCs were found in vitro to 
secrete high amounts of vascular endothelial growth factor and transforming growth factor-β1 
(Kunter et al. 2006). Similar results were observed in a progressive rat model of 
glomerulonephritis. In this model, anti-Thy1.1 mesangioproliferative glomerulonephritis was 
induced after a right-sided uninephrectomy. Following the injury, rat MSCs were injected intra-
arterially into the left kidney. After administration, MSCs localized to glomeruli and ameliorated 
acute renal failure by enhancing the functional recovery. In addition, more glomeruli were 
counted in kidneys of animals receiving MSCs following the injury (Kunter et al. 2007). 
Ultimately, MSCs derived from adipose tissue were used in kidney injury models to test their 
contribution to regeneration. Mouse adipose-derived MSCs were injected in mice following 
cisplatin-induced renal injury. Subsequently, the cells were shown to increase functional and 
structural recovery and improve the survival of injured animals in a similar manner as bone 
marrow-derived MSCs. Interestingly, despite the renoprotective effect, no cells were found 
engrafted into the renal tissue in this study (Bi et al. 2007). On the other hand, human adipose-
derived MSCs were demonstrated to engraft into the renal tubular epithelium, replacing dead 
tubular cells in mice with induced ischemia–reperfusion injury:  in this study, it appeared that the 
MSCs, helped maintain the structural integrity of the damaged tubules, facilitating regeneration 
(Li et al. 2010). 
1.3.3. Mesenchymal stem cells kidney specific kidney differentiation in vitro 
Some reports have suggested that MSCs can also be differentiated directly towards kidney-
specific cell types in vitro (Qian et al. 2008; Singaravelu and Padanilam 2009; Matsushita et al. 
2010). Rat bone marrow-derived MSCs were reported to acquire expression of aquaporin-1 
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(AQP1) following in vitro co-culture with glycerol-injured rat kidney tissue. MSCs were 
indirectly co-cultured for up to 7 days with injured kidney tissues obtained from rats that 
underwent glycerol-induced kidney injury 48 h before the co-culture. Accordingly, MSCs 
became more rounded, and thus morphologically, became more similar to renal tubular epithelial-
like cells and started to express AQP1. The analysis showed also that MSCs were induced to 
express high levels of cytokeratin when incubated with injured tissue (Qian et al. 2008). 
Similarly, it was shown that co-culture with injured cortical tubular epithelial cells induced 
mouse MSCs to acquire a tubular epithelial-like phenotype and express AQP1 and kidney-specific 
cadherin (Singaravelu and Padanilam 2009). It has been also described that MSCs can acquire a 
phenotype similar to juxtaglomerular cells which are specialized renal endocrine cells that 
express renin. As the expression of renin is regulated by the nuclear hormone receptor, liver X 
receptor-α (LXR-α), the treatment with 22-hydroxycholesterol or cyclic adenosine 
monophosphate (cAMP), which are the natural ligands for LXR-α, was demonstrated to increase 
the expression of renin in both mouse and human bone marrow-derived MSCs. In addition, 
stimulation with a synthetic ligand for LXR-α resulted in a significant increase in renin 
expression in the studied cells. Furthermore, mouse MSCs over-expressing the liver X receptor-α, 
were shown to produce, accumulate and subsequently release renin into the culture medium 
(Matsushita et al. 2010).  
Finally, an MSC-like population obtained from human glomeruli was demonstrated to 
differentiate into kidney-specific cell types upon stimulation. Accordingly, in the presence of 
PDGF-BB and TGF-β1, the cells acquired a mesangial-like phenotype, characterized by the 
expression of α-smooth muscle actin (α-SMA) and angiotensin II receptor 1. Furthermore, they 
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were shown to contract in response to simulation with angiotensin II. On the other hand, in the 
presence of all-trans retinoic acid, MSCs were demonstrated to express cytokeratin as well as 
podocyte-specific markers such as podocin, nephrin and synaptopodin (Bruno et al. 2009). 
1.3.4. Mesenchymal stem cells in nephrogenesis 
The expression of the following  early kidney markers was recently confirmed in primary mouse 
bone marrow-derived MSC: Eya1, Six2, Osr1, cadherin 11, Gdnf, Wnt4 and Bf2 (Lusis et al. 
2010). The first attempt to introduce MSCs into embryonic kidney in order to evaluate the 
contribution of MSCs  to kidney development was made by Yokoo and co-workers (Yokoo et al. 
2005). Human bone marrow-derived MSCs were injected into the IM of rat embryos at the site of 
nephrogenesis before the initiation of metanephric development. Subsequently, the embryos were 
cultured for 48 h ex utero, followed by the isolation of metanephroi and further in vitro culture of 
kidney rudiments harbouring MSCs for another 6 days. Figure 1.7 illustrates briefly the technique 
used by Yokoo and co-workers. Using this system, human MSCs were shown to contribute to the 
development of both the glomerular and tubular epithelium, as well as the interstitium of 
metanephric kidneys. Two genes expressed during early ureteric bud and nephron development, 
Kir6.1 and SUR2, were initially detected in human MSCs prior to their integration into kidney 
rudiments (Yokoo et al. 2005). Integration of human MSCs into renal structures was 
accompanied by expression of the podocyte-specific genes, nephrin, podocin and glomerular 
epithelial protein 1, and tubular epithelial cell-specific markers, AQP1, 1α hydroxlyase, 
parathyroid hormone receptor 1 and HCO3- co-transporter (Yokoo et al. 2005; Yokoo et al. 
2006). Moreover, the metanephroi containing integrated human MSCs were transplanted into the 
omentum of recipient rats and after 2 weeks became vascularised and were able to produce fluid 
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similar to urine (Yokoo et al. 2006). Importantly, in order to increase the number of MSC-derived 
renal structures, in all experiments, human MSCs were transduced with a virus encoding human 
GDNF (Yokoo et al. 2005; Yokoo et al. 2006). At the same time it has been shown that simple 
injection of human MSCs into an isolated kidney rudiment followed by in vitro culture for 6 days 
is insufficient to trigger differentiation of the cells, as the MSCs remained aggregated, did not 
disperse and consequently did not form any recognizable renal structures. MSCs also failed to 
express kidney specific genes (Yokoo et al. 2005). Experiments performed by Yokoo et al. led to 
the conclusion that MSCs can be reprogrammed towards nephron-specific cell types when put 
into an appropriate embryonic environment (Yokoo et al. 2005; Yokoo et al. 2006).  
 
Figure 1.7 Technique used by Yokoo and co-workers to integrate successfully human MSCs into rodent 
metanephric kidneys  
Efforts have also been made using a similar methodology described by Yokoo et al. to induce 
human MSCs to take part in the formation of the kidney collecting duct system (Fukui et al. 
2009). Consequently, human bone marrow-derived MSCs expressing chicken Pax2 were 
transplanted into the region of the chicken embryo that was described to contain collecting duct 
progenitors. Human MSCs transfected with chicken Pax2 acquired expression of SALL1 and 
WNT4, and 24h following transplantation, were shown to migrate along the elongating Wolffian 
Gdnf transduction  
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duct. Subsequently, on the 2nd day following transplantation, integration of human cells into the 
duct epithelia occurred accompanied by the acquisition of LIM1 expression by the cells. In these 
experiments, although MSCs were demonstrated to integrate into the Wolffian duct, at the same 
time, it was shown that they were unable to incorporate into the ureteric bud, which gives rise 
directly to the collecting ducts of the adult kidney (Fukui et al. 2009). 
In addition, Yokoo and co-workers administered human MSCs, using the methodology earlier 
described (Figure 1.7), into Fabry mice which accumulate glycosphingolipids in the kidneys due 
to lack of α-galactosidase A enzyme. Accordingly, analysed metanephroi harbouring engrafted 
human MSCs showed increased α-galactosidase A enzyme activity compared with untreated 
metanephroi. This was accompanied by a marked reduction in the levels of glycosphingolipids in 
ureteric buds and S-shaped bodies in the metanephric kidneys containing human MSCs (Yokoo et 
al. 2005). Furthermore, human MSCs isolated from foetal blood were transplanted into the 
offspring of pregnant mice carrying a deletion in the alpha2 chain of the procollagen type I gene 
(Guillot et al. 2008). The transplantation was performed intra-peritoneally in utero at embryonic 
day (E) 13.5-15. Mice harbouring this defect were shown previously to display skeletal fragility 
as well as developing glomerulopathy due to deposition of abnormal homotrimeric collagen type 
I in the kidneys. Accordingly, injected human MSCs were found engrafted into the foetal 
glomeruli, localizing among mesangial cells, in the offspring of colIα2-deficient mice analysed 
between 1-12 weeks of age. The injection of human MSCs was shown to reduce the occurrence 
of abnormal collagen depositions in renal glomeruli in the offspring of colIα2-deficient mice. In 
addition, the presence of the α2 chain of type I collagen was detected in the kidneys (Guillot et al. 
2008). Nevertheless, it is important to mention that transplantation of human MSCs into wild-
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type animals, without any defects, did not result in the engraftment of the cells. This result 
highlights again the essential role of renal injury for homing and engraftment of MSCs in the 
kidneys (Guillot et al. 2008). 
1.3.5. Controversies regarding the renoprotective and renogenic action of mesenchymal 
stem cells 
Observations made by several groups highlighted the potential role of bone marrow cells in renal 
regeneration (Ito et al. 2001; Poulsom et al. 2001; Gupta et al. 2002; LeBleu et al. 2009). 
However, at least two populations found in the bone marrow, namely the MSCs and HSCs, may 
be involved in the regeneration. According to data presented by Morigi et al., MSCs have the 
potential to engraft in the proximal and distal tubules and ameliorate kidney injury in the 
cisplatin-induced kidney injury, while HSCs demonstrate only occasional engraftment into 
injured tubules and no renoprotective capacity. Contradictory results were published by Fang et 
al., comparing the engraftment potential of MSCs and hematopoietic lineage marrow cells in 
HgCl2-induced acute tubular injury in mice. Upon injury, mouse hematopoietic cells were found 
in renal tubules, while mouse MSCs only occasionally engrafted into the interstitium of the 
injured kidneys (Fang et al. 2008). The differences discussed above could arise due to dissimilar 
approaches used to induce kidney injury, like cisplatin and HgCl2 (Fang et al. 2008). It is also 
worth mentioning that different MSC populations were injected in both studies. Morigi et al. used 
short-term cultures of MSCs still harbouring CD45-positive contaminating hematopoietic cells, 
while Fang et al. administered cells obtained from a long-term culture of MSC containing no 
CD45-positive cells (Morigi et al. 2004; Fang et al. 2008).   
In summary, the renoprotective effects of MSCs in kidney injury have been confirmed; however, 
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not all authors could demonstrate the engraftment of MSCs into renal structures, as observed by 
Morigi et al. and Herrera et al. (Herrera et al. 2004; Morigi et al. 2004). In contrast, there is a vast 
body of evidence showing a differentiation-independent action of MSCs in experimental models 
of acute kidney injury and it appears that the paracrine activity of MSCs plays the major role in 
achieving the enhanced recovery from kidney injury (Togel et al. 2005; Bi et al. 2007; Imberti et 
al. 2007; Semedo et al. 2007; Togel et al. 2007; Togel et al. 2009). Accordingly, it has been 
demonstrated that injection of rat bone marrow-derived MSCs in the model of ischemia-
reperfusion acute renal failure was able to improve renal function, despite that only a small 
number of MSCs was detected in the injured renal tissue (Togel et al. 2005). Furthermore, it has 
been shown that injection of conditioned medium derived from mouse MSCs is able, in a similar 
manner as the injection of the cells, to reduce kidney injury in cisplatin-induced acute renal 
failure. These results were also repeated in an in vitro model where conditioned medium derived 
from mouse MSCs was shown to increase the survival of immortalized mouse proximal tubule 
cells treated with cisplatin (Bi et al. 2007). Subsequently, some factors secreted by MSCs were 
identified that mediate the enhanced recovery, like the insulin-like growth factor-1 (IGF-1) and 
vascular endothelial growth factor (VEGF) (Imberti et al. 2007; Togel et al. 2009). Both were 
confirmed to be present in conditioned medium of MSCs (Kunter et al. 2006; Togel et al. 2007). 
Accordingly, the inhibition of VEGF expression in rat bone marrow-derived MSCs resulted in 
reduced functional renal recovery following ischemia-reperfusion injury (Togel et al. 2009). In 
addition, the inhibition of IGF-1 expression in mouse bone marrow-derived MSCs led to lower 
renoprotective potential of the cells following cisplatin-induced injury (Imberti et al. 2007). 
Furthermore, a recent study demonstrated poor survival of MSCs during acute kidney injury. Rat 
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bone marrow-derived MSC were injected intravenously into rats following ischemia-reperfusion 
injury. The analysis revealed that 1 h after injection, most of the cells were trapped in the lung or 
liver, and only very few cell could be detected in the injured kidney, where they were detected 
only in the tubulointerstitial areas. No beneficial effect of MSC administration on renal function 
was observed. Direct injection of MSCs into the renal parenchyma did result in higher numbers 
of cells detected in the injured kidneys and improved renal function in the injured animals. Still, 
MSCs were unable to repopulate the kidney in the longer term. In addition, many cells were 
found in the lungs or liver. The authors of this study conclude that the type of renal injury model 
might have an impact on the engraftment potential of the cells (Burst et al. 2010). Similar 
observations were made by Ninichuk et al. who found that while the administration of mouse 
bone-marrow MSCs reduced fibrosis, it did not protect mice lacking collagen type IV α-3 from 
renal failure (Ninichuk et al. 2006).  
Finally, as demonstrated by Kunter et al., administration of MSCs in the rat model of progressive 
glomerulonephritis results in short-term renoprotective effects, but in the long-term, has a 
detrimental effect on the kidneys (Kunter et al. 2007). Accordingly, injured kidneys receiving 
MSCs expressed significantly more collagen types I, III, and IV and α-SMA, 60 days after the 
onset of injury, suggesting a fibrotic response in MSC-treated kidneys. Furthermore, at day 60, 
adipocyte-like cells were detected in about 20% of the glomeruli of MSC-treated kidneys. The 
vacuoles present in these cells stained with Oil Red O which detects intracellular lipid droplets 
normally observed in adipocytes. Importantly, these cells contained the fluorescent marker used 
for tracking MSCs, strongly suggesting that the cells were MSCs that had differentiated towards 
the adipogenic lineage. The areas containing adipocyte-like cells were surrounded by a matrix 
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containing collagen types I, III, IV and cells expressing α-SMA as well as by some 
monocytes/macrophages (Kunter et al. 2007).  
1.4. Other stem cells/progenitors in kidney repair and regeneration 
In the section 1.3 the characteristics of MSCs and as well as their kidney regenerative potential 
have been discussed. MSCs are an adult stem cell population, similarly as hematopoietic stem 
cells, and therefore they have only a limited differentiation potential. On the contrary, other stem 
cell type the embryonic stem cells (ESCs) are pluripotent. They possess the capacity to 
differentiate into all three embryonic germ layers. Although ESCs seem to be an ideal tool for 
regenerative approaches, there are several essential issues associated with the use of the cells for 
the purpose of regenerative medicine, such as the ethical considerations, as a therapy involving 
human ESCs would implicate destruction of human embryos. Except ethical issues, ESCs were 
found to form tumours when transplanted in vivo. Therefore only already committed populations 
of differentiated ESCs might be used for clinical applications. Further, differently as in case of 
MSCs that have low immunogenicity, transplantation of ESCs into patients would need to be 
accompanied by immunosuppression (Brignier and Gewirtz 2010). As demonstrated by 
Nussbaum et al transplantation of mouse allogeneic ESCs in the heart not only resulted in 
formation of teratomas but also triggered an immune response against the cells. The authors 
suggested that the immunogenicity of the ESCs derived cells increases in presence of 
inflammatory cytokines (Nussbaum et al. 2007). Except ESCs there exists another source of 
pluripotent cells that might be used in the future for therapy, namely the induced pluripotent stem 
cells (iPSCs). These cells display similar characteristics to ESCs but are created from somatic 
cells by transfer of particular genes. In this case it is possible to obtain patient specific cells with 
 38 
high differentiation potential (Brignier and Gewirtz 2010). Nevertheless, it has been 
demonstrated that also iPSCs might have immunogenic potential in vivo (Zhao et al. 2011). 
Recently, a new population of stem cells has been identified, namely the amniotic fluid stem cells 
(AFSCs). AFSCs are a stem cell population that combines the features of embryonic and adult 
stem cells. The undifferentiated cells expand extensively and can be induced to differentiate 
towards several lineages, including the neuronal, hepatic and osteogenic lineages (De Coppi et al. 
2007).Accordingly other stem cell/progenitor populations were demonstrated to be involved the 
enhanced recovery in models of acute renal injury, similarly as it has been described for MSCs 
(Bussolati et al. 2005; Dekel et al. 2006; Gupta et al. 2006; Sagrinati et al. 2006; Hauser et al. 
2010; Lee et al. 2010). Similarly, other stem cell/progenitor types were shown to have potential 
to contribute to metanephric development following injection into kidney rudiments (Kim and 
Dressler 2005; Steenhard et al. 2005; Challen et al. 2006; Maeshima et al. 2006; Perin et al. 2007; 
Vigneau et al. 2007). In the following sections, a brief summary is given of the outcomes of 
administration of other stem cells and progenitors in the models of acute renal injury, and their in 
vitro differentiation potential towards renal cell types. Table 1.1 summarizes different 
methodologies used to assess the renogenic potential of progenitors, including MSCs, in the 
metanephric environment.  
1.4.1. Kidney progenitors 
Multipotent renal progenitor cells (MRPC) were isolated from adult rat kidneys. When MRPC 
were injected into the kidneys of rats with ischemia-reperfusion injury, they became incorporated 
into renal tubules in the cortex and outer medulla and expressed the proximal tubule marker, 
Phaseolus vulgaris erythroagglutinin, and the distal tubule marker, peanut agglutinin, as well as 
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the epithelial cell marker, zona occludens-1 (ZO-1). In addition, when injected under the capsule 
of rat kidneys, undifferentiated MRPC were shown to form nodules and cyst-like structures, and 
integrated into the renal tubules and formed multiple tubular-like structures. It has also been 
attempted to differentiate MRPC toward a renal cell lineage using a combination of fibroblast 
growth factor 2, TGF-β and leukaemia inhibitory factor. Under these conditions, the cells started 
to grow in aggregates and express cytokeratin and ZO-1 (Gupta et al. 2006). Another renal 
progenitor population that was demonstrated to engraft into damaged kidneys was derived from 
the adult mouse. These cells were shown to express the stem cell antigen-1 (Sca-1) and lacked 
CD45 expression. Also, the Sca-1+CD45- population was demonstrated to incorporate into renal 
tubules in mice in the ischemia-reperfusion injury model (Dekel et al. 2006). Direct injection of 
other murine progenitors, such as mouse kidney progenitor cells (MKPC), was demonstrated to 
protect mice with ischemia-reperfusion renal injury from the renal function deterioration and to 
improve renal structure following the injury. In consequence, the mice with renal injury that 
received MKPC survived longer then untreated mice. Ultimately MKPC after injection into the 
medulla of normal mice were found incorporated into vessels and capillaries as well as into distal 
tubules and Henle’s loop expressing Tamm-Horsfall glycoprotein (THP) (Lee et al. 2010).  
Several groups have demonstrated the significance of a renal progenitor population expressing 
the CD133 antigen in the amelioration of acute kidney injury and in vitro differentiation 
(Bussolati et al. 2005; Sagrinati et al. 2006; Lazzeri et al. 2007; Ronconi et al. 2009). 
Accordingly, human CD133-positive renal progenitors derived from the cortex of normal human 
kidney were injected into mice with glycerol-induced acute kidney injury. The cells were found 
in the proximal and distal tubules of injured kidneys where they expressed the epithelial marker, 
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cytokeratin. In addition, the CD133-positive cells were shown to undergo in vitro epithelial 
differentiation upon stimulation with hepatocyte growth factor (HGF) and fibroblast growth 
factor-4, as the cells started to express cytokeratin, E-cadherin and ZO-1, as well as renal markers 
such as alkaline phosphatase, amino peptidase A, normally found in proximal tubular epithelial 
cells, and the thiazide-sensitive NaCl co-transporter present in distal tubular epithelial cells. 
When injected into severe combined immunodeficiency (SCID) mice, they also showed 
spontaneous in vivo differentiation towards tubular epithelia, characterized by the formation of 
tubular-like structures with a lumen harbouring cells that display short microvilli and tight 
junctions, and accompanied by the expression of cytokeratin, thiazide-sensitive NaCl co-
transporter and alkaline phosphatase (Bussolati et al. 2005). Sagrinati et al. demonstrated that 
CD24+133+ human adult stem cells derived from the Bowman’s capsule can ameliorate glycerol-
induced kidney injury and subsequently engraft into both proximal and distal tubules following 
injury. Differentiation towards tubular cells was accompanied by the acquisition of the expression 
of alkaline phosphatase and THP as well as the up-regulation of other renal markers like 
aminopeptidase A, AQP1, AQP3, and the thiazide-sensitive Na/Cl transporter. Finally, the 
tubular-like cells also acquired the ability to respond to angiotensin II with intracellular calcium 
influx (Sagrinati et al. 2006). Correspondingly, the behaviour of adult human CD133+CD24+ cells 
derived from the Bowman’s capsule was assessed in a model of adriamycin-induced renal injury 
in mouse. The administration of the cells led to enhanced functional and structural recovery of 
the injured kidneys. Accordingly, the cells were present in glomerular structures, expressing the 
podocyte-specific markers synaptopodin, WT1, nephrin, and podocin, as well tubules expressing 
binding sites for Lotus tetragonolobus agglutinin (LTA), a marker for proximal tubules. 
Furthermore, CD133+CD24+ cells were differentiated in vitro towards the tubular lineage using 
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HGF, and towards the podocyte lineage using vitamin D3 and retinoic-acid. Accordingly, tubular 
differentiation resulted in the acquisition of binding of LTA as well as up-regulation of the 
expression proximal tubule-specific genes, including aminopeptidase A, aquaporin-1, aquaporin-
3, and thiazide-sensitive Na/Cl transporter. At the same time, following podocyte differentiation, 
the cells started to express podocyte markers like nephrin, WT1, synaptopodin and podocin 
(Ronconi et al. 2009). Finally, a similar population of cells was derived from human foetal 
kidneys. In the glycerol-induced kidney injury model in SCID mice, the cells incorporated into 
tubules stained with the proximal tubule marker, LTA, and the collecting duct marker, Dolichos 
biflorus agglutinin. The cells improved the function as well as the structural recovery of the 
kidneys following the treatment with glycerol. Finally, following in vitro stimulation, the cells 
were shown to up-regulate expression of some important kidney genes, such as aminopepetidase 
A, aquaporin 1 and 3, thiazide-sensitive Na/Cl, megalin or THP (Lazzeri et al. 2007). 
Ultimately, kidney-derived progenitors have been demonstrated to harbour the potential to 
contribute to the development of different compartments during nephrogenesis when injected into 
metanephroi (Challen et al. 2006; Maeshima et al. 2006; Ward et al. 2011) (Table 1.1). Among 
several types of renal progenitor populations, the label-retaining tubular cells (LRTC), or kidney 
side population (SP), showed renogenic potential. On the 5th day following  injection into E15 rat 
kidney rudiment, the LRTC were found in and around the ureteric buds, as well as in tubules 
positive for LTA (Maeshima et al. 2006). Similarly, the SP cells (isolated from adult mouse 
kidneys using their ability to efflux the Hoechst dye), were shown to have the potential to 
contribute to kidney development. After 3 days from the injection of the cells into mouse E12.5 
metanephroi, SP cells were found in UBs stained with calbindin and Pax2, as well as in MM 
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stained with Wt1 and Pax2. Importantly, it was shown that the kidney main population cells (i.e., 
the cells that were unable to efflux the Hoechst dye) were also able to engraft into UB and MM, 
albeit at a much lower percentage than the SP cells (Challen et al. 2006). Finally, human 
CD133/1+ kidney progenitors isolated from both the papilla and the cortex were injected into 
E12.5 mouse kidney rudiments. Accordingly, the cells demonstrated an ability to engraft into the 
tubular compartment of the metanephric kidney after 3 days of culture (Ward et al. 2011). 
1.4.2. Amniotic fluid stem cells 
Similar to MSCs and kidney progenitors, human AFSC were described to enhance functional and 
structural recovery of mouse kidneys following glycerol-induced acute renal failure. 
Furthermore, it has been demonstrated that following their administration, the AFSCs 
differentiated into renal tubules as they stained positively with peanut agglutinin and Dolichos 
biflorus agglutinin in the damaged kidneys (Perin et al. 2010). Interestingly, the intravenous 
injection of human AFSCs was demonstrated to lead to a more rapid recovery of renal function in 
glycerol-induced acute kidney injury in comparison to MSCs. In addition, in these experiments, 
MSCs were demonstrated to induce more effectively the proliferation of tubular cells, while 
AFSC had a more pronounced anti-apoptotic effect on injured kidneys (Hauser et al. 2010). 
Ultimately, AFSCs were demonstrated to contribute to developing renal structures following 
injection into mouse metanephric kidneys. Accordingly, after 5 days from injection, human 
AFSCs were found integrated into stroma and the renal vesicle, C- and S-shaped bodies. This was 
accompanied by expression of some human kidney-associate genes, such as ZO-1, claudin and 
GDNF (Perin et al. 2007) (Table 1.1). Recently, another group confirmed these results by 
demonstrating that human AFSCs could contribute to nephron formation as well as to ureteric 
 43 
bud structures during metanephric development (Siegel et al. 2010) (Table 1.1).  
1.4.3. Embryonic stem cells 
Regarding embryonic stem cells (ESCs) or ESC-derivatives, the cells were injected into 
developing metanephroi, similarly as for kidney progenitors and AFSCs, but were found 
primarily in tubular compartments (Kim and Dressler 2005; Steenhard et al. 2005; Vigneau et al. 
2007) (Table 1.1). The injection of undifferentiated ESCs into E13 mouse kidney rudiments 
resulted after 5 days of culture, in the formation of large tubule-like structures consisting of cells 
displaying apical microvilli, junctional complexes and basal bodies, surrounded by a basement 
membrane. Furthermore, such ESC-derived structures stained with LTA, a marker for proximal 
tubules. It has been also observed that ESCs did not mix with native kidney cells to create 
chimeric tubules in the metanephroi. In addition, injected ESCs were rarely observed in 
developing glomeruli (Steenhard et al. 2005). Other groups injected pre-differentiated ESCs into 
kidney rudiments (Kim and Dressler 2005; Vigneau et al. 2007). For instance, Kim and Dressler 
used undifferentiated ESCs to form embryoid bodies (EBs), which after 5 days of culture, were 
further induced with retinoic acid, activin-A and bone morphogenic protein-7. Following the 
induction, the cells started to express genes involved in early kidney development, such as Pax2, 
Wt1, Wnt4, Lim1, Six2, Eya1 and Gdnf. These differentiated ESCs engrafted into tubules of E12.5 
mouse kidney rudiments after 5 days of in vitro culture. Furthermore, tubules generated by the 
differentiated cells stained with laminin and LTA. In addition, EB-derived cells that were not 
induced with the nephrogenic cocktail had a lower ability to incorporate into tubules and were 
found mainly in non-tubular structures (Kim and Dressler 2005). Another group demonstrated 
that if ESCs were differentiated towards an early renal phenotype prior to their injection into the 
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E11.5 kidney rudiment, the cells were found in pretubular aggregates after 4 days of culture. 
Accordingly, when injected into the kidneys of newborn mice, the cells incorporated into 
proximal tubules. The cells used in these experiments were derived from EBs, similarly as in the 
previous study, but with the difference that they were cultured in the presence of activin-A for 4 
days before injection. This resulted in high expression levels of the nascent mesodermal marker, 
brachyury, which was subsequently used to divide the EB cell population in two separate 
fractions. Interestingly, in comparison to the brachyury positive fraction, which integrated into 
proximal tubules, the brachyury negative cells integrated into ureteric buds (Vigneau et al. 2007). 
Recently, it has been shown that conditioned medium from a UB culture can trigger ESCs 
previously induced by retinoic acid and activin, to differentiate towards a renal phenotype, as 
assessed by expression of WT1, Pax2 and binding of Dolichos biflorus agglutinin (Ren et al. 
2010). 
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Table 1.1 Different techniques used to introduce stem cell/progenitor populations into the embryonic 
kidney environment with the aim of differentiating them towards a kidney-specific phenotype. 
 Stem 
cell/progenitor 
No. of 
cells 
Outcome Methodology Reference 
Human MSCs 1000 Glomerular and 
tubular epithelium 
and interstitium  
Injection into intermediate 
mesoderm of  a rat embryo  
or E13 rat kidney 
Yokoo et al. 
2005; Yokoo 
et al. 2006 
Human MSCs 50-100 Wolffian duct Injection into intermediate 
mesoderm of a chicken 
embryo 
Fukui et al. 
2009 
Human AFSCs 1000 Stroma, renal 
vesicle, C- and S-
shaped bodies 
Injection into E12.5-E18 
mouse kidney rudiment  
Perin et al. 
2007 
Human AFSCs 10 000 Developing 
nephron, UB 
Recombination of AFSCs 
with E11.5 mouse kidney 
cells (1:10) 
Siegel et al. 
2010 
Human kidney 
progenitors 
4500 Integration into 
tubules 
Injection into E12.5 mouse 
kidney rudiment 
Ward et al. 
2011 
Mouse ESCs 1500 Proximal tubules Injection into E12-E13 
mouse kidney rudiment 
Steenhard et 
al. 2005 
Mouse ESC-
derived progenitors 
1000-
2000 
Proximal tubules Injection into E12.5 mouse 
kidney rudiment 
Kim and 
Dressler 2005 
Mouse ESC-
derived progenitors 
300 Pretubular 
aggregates 
Injection into E11.5 mouse 
kidney rudiment 
Vigneau et al. 
2007 
Mouse kidney 
progenitors 
100 Ureteric buds and 
condensing 
metanephric 
mesenchyme 
Injection into E12.5 mouse 
kidney rudiment 
Challen et al. 
2006 
Rat kidney 
progenitors 
200 Interstitium, 
ureteric buds, 
proximal tubules  
Injection into E15 rat kidney 
rudiment 
Maeshima et 
al. 2006 
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Aim of the study 
The aim of the study is to investigate the potential of mesenchymal stem cells (MSCs), a 
multipotent cell population (Prockop 1997), to contribute to in vitro nephrogenesis by 
differentiating into kidney-specific cell types in a metanephric environment of mouse kidney 
rudiment. MSCs might be potential candidates for stem cell-based renal tissue generation as they 
not only exert renoprotective effects in different acute kidney injury models, but also engraft into 
the tubules of injured kidneys, and to some extent, differentiate into tubular epithelial cells 
(Herrera et al. 2004; Morigi et al. 2004; Qian et al. 2008; Li et al. 2010). Moreover, human MSCs 
were shown to give rise to nephron-specific cell types after they underwent specific 
reprogramming in the embryonic environment of the metanephric kidney (Yokoo et al. 2005; 
Yokoo et al. 2006). Additionally, human MSCs were shown to ameliorate renal pathologies when 
incorporated into embryonic kidneys containing renal defects (Yokoo et al. 2005; Guillot et al. 
2008). Nevertheless to achieve a significant contribution of MSCs to metanephric development, a 
sophisticated methodology is required, as demonstrated by Yokoo et al. (Yokoo et al. 2005). 
Since the direct injection of human MSCs into the developing kidney in vitro, is insufficient to 
enable MSC differentiation, the cells need to be genetically modified to over-express glial cell-
derived neurotrophic factor before they are injected into the intermediate mesoderm of an 
embryo, followed by ex utero culture of the embryos (Yokoo et al. 2005; Yokoo et al. 2006; 
Fukui et al. 2009). The current study is therefore aimed at re-evaluating the renogenic capacity of 
mouse and human bone marrow-derived MSCs using a much simpler protocol described by 
Unbekandt and Davies, which is based on disaggregation and subsequent re-aggregation of 
mouse metanephroi (Unbekandt and Davies 2010). This new methodology allows incorporation 
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of cells from different origins into kidney rudiments to form kidney chimeras and to determine 
the contribution of the cells to nephrogenesis in an in vitro environment, which mimics 
metanephric development. Furthermore, in this study an attempt will be made to enhance the 
potential of MSCs to engraft into structures of developing kidney chimeras by incubating the 
cells with conditioned medium from a kidney cell culture. The use of conditioned medium to 
induce differentiation of MSCs has been described before. It has been demonstrated that MSCs 
can adopt the characteristics of the cells from which the conditioned medium was derived (Rivera 
et al. 2006; Pan et al. 2008; Baer et al. 2009; Schittini et al. 2010). The conditioned medium from 
neonatal kidney cells will be used in this study to pre-condition both mouse and human MSCs 
and accordingly the renogenic potential of pre-conditioned MSC will be evaluated. Finally, the 
paracrine activity of MSCs was shown to play a major role in promoting recovery from kidney 
injury (Togel et al. 2005; Bi et al. 2007; Imberti et al. 2007; Semedo et al. 2007; Togel et al. 
2007; Togel et al. 2009). However, it is not clear what effect factors secreted by MSCs might 
have on embryonic kidneys. Therefore the paracrine action of MSCs on metanephric kidneys will 
be additionally assessed in this study.  
The following is a summary of the most important issues addressed in this study: 
• the ability of the MSC to contribute to developing renal structures in a chimeric kidney 
culture assay based on the protocol of Unbekandt and Davies  
• the potential of other cells, such as embryonic stem cells and neonatal kidney cells, to 
contribute to developing renal structures using the protocol of Unbekandt and Davies 
• the renogenic potential of MSCs pre-treated with conditioned medium derived from 
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neonatal kidney cells using the protocol of Unbekandt and Davies 
• the effects exerted by MSCs on embryonic kidney development  
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Chapter 2: Material and methods 
2.1. Primary cells and stem cell lines 
2.1.1. Mesenchymal stem cells 
Mouse mesenchymal stem cells 
Mouse mesenchymal stem cells (MSCs) used in this study were the D1 MSC line, derived from 
bone marrow of BALB/c mice (Diduch et al. 1993). The D1 line was purchased from ATCC 
(CRL-12424).  
Human mesenchymal stem cells 
Primary human MSCs were obtained from bone marrow of healthy donors following 
immunodepletion of CD45 cells. Human MSCs were purchased from Lonza (Lonza Walkersville, 
Inc., USA) 
2.1.2. Mouse embryonic fibroblasts 
Mouse embryonic fibroblasts (MEFs) were isolated from mouse embryos at embryonic day (E) 
11.5-12.5. The isolation protocol is described in section 2.2.8. 
2.1.3. Mouse embryonic stem cells 
Mouse embryonic steam cells (ESCs) used here were the E14 line, established from mouse strain 
129/Ola by Martin Hooper (Hooper et al. 1987). E14 ESCs were obtained from Mark Boyd at the 
University of Liverpool.  
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2.1.4. Mouse neonatal kidney cells 
Mouse neonatal kidney cells (NKCs) were derived from kidney of CD-1 mice by Cristina Fuente 
Mora at the University of Liverpool (Mora 2009). The isolation protocol is briefly described in 
section 2.2.5. 
2.2. Cell culture 
2.2.1. Cell thawing protocol 
In order to thaw cells employed in this study, cryovials containing frozen cells were removed 
from the liquid nitrogen container and promptly transferred into a water bath at 37°C. As soon as 
the cells thawed, the cell suspension was transferred into a 15ml conical tube (Greiner Bio One, 
UK) filled with pre-warmed standard culture medium (see section 2.11.1). Subsequently the cells 
were centrifuged at 400g for 2.5 min and the supernatant discarded. Accordingly the cell pellet 
was resuspended in appropriate culture medium and placed in a humidified incubator (Thermo 
Fisher Scientific Inc., USA) at 37°C, 5% CO2 (v/v) in air. 
2.2.2. Cell freezing protocol 
In order to freeze cells used in this study, the medium was aspirated, the cell cultures were 
washed once with Dulbecco’s Phosphate Buffered Saline (PBS) without CaCl2 and MgCl2 
(Sigma-Aldrich, USA) and subsequently incubated with 0.25% trypsin/EDTA (Sigma-Aldrich) 
solution at 37°C for 1-5 min. Depending on size of the culture dish, an appropriate volume of 
trypsin/EDTA solution was added. Accordingly, cells cultured in 3.5 cm dishes were incubated 
with 0.5ml of 0.25% trypsin/EDTA solution. Next, the trypsin reaction was stopped by adding 
1ml of pre-warmed standard culture medium (see section 2.11.1) to the dish. The obtained cell 
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suspension was transferred into a 15ml conical tube and centrifuged at 400g for 2.5 min. 
Following the centrifugation, the supernatant was discarded and the cell pellet resuspended in 
Recovery™ Cell Culture Freezing Medium (Invitrogen, USA). Accordingly, cells obtained form 
3.5 cm dish were resuspended with 1ml of the Recovery™ Cell Culture Freezing Medium. The 
cell suspension was then divided between two cryovials (Corning, Holland), which were then left 
overnight in a freezing container (Nalgene, Denmark) filled with isopropanol (Sigma-Aldrich) at 
-80°C, to facilitate slow freezing of the cells. Next day the cryovials were transferred into a liquid 
nitrogen container.  
2.2.3. Cell passaging 
All cells used in this study were adherent cells. In order to passage the cells, culture medium was 
aspirated and the cultures were washed once with PBS without CaCl2 and MgCl2. Next the 
cultures were incubated with 0.25% trypsin/EDTA (Sigma-Aldrich) solution at 37°C for 1-5 min. 
The appropriate volume of trypsin/EDTA solution was added to sufficiently cover the cells. In 
order to stop the action of trypsin 1ml of pre-warmed standard culture medium (see section 2.11) 
was added to the dishes. Next the cell suspension was transferred into a 15ml conical tube and 
centrifuged at 400g for 2.5 min. The supernatant was discarded and the cell pellet resuspended in 
warmed culture medium.  D1 cells and NKCs were resuspended in standard culture medium (see 
section 2.11.1); human MSCs were resuspended in culture medium provided by the manufacturer 
(Lonza); MEFs were resuspended in MEF culture medium (see section 2.11.1); ESCs in ESC 
culture medium (see section 2.11.1). Usually the cells were passaged in 1 to 3 or 1 to 4 ratios. In 
order to obtain exact number of cells following detachment, the cells were counted beforehand 
using a Neubauer haemocytometer (Hausser Scientific, USA).  
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2.2.4. Routine mesenchymal stem cell culture 
Mouse mesenchymal stem cells 
D1 cells were cultured in standard culture medium (see section 2.11.1) on uncoated plastic 
culture dishes (Nunc, Denmark) in a humidified incubator at 37°C, 5% CO2. The cells were 
passaged 1 to 3 or 1 to 4 every 2-3 days according to the protocol in section 2.2.3. D1 cells were 
used be between 10th and 30th passage. 
Human mesenchymal stem cells  
Human MSCs were cultured according to the manufacturer’s instructions (Lonza). In brief, the 
cells were maintained in Mesenchymal Stem Cell Growth Medium (MSCGM™) on uncoated 
plastic culture dishes (Nunc) in a humidified incubator at 37°C, 5% CO2. The medium was 
changed every 3-4 days. The cells were passaged approximately once a week when the cultures 
reached around 90% confluency. Subsequently the cells were seeded, according to the 
instructions provided by Lonza, at 5,000-6,000 cells per cm2 of surface area. Human cells were 
used up to 8th passage. 
2.2.5. Preparation of mouse neonatal kidney cells 
NKC cultures were first established by Cristina Fuente Mora at the University of Liverpool 
(Mora 2009). In brief, the cells were isolated from kidneys of 2–6 days old CD-1 mice, cut into 
<1 mm pieces and incubated for 20 min at 37°C in 1mg/ml collagenase type I (Sigma-Aldrich) 
and 0.1mg/ml deoxyribonuclease I (Sigma-Aldrich) in Hank's Buffered Salt Solution (HBSS) 
containing calcium and magnesium (Invitrogen). The suspension was washed with HBSS and 
incubated with 0.5mM EDTA (Sigma-Aldrich) for 20 min at 37°C. Next the suspension was 
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passed through 21-gauge and 23-gauge hypodermic needles (Becton Dickinson, USA), 
centrifuged at 200g and resuspended in HBSS cells were passed though a 30µm pre-separation 
filter. The obtained cell suspension was cultured on fibronectin coated dishes in the presence of 
conditioned medium derived from the STO embryonic mouse fibroblast cell line.  
2.2.6. Routine mouse neonatal kidney cell culture 
NKCs used in this study were cultured under previously described conditions (Mora 2009). 
Accordingly NKCs were maintained in standard culture medium (see section 2.11.1) on uncoated 
plastic culture dishes (Nunc) a humidified incubator at 37°C, 5% CO2. The cells were passaged 1 
to 3 or 1 to 4 every 2-3 days as described in the protocol in section 2.2.3. The cells were used be 
between 5th and 15th passage. 
2.2.7. Gelatinization of culture dishes 
Some culture dishes were coated with 0.1% (w/v) gelatine solution (see section 2.11.2) before 
seeding the cells. Accordingly, 3.5 cm culture dishes were incubated with 2ml of the gelatine 
solution in room temperature for 15 min. Subsequently, the dishes were washed 3 times with 
warm PBS and used to culture MEFs and ESCs. 
2.2.8. Preparation of mouse embryonic fibroblasts 
MEF cultures were established as follows: CD-1 E11.5-12.5 mouse embryos were decapitated, 
eviscerated and minced into small pieces. After that, they were incubated with 0.25% 
trypsin/EDTA (Sigma-Aldrich) at 37°C for 20-30 min. The reaction was stopped by adding MEF 
culture medium (see section 2.11.1). The obtained cell suspension was allowed to adhere to a 10 
cm culture dish (Corning) in 37°C, 5% CO2 humidified incubator for 3-4 days. Subsequently 
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when the primary cultures reached around 90% of confluency they were passaged 1 to 3 on 
gelatinized dishes. When the cultures reached passage 4 they were treated with 20µg/ml 
mitomycin C (Sigma-Aldrich) which covalently binds to the DNA crosslinking complementary 
DNA strands thus preventing further proliferation of the treated cells. To obtain appropriate 
concentration of mitomycin for a 10 cm culture dish, 5ml of MEF medium was mixed with 100µl 
of previously prepared 2mg/ml mitomycin C in PBS. Next, the treated cells were incubated for 2-
3 h in a humidified incubator at 37°C, 5% CO2. After the incubation, the cells were washed three 
times with PBS and were prepared for freezing as described in section 2.2.2. The cells were 
frozen at a final cell density of 2 million cells in 1ml of freezing recovery medium per cryovial. 
In order to be used in subsequent experiment, the mitomycin C treated MEFs, also referred as 
inactivated MEFs, were thawed according to the protocol in section 2.2.1.  
2.2.9. Routine mouse embryonic fibroblast culture 
In this study, inactivated MEFs were used as feeder layers for mouse ESCs and to obtain 
conditioned medium for mouse MSC stimulation. The cells were thawed using the protocol 
described in section 2.2.1. The cells were then seeded on 3.5 cm gelatinized dishes (Nunc) (see 
section 2.2.7). From each cryovial 3 dishes were prepared. The cells were allowed to attach 
overnight in a humidified incubator at 37°C, 5% CO2 before use. Accordingly, the inactivated 
MEFs were maintained in MEF medium in 37°C, 5% CO2 humidified incubator for a maximum 
of 2 weeks. The medium was changed every other day.  
2.2.10. Routine mouse embryonic stem cell culture 
Mouse ESCs were cultured on a monolayer of inactivated MEFs in ESC culture medium (see 
section 2.11.1) in humidified incubator at 37°C, 5% CO2. The medium was changed every 
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other day. The cells were passaged 1 to 4 every 3-4 days (see section 2.2.3). To ensure absence of 
the fibroblasts in the recombination experiments (in the chimeric kidney assay, see section 2.6), 
ESCs were cultured in the presence of ESC culture medium on gelatinized dishes but in the 
absence of feeder cells for two subsequent passages. The cells were used between 10th and 20th 
passage. 
2.3. Conditioned medium treatment 
2.3.1. Conditioned medium preparation 
In this study, different conditioned media were used to stimulate either D1 cells or intact kidney 
rudiments. In order to obtain conditioned medium from NKCs (NKC CM), sub-confluent cultures 
of NKCs were cultured in standard culture medium for 2 days before medium collection. In order 
to obtain conditioned medium from MEFs, confluent inactivated MEF were maintained in MEF 
culture medium for 2 days before the collection. Ultimately, in order to derive conditioned 
medium from D1 cells (MSC CM), sub-confluent cultures of D1 cells were cultured in standard 
culture medium for 1 day before the collection. The collected conditioned media were 
centrifuged at maximum speed in a table-top centrifuge for 3 min. Subsequently, the supernatant 
was collected and filtered with 0.22µm syringe filter (Sartorius Stedim Biotech GmbH, 
Germany). Conditioned media were then stored in -20°C. Before use, they were thawed and 
mixed with fresh standard culture medium in a ratio of 1:1. In order to achieve different 
concentrations of NKC CM, Vivaspin centrifugal ultra-filtration devices (Sartorius Stedim 
Biotech GmbH, Germany) were used.  
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2.3.2. Stimulation with conditioned medium 
Stimulation of mesenchymal stem cells 
In order to increase renogenic potential of D1 cells, the cells were stimulated with NKC CM for 4 
days. Accordingly, 2.5x105 D1 cells were seeded in an uncoated 3.5 cm culture dish (Nunc) in the 
presence of NKC CM 1:1 mixed with standard culture medium and incubated for 4 days in 
humidified incubator at 37°C, 5% CO2.  The conditioned medium was replaced with a fresh mix 
on the second day of culture. Subsequently the same conditions were used to stimulate D1 cells 
with MEF CM. In order to pre-condition human MSCs, sub-confluent human cultures were used. 
The cells were incubated with NKC CM 1:1 mixed with standard culture medium for 4 days in a 
humidified incubator at 37°C, 5% CO2.  
Stimulation of intact kidney rudiments 
In order to assess if MSCs may exert an indirect effect on metanephric development in vitro, 
intact kidney rudiments were cultured for 3 days in the presence of conditioned medium derived 
from D1 cells (MSC CM) or D1 cells previously stimulated with NKC CM (sMSC CM). MSC 
CM used in these experiments was obtained from sub-confluent MSCs cultures after 1 day of 
conditioning. In order to collect sMSC CM, D1 cultures were first stimulated with NKC CM for 
4 days. The cultures were subsequently washed with PBS and the medium was changed to 
standard culture medium. After 1 day the conditioned media was collected and prepared for 
stimulation. Accordingly E11.5 kidney rudiments obtained from littermate embryos were 
cultured in the presence of MSC CM or sMSC CM mixed 1:1 with standard culture medium for 3 
days. The condition for embryonic kidney culture is described in detail in section 2.5.2. 
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2.4. In vitro multilineage differentiation protocols 
2.4.1. Adipogenesis assay 
Mouse mesenchymal stem cells 
The adipogenic assay was performed as described previously by Peister et al (Peister et al. 2004). 
Accordingly confluent D1 cultures were stimulated twice a week with adipogenic inductive 
media (see section 2.11.1). After 2 weeks the cells were fixed with 4% paraformaldehyde (w/v) 
(PFA) (see section 2.11.2) for 10 min and subjected to analysis. At the same time the non-
induced cells were cultured in standard culture medium. Intracellular lipid vacuoles were detected 
using Oil Red O staining. Accordingly the cells were covered with 0.5% (w/v) Oil Red O 
solution (see section 2.11.1) diluted 3:2 in water before  use. For a 3.5 cm culture dish 1ml of Oil 
Red O solution was used. The dishes were incubated for 15 min at room temperature. In this 
solution lipid droplets were stained red. Subsequently the cells were washed several times with 
large volumes of H20 to get rid of excess of the solution. Finally 1ml of H20 was added to the 
dishes and images of stained cultures were acquired using Leica DM2500 microscope and 
DFC350FX camera. 
Human mesenchymal stem cells 
Human MSCs were confirmed to undergo adipogenesis using Differentiation Media BulletKit® 
(PT-3004) supplied by Lonza according to manufacturer’s instructions. In brief, the adipogenic 
assay was started when human MSC reached confluency. Three cycles of induction/maintenance 
were performed using the adipogenic inductive and maintenance medium. Each cycle consisted 
of incubating the cells with supplemented adipogenesis induction medium (Lonza) for 3 days 
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followed by 1-3 days of culture in supplemented with adipogenic maintenance medium (Lonza). 
At the same time, non-induced control cells were cultured in maintenance medium only. Finally, 
the cells were cultured for the next 7 days in maintenance medium, replaced every 2-3 days. The 
lipid vacuoles were detected as described above for mouse MSCs, using the Oil Red O solution 
(see section 2.11.1) after the cells were fixed with 4% PFA. 
2.4.2. Osteogenic assay 
Mouse mesenchymal stem cells 
The osteogenic assay was performed as described previously by Peister et al (Peister et al. 2004). 
Confluent D1 cultures were stimulated twice a week with osteogenic inductive media (see section 
2.11.1). At the same time the non-induced cells were cultured in standard culture medium. After 
2 weeks the cells were fixed with 4% PFA for 10 min and calcium deposits visualised using 2% 
(w/v) Alizarin Red S solution (see section 2.11.2) adjusted to pH 4.2 with ammonium hydroxide 
(Sigma-Aldrich). For a 3.5 cm culture dish 1ml of Alizarin Red S solution was added. The dishes 
were incubated for 20 min at room temperature. Extracellular calcium deposits produced by 
osteoblasts were stained red/orange. Subsequently the cells were washed several times with large 
volumes of H20 to get rid of excess of the solution. Finally 1ml of H20 was added to the dishes 
and images of stained cultures were acquired using Leica DM2500 microscope and DFC350FX 
camera. 
Human mesenchymal stem cells 
Human MSCs were confirmed to undergo osteogenesis using Differentiation Media BulletKit® 
(PT-3002) supplied by Lonza according to manufacturer’s instructions. In brief, human MSCs 
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were plated at a density of 3.1x103 per cm2 of tissue culture surface area in Mesenchymal Stem 
Cell Growth Medium (Lonza). The cells were allowed to adhere for 24 h. In order to induce 
osteogenic differentiation the growth medium was replaced with osteogenesis induction medium 
(Lonza) and the cells were cultured in the inductive medium for the next 2 weeks. Medium was 
changed every 3-4 days. The non-induced control human MSCS were maintained for the same 
period of time in growth medium. The calcium deposits were detected as described above for 
mouse MSCs, using Alizarin Red S solution (see section 2.11.2) after the cells were fixed with 
4% PFA. 
2.4.3. Chondrogenic assay 
The chondrogenic assay was performed as described by Peister et al (Peister et al. 2004). 
Accordingly, 3x105 D1 cells were spun down to form a pellet at the bottom of a 15ml 
polypropylene tube. The supernatant was carefully discarded, in order not to disturb the pellet 
and 0.5ml of chondrogenic inductive media (see section 2.11.2) was added. The cells were then 
stimulated twice a week with this medium. After 2 weeks the micromass (pellet) culture was 
fixed with 4% PFA for 20 min and 10µm cryosections were prepared. For this purpose the 
micromasses were washed with PBS 3x10 min and incubated overnight in 15% (w/v) sucrose 
solution (see section 2.11.2) at 4°C. The sucrose solution was aspirated and the micromasses then 
embedded using cryo-embedding medium (Bright Instrument Ltd., UK) and frozen using liquid 
nitrogen-chilled isopentane (Sigma-Aldrich). Frozen cultures were cut at -20°C using a cryostat 
(HM505, Microm International, Germany) with C35 Feather microtome blades (VWR, UK). 
Subsequently the sections were transferred onto subbed glass microscope slides 76x26x0.8mm 
(VWR). Frozen sections were stored at -20°C. The subbed slides were prepared as follows:  
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slides were soaked for 10-15 min in absolute ethanol (University of Liverpool solvent service) 
and washed 5x in distilled water. Then they were treated with a solution of 0.5% (w/v) porcine 
gelatine (Sigma-Aldrich) and 0.05% (w/v) CrKSO4 (Sigma-Aldrich) in distilled water for 25 sec 
and allowed to dry before being stored for future use. In order to visualize chondrogenic 
differentiation, 1% (w/v) Alcian Blue solution (see section 2.11.2) was used to detect 
extracellular proteoglycans. Accordingly the frozen sections were incubated with 0.1N HCl 
(Invitrogen) for 5 min in room temperature prior staining. Next the solution was applied onto 
sections and incubated for 30 min at room temperature. Finally the sections were washed twice 
with 0.1N HCl. The images of stained sections were acquired using Leica DM2500 microscope 
and DFC350FX camera. 
2.5. Cell labelling 
2.5.1. Quantum dot labelling 
For Quantum dot (QD) labelling, the Qtracker® 655 Cell Labelling Kit (Invitrogen) was used 
according to manufacturer’s instructions. First, 1µl of component A (QD nanocrystals) and 1µl of 
component B (carrier) were mixed in a microcentrifuge tube and incubated for 5 min at room 
temperature. In order to obtain the 10nM final concentration of the QDs for labelling, 200µl of 
standard culture medium was added to mixed components and subsequently vortexed for 30 sec 
at room temperature. The labelling solution was added to a suspension of the appropriate cell 
type and incubated in humidified incubator at 37°C, 5% CO2 for 45-60 min. In order to obtain the 
cell suspension, the adherent cultures of MSCs, NKCs or ESCs were treated with 0.25% 
trypsin/EDTA as described in section 2.2.3 before QD labelling. Following labelling, the cells 
were centrifuged at 400g for 3 min and the supernatant aspirated. Finally, the cells were washed 
 61 
four times with standard culture medium to remove any QDs that had not incorporated into the 
cells. In order to test efficiency of QD-labelling, labelled D1 cells were resuspended in 2ml of 
standard culture medium, seeded at 2.5x105 on uncoated 3.5 cm culture dishes and cultured for 5 
days at 37°C, 5% CO2. Ultimately, QD-labelled cells resuspended in standard culture medium 
were used in the chimeric kidney assay (see section 2.6). 
2.5.2. CFDA SE labelling 
For CFDA SE (carboxyfluorescein diacetate succinimidyl ester) labelling, the Vybrant® Cell 
Tracer Kit (Invitrogen) was used. Initially 10mM CFDA SE stock solution was prepared by 
dissolving the contents of Component A (CFDA SE) in 90µl of Component B (dimethyl 
sulfoxide). Next, the stock solution was diluted to reach 0.5µM working concentration in high 
glucose Dulbecco’s Modified Eagle Medium (Sigma-Aldrich). The labelling was performed on 
D1 cells in suspension, similarly as described for QD labelling. Accordingly, cells were 
incubated with the labelling solution in a humidified incubator at 37°C, 5% CO2 for 45 min. 
Subsequently the cells were centrifuged at 400g for 5 min and the supernatant aspirated. They 
were washed three times with standard culture medium. Next the cells were seeded at 2.5x105 on 
uncoated 3.5 cm culture dishes and cultured for 5 days at 37°C, 5% CO2, in order to compare the 
effectiveness of labelling with CFDA SE and QDs. 
2.5.3. Lentiviral transduction 
For constitutive expression of green fluorescent protein (GFP), mouse MSCs were transduced 
with pHR-SFFV-GFP a lentiviral vector encoding enhanced GFP under the spleen focus-forming 
virus (SFFV) promoter. The lentiviral supernatant, containing the GFP vector, was obtained from 
Sokratis Theocharatos at the University of Liverpool. Before the transduction, D1 cells were 
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seeded at 2.5x105 on uncoated 3.5 cm culture dishes in standard culture medium and allowed to 
adhere for 1 h. Next the medium was discarded and the cells were maintained for 6 h in the 
presence of 200µl lentivirus supernatant mixed with 1800µl standard culture medium in 
humidified incubator at 37°C, 5% CO2. Following the incubation the medium was replaced with 
standard culture medium and the transduced cells were cultured for 3 days at 37°C, 5% CO2. On 
the third day GFP expression was verified using Leica DMIL fluorescent microscope (Leica, 
Germany). GFP-transduced D1 cells were cultured as described for non-modified cells in section 
2.2.4. 
2.5.4. Immunostaining of human mesenchymal stem cells 
In this study a mouse anti-human nuclei antibody was used to detect human MSCs. First the 
suitability of the antibody was determined in a monolayer culture in a 3.5 cm culture dish. 
Accordingly, the culture medium was discarded and human MSCs were fixed with -20°C 100% 
methanol (Sigma-Aldrich) for 10 min at room temperature. Next, the methanol was aspirated and 
the fixed cells washed with PBS (see section 2.11.2) for 30 min at room temperature. 
Subsequently, the PBS was aspirated and the cells were incubated in the blocking solution 
containing 0.1% (v/v) Triton X-100 (Sigma-Aldrich) and 10% (v/v) goat serum (Sigma-Aldrich) 
in PBS for 45 min which was then replaced with primary antibody solution containing 0.1% (v/v) 
Triton X-100 and 1% (v/v) goat serum in PBS and 1:200 diluted mouse anti-human nuclei 
antibody (MAB1281, Millipore). The cells were incubated with the primary antibody solution 
overnight at 4°C in a humidified chamber. Next day the cells were washed 1 h in PBS and 
subsequently incubated with secondary antibody solution containing 0.1% (v/v) Triton X-100 and 
1% (v/v) goat serum in PBS and 1:500 diluted goat anti-mouse Alexa Fluor488 antibody 
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(A21121, Invitrogen) for 2 h at room temperature in a humidified chamber in dark. Then the cells 
were washed for 30 min with PBS and incubated for 10 min in dark in the presence of 4',6-
diamidino-2-phenylindole (DAPI) (Invitrogen) diluted 1:100 000 in PBS in order to visualize 
nuclei of the cells. Finally, the cells were washed three times with PBS and mounted with 80% 
(v/v) glycerol (Sigma-Aldrich) in PBS and cover slips. Stained human MSC cultures were 
observed using Leica DM2500 microscope and images were acquired using the DFC350FX 
camera. Blocking solution and subsequent primary and secondary antibody solutions were 
centrifuged before use at 13 400g for 5 min in a table-top centrifuge (Sanyo, Japan). A control 
was included where the primary antibody was omitted from the primary antibody solution. 
Ultimately the anti-human nuclei antibody was used to detect human MSCs in the kidney 
chimeras, according to the protocol described in section 2.7.1.   
2.6. Metanephric kidney culture 
2.6.1. Dissection of mouse kidney rudiments 
In order to obtain kidney rudiments in this study, mouse embryos were dissected from timed-
mated pregnant CD1 mice (Charles River) at embryonic day (E) 11.5 and 13.5. The dissection 
protocol was performed as described earlier by Davies (Davies 2010). Accordingly, mice were 
sacrificed by cervical dislocation and the uterine horns were removed and placed into a 50ml 
conical tube at 4°C. Subsequently the uterine horns were transferred into a dish with cold high 
glucose Dulbecco’s Modified Eagle Medium (DMEM) (Sigma-Aldrich) and the embryos were 
removed from the uteri and cleaned from extra-embryonic membranes using forceps and small 
scissors. Then the embryos were decapitated and the caudal parts were removed and transferred 
to a new dish filled with DMEM. The tail was removed and the caudal parts were placed on their 
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dorsal side and cut sagittally in half, then the kidney rudiments were dissected using 27 gauge 
hypodermic needles (Becton Dickinson) under a stereoscopic microscope Nikon SMZ1000 
(Nikon Instruments Inc., USA). Following  isolation, the kidney rudiments were transferred into 
dishes filled with DMEM using a glass pipette and placed in a humidified incubator at 37°C, 5% 
CO2. Kidney rudiments dissected using the protocol described above were in vitro cultured (see 
section 2.5.2), as well as used for the chimeric kidney assay (see section 2.6) or RNA extraction 
(see section 2.8.1) 
2.6.2. Culture of mouse kidney rudiments in vitro 
In order to culture in vitro kidney rudiments dissected mouse embryonic kidneys were transferred 
using a glass pipette onto a 1.2µm membrane filter (Millipore, USA) and placed on a Trowell 
screen (a grid made from stainless steel mesh (Sigma-Aldrich)) (Figure 2.1). The grid supports 
kidney growth as the culture has to be performed at the gas/medium interface (Davies 2010). 
Embryonic kidneys were cultured in the presence of standard culture medium (see section 2.11.1) 
at the gas/medium interface in 37°C, 5% CO2 humidified incubator. The intact kidney rudiments 
were analysed using immunostaining, as described in section 2.7. 
 
Figure 2.1 Culture condition for kidney rudiments in vitro. 
 
medium 
filter 
metal grid 
kidney rudiment 
 65 
2.7. Chimeric kidney assay 
Disaggregation, subsequent re-aggregation and culture of re-aggregated mouse embryonic 
kidneys has been reported previously (Unbekandt and Davies 2010). In the current study this 
protocol was used to incorporate different stem cells into mouse kidney rudiments. Accordingly 
the embryonic kidneys were dissected from embryos at E11.5 from pregnant CD-1 mice (Charles 
River), as described in section 2.5.1. Kidney rudiments were transferred into a 1.5ml 
microcentrifuge tube (Eppendorf, Germany) and disaggregated using 1ml of 0.25% 
trypsin/EDTA (Sigma-Aldrich) in high glucose Dulbecco’s Modified Eagle Medium (Sigma-
Aldrich) for 4 min at 37°C. After the incubation, the rudiments were mixed using a Gilson 
pipette. If no single cell suspension was obtained after the first incubation step, the rudiments 
were incubated for an additional 1-2 min at 37°C. Next the embryonic kidney cell suspension was 
spun down at 400g for 2 min, the trypsin/EDTA discarded and 1ml of standard culture medium 
(see section 2.11.1) was used to resuspend the cells. This was followed by incubation for 5 min at 
37°C. After that the suspension was spun down at 400g for 2 min and resuspended in 200µl of 
standard culture medium. Finally, kidney cells were counted using a haemocytometer. Labelled 
stem cell suspension was mixed with the embryonic kidney cell suspension in a ratio of 1:5 to 
reach approximately 100 000 cells in total. The recombined cells were spun down at 400g for 2 
min to form a pellet which was then transferred using a glass pipette on a 1.2µm membrane filter 
(Millipore) supported by a metal grid. Re-formed embryonic kidneys containing labelled stem 
cells were cultured for 5 or 7 days in standard culture medium at the gas/medium interface in 
37°C, 5% CO2 humidified incubator, as demonstrated in section 2.5.2. For the first 24h the 
standard culture medium was supplemented with 5µM Y-27632 Rho kinase inhibitor 
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(Calbiochem) to promote the survival of the reformed kidneys (Unbekandt and Davies 2010). 
Medium was changed every second day. After 5 or 7 days the chimeras were immediately fixed 
with 100% methanol or 4% PFA and analysed using immunostaining (see section 2.8). 
2.8. Immunostaining of intact kidney rudiments and kidney chimeras 
In this study both intact kidney rudiments and re-aggregated kidney chimeras were fixed with 
ice-cold (stored at -20°C) 100% methanol for 10 min at room temperature in the dark. An 
exception was made for chimeras harbouring D1 cells expressing GFP as it was found that the 
GFP signal was lost after methanol treatment. Accordingly such chimeras were fixed with 4% 
PFA in PBS for 30 min at room temperature in the dark. In order to perform the fixation step the 
culture medium was aspirated and replaced with either methanol or PFA until the filters with 
cultured kidney rudiments and chimeras started to float. After the fixation specimens were 
transferred into 1.5ml microcentrifuge tubes and subsequently washed with PBS for 30 min and 
blocked with a blocking solution containing 10% (v/v) goat serum and 0.1% (v/v) Triton X100 in 
PBS for 45 min at room temperature in the dark. Next the specimens were transferred into 
primary antibody solution containing 0.1% (v/v) Triton X-100 and 1% (v/v) goat serum in PBS 
and appropriate antibody or antibodies to incubate overnight at 4°C in dark. All primary 
antibodies used in this study and their working concentrations are listed in Table 2.1. In addition, 
for chimeras harbouring human MSCs, an anti-human antibody (MAB1281, Chemicon) was 
included in the primary antibody solution, diluted 1:200. Subsequently the specimens were 
washed for 1 h in PBS and incubated with secondary antibody solution containing 0.1% (v/v) 
Triton X-100 and 1% (v/v) goat serum in PBS and appropriate secondary antibody or antibodies 
overnight at 4°C in the dark. All secondary antibodies used in this study and their working 
 67 
concentrations are listed in Table 2.2. In order to visualize human MSCs in the kidney chimeras, 
goat anti-mouse Alexa Fluor488 antibody (A2112, Invitrogen) was added to the secondary 
antibody solution diluted 1:500 in the mix. Finally, the stained kidneys and chimeras were 
washed for 30 min with PBS at room temperature in dark and mounted using 80% (v/v) glycerol 
(Sigma-Aldrich) in PBS and cover slips. Nail polish was applied onto edges of cover slips to seal 
the samples. Accordingly the slides were stored in at 4°C in dark. Blocking solution and 
subsequent primary and secondary antibody solutions were spun down before use at 13 400g for 
5 min in a table-top centrifuge (Sanyo). Controls consisted of samples where primary antibody 
was omitted. The images were acquired using Leica AOBS SP2 confocal laser scanning 
microscope (Leica).  
2.9. Confocal imaging 
The confocal analysis was performed on whole mount re-aggregated kidneys and kidney 
chimeras. The images were acquired either as xyz stacks or single plane in the 1024x1024 format. 
In order to simplify the statistical analysis of MSC integration into kidney structures, only single 
plane images were used in the study. In order to obtain images containing merged green, red and 
blue channels ImageJ software was used. To obtain xyz stacks (3D Series) the beginning and end 
of the 3D series was determined using the Leica software. In order to define the frequency of 
sampling required to capture the z resolution, the optimal number of sections suggested by the 
software was selected. For imaging of AlexaFluor488 (excitation/emission of 495/519nm), 
enhanced GFP (excitation/emission of 488/507nm), as well as quantum dots (excitation/emission 
of 488/655nm) the argon laser was used. The helium-neon laser and the ultraviolet laser were 
used for imaging of AlexaFluor594 (excitation/emission of 590/617nm) and AlexaFluor350 
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(excitation/emission of 346/442nm), respectively. For each sample the gain and offset were 
adjusted separately. To regulate the intensity of the acquired signal, the Q-LUT option was used 
in the Leica software. Consequently, the regions containing signal were set up not to have any 
green, while the background intensity was set up as green pixels. Further, only few saturated, 
blue pixels were allowed in the areas containing signal. Other parameters used to acquire the 
images included: beam expander – 6, scan speed – 400Hz, pinhole – airy, frame average – 4, line 
average – 2. 
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Table 2.1 Primary antibodies used for immunostaining of kidney chimeras 
Antibody Type Concentration Supplier 
anti-Wt1 mouse  IgG1 
monoclonal 
1:500 05-753/Upstate 
anti-Wt1 rabbit IgG 
polyclonal 
1:200 SC-192/Santa Cruz 
Biotechnology 
anti-laminin rabbit IgG 
polyclonal 
1:1000 L9393/Sigma-Aldrich 
anti-calbindin mouse IgG1 
monoclonal 
1:500 ab9481/Abcam 
anti-Six2 rabbit IgG 
polyclonal 
1:200 11562-1-AP/Proteintech 
anti-human 
nuclei 
mouse  IgG1 
monoclonal 
1:200 MAB1281/Millipore 
 
Table 2.2 Secondary antibodies used for immunostaining of kidney chimeras 
Antibody Type Concentration Supplier 
anti-rabbit AlexaFluor350 goat IgG 1:500 A11046/Invitrogen 
anti-mouse AlexaFluor350 goat IgG1 1:500 A21120/Invitrogen 
anti-mouse AlexaFluor488 goat IgG1 1:500 A21121/Invitrogen 
anti-mouse AlexaFluor594 goat IgG1 1:500 A21125/Invitrogen 
anti-rabbit AlexaFluor594 chicken IgG 1:500 A21442/Invitrogen 
 
2.10. Molecular biology 
2.10.1. RNA extraction 
Total RNA was isolated using TRIzol® reagent (Invitrogen) according to manufacturer’s 
instructions. In brief, in order to extract RNA from cells, culture medium was aspirated and the 
cells were washed with PBS. After the PBS was discarded 1ml of TRIzol® reagent was directly 
 70 
add to the cultures and gently mixed until a homogenous suspension was obtained. The lysed 
cells were subsequently transferred to a 1.5ml microcentrifuge tube. In order to extract RNA 
from embryonic kidneys, kidney rudiments were collected at the bottom of a microcentrifuge 
tube and 1ml of TRIzol® reagent was added. The suspension was vigorously mixed using Gilson 
pipette until a homogenous suspension was obtained. Next 200µl of chloroform (Sigma-Aldrich) 
was added to the homogenous mixture. The tubes were shaken for 15 sec and subsequently 
centrifuged at 12,000g for 15 min at 4°C. Following the centrifugation step three phases could be 
distinguished. For the purpose of RNA extraction only the upper aqueous phase was collected. 
Nevertheless it is possible to perform sequential precipitation of RNA, DNA and proteins from a 
single sample using the TRIzol® reagent. According to the manufacturer’s instructions, RNA is 
obtained from the aqueous layer using isopropanol, while the DNA can be precipitated with 
ethanol from the two other phases, namely the interphase and the organic layer. Subsequently 
proteins are precipitated from the phenol-ethanol supernatant layer left over after the DNA 
precipitation step. In order to obtain RNA, the upper phase was transferred into a new 
microcentrifuge tube containing 1µg/µl of glycogen (Boehringer Mannheim GmbH, Germany) 
and an equal volume of isopropanol (Sigma-Aldrich) (approximately 0.5ml) was added. Next the 
solution was mixed 6 times by inversion. Following overnight incubation at -20°C, the solution 
was centrifuged at 12,000g for 10 min at 4°C and the supernatant was discarded. The obtained 
pellet was then washed with 1ml of cold 75% (v/v) ethanol (Sigma-Aldrich) in nuclease-free 
water (Sigma-Aldrich) and centrifuged at 4,400g for 5 min at 4°C. Finally, the ethanol was 
discarded and the pellet was allowed to air dry for few minutes at room temperature. The pellets, 
depending on size, were dissolved in 15-25µl nuclease free water (Sigma-Aldrich) and subjected 
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to DNase treatment (see section 2.9.2). 
2.10.2. DNase treatment 
Before cDNA synthesis, DNase treatment was performed in order to remove contaminating 
genomic DNA from RNA samples. Accordingly, 8µl RNA, extracted as described above, was 
placed in 0.2ml microfuge tubes and incubated with 1µl of DNaseI (1000U/ml) (Promega, USA) 
and 1µl DNase buffer (Promega) at 37°C for 30 min. In order to stop DNase treatment, 1µl of 
STOP buffer (Promega) was added and the tubes incubated for 15 min at 60°C. DNase 
inactivation is important, as the remaining active DNase might affect subsequent PCR reactions. 
The DNase-treated RNA was immediately used for cDNA synthesis (see section 2.9.3) or stored 
in -20°C until further use.  
2.10.3. cDNA synthesis 
In order to synthesize cDNA, a mix was prepared consisting of 5µl of DNase-treated RNA, 2µl of 
100ng/µl random hexamers (ABgene, UK) and 5µl nuclease-free water (Sigma-Aldrich). This 
mix was incubated at 80°C for 3 min and subsequently chilled on ice for 1 min and the contents 
were collected by brief centrifugation. Next 4µl of 5x 1st strand buffer (Invitrogen), 2µl 
dithiothreitol (DDT) (0.1M) (Invitrogen) and 1µl of 10mM dNTP mix (Bioline, UK) were mixed 
together. In order to facilitate of the random hexamers annealing to RNA, the solution was 
incubated at 42°C for 2 min. Then 1µl of reverse transcriptase SuperScript III (200U/µl) 
(Invitrogen) was added to the mixture and the solution was incubated at 42°C for 50 min. In this 
time reverse transcriptase, which is a DNA polymerase, catalyzed the synthesis of a 
complementary DNA (cDNA) from the RNA template. Finally, the reverse transcriptase was 
inactivated at 65°C for 10 min, followed by short incubation on ice and collection of the contents 
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by brief centrifugation. The nucleic acid concentration was determined using NanoDrop™ 1000 
spectrophotometer (Thermo Fisher Scientific Inc.) and diluted using nuclease-free water to a final 
concentration of 250ng/µl before the use. 
2.10.4. Primers 
Primers used in this study were purchased from Sigma-Aldrich. Details of primer sequences and 
product length are shown below (Table 2.3). The primers were designed to span different exons 
to minimize the risk of genomic DNA amplification. All primers were delivered in lyophilised 
form. Accordingly, they were reconstituted using nuclease-free water to reach the working 
concentration of 6.25pmol/µl. Products of all in house designed primers were sequenced by the 
Sequencing Service, University of Dundee, UK. 
Table 2.3 Mouse primer sequences 
Gene Sequence Product 
length 
(bp) 
Annealing 
temperature 
(°C)/cycle 
number 
Source 
Wt1 F: CCAGTGTAAAACTTGTCAGCGA 
R: TGGGATGCTGGACTGTCT 
234 60/33 Yamamoto et 
al. 2006 
Pax2 F: AAGTTCAGCAGCCTTTCCAC 
R: GCCCTCAGACACATCTCTTA 
274 62/33 In house 
Six2 F: GCCTGCGAGCACCTCCACAAGAAT 
R: CACCGACTTGCCACTGCCATTGAG 
522 67/33 Fogelgren et 
al. 2008 
Gdnf F: TGCCAGCCCAGAGAATTCCA 
R: AGCCTTCTACTCCGAGACAG 
216 62/33 In house 
Lim1 F: CAACATGCGTGTTATCCAGG 
R: CTTGCGGGAAGAAGTCGTAG 
239 63/33 Yamamoto et 
al. 2006 
Sall1 F: GCACATGGGAGGCCAGATCC 
R: GGAAGCGTCCGCTGACTTGG 
181 62/33 In house 
Osr1 F: GCAGCGACCCTCACAGAC 
R: GCCATTCACTGCCTGAAGGA 
169 62/33 In house 
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Bf2 F: GGTGAAGCCGCCCTACTC 
R: AGGTTGTGACGGATGCTGTT 
162 62/35 In house 
Rarβ2 F: CTCTCAAAGCCTGCCTCAGT 
R: GTGGTAGCCCGATGACTTGT 
182 62/35 Ulven et al. 
2000 
Bmp4 F: GCGCCGTCATTCCGGATTAC 
R: CATTGTGATGGACTAGTCTG 
402 63/33 Luppen et al. 
2008 
Ret F: GCGTCAGGGAGATGGTAAAG 
R: CATCAGGGAAACAGTTGCAG 
217 62/33 In house 
Gapdh  F: TGAAGCAGGCATCTGAGGG 
R: CGAAGGTGGAAGAGTGGGAG 
102 56/33 In house 
 
Table 2.4 Human primer sequences 
Gene Sequence Product 
length 
(bp) 
Annealing 
temperature 
(°C)/cycle 
number 
Source 
WT1 F: GGCATCTGAGACCAGTGAGAA 
R: GAGAGTCAGACTTGAAAGCAGT 
483 62/33 In house 
PAX2 F: CATCAAGCCGGGTGTGATC 
R: GATTCTGTTGATGGAAGAGACGC 
184 62/33 In house 
OSR1 F: GTTCCCTCATGTCATTCAACC 
R: CCCACAGGTTCTATTAGCA 
542 62/33 In house 
SALL1 F: GCTTTCACGACTAAAGGCAATCTT 
R: GAGCGCTGCTGCATACTGAT 
216 62/33 In house 
GAPDH F: GTGGTCTCCTCTGACTTCAA 
R: TCTCTTCCTCTTGTGCTCTT 
211 62/33 In house 
 
2.10.5. Polymerase chain reaction 
Polymerase chain reaction (PCR) was used to assess expression of different kidney-specific 
genes in MSCs. The reactions were prepared according to the following protocol. Each 25µl 
reaction mix contained 17µl nuclease-free water (Sigma-Aldrich), 2.5µl 10x NH4 Reaction buffer 
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(Bioline), 0.5µl MgCl2 (25mM) (Bioline), 0.5µl dNTP mix (10mM) (Bioline), 1µl forward primer 
(6.25pmol/µl) (Table 2.3), 1µl reverse primer (6.25pmol/µl) (Table 2.3), 2µl template (250ng/µl) 
and 0.5µl Taq DNA Polymerase (Bioline). Glyceraldehyde 3-phosphatedehydrogenase (Gapdh) 
was used as a reference gene throughout all experiments (Table 2.3). Gapdh is a housekeeping 
gene, which expression remains constant in the cells. Consequently it can be used to compare 
expression levels of other genes between different samples. In addition, a no-template control (a 
reaction mix prepared without cDNA) was included in each experiment, in order to detect 
potential contamination. The template prepared from E13.5 kidney rudiments was used as 
positive control. All mixes were prepared in 0.2ml tubes on ice and briefly spun down before 
being transferred to a GeneAmp PCR Systems 9700 thermal cycler (Applied Biosystems, USA). 
The conditions used to perform PCR reactions were set as described below. The exact number of 
cycles performed with given primers and their annealing temperatures are shown in Table 2.3. 
All PCR reactions started with the initial incubation for 5 min at 95°C, followed by 33-35 cycles 
(depending on primer pair used) with each cycle consisting of denaturation of cDNA template, 
followed by annealing of the primers and subsequent elongation of the complementary DNA 
strand. Accordingly, the samples were heated for 6 sec at 95°C for denaturation, then incubated 
for 30 sec at 56-67°C (depending on primer used) for annealing followed by 30 sec at 72°C for 
elongation. After the last cycle the samples were maintained for another 5 min at 72°C to ensure 
final elongation. PCR reactions were stored at 4°C before analysis. 
2.10.6. Electrophoresis 
In order to analyse PCR results, electrophoresis using agarose gels was performed. Accordingly, 
for each gel 120ml of 2% (w/v) agarose solution (Bioline) in 1x TAE buffer (see section 2.11.2) 
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was prepared. The solution was then heated to dissolve agarose and following cooling; 2µl 
ethidium bromide solution (10mg/ml) (Sigma-Aldrich) was added to the solution and poured into 
a tray with inserted comb. Any bubbles that were created during pouring the gel were pushed to 
the side using a disposable pipette tip. The agarose gel was left to set for at least 30 min and 
subsequently transferred to a tank filled with 1x TAE. 10µl of each PCR sample was mixed with 
2µl of 6X loading dye (see section 2.11.2) before loading onto the gel. Accordingly the 
electrophoresis was set for 30 min and 140V. Hyperladder IV (Bioline) was used as a DNA 
molecular weight marker. The gels were analyzed using Chemi Imager 4400 UV transilluminator 
(Alpha Innotech Corporation, USA). 
2.10.7. Real-time polymerase chain reaction 
Real-time (quantitative) PCR using SYBR green was performed in order to quantify differences 
in expression levels of Gdnf and Bmp4 between unstimulated and NKC CM- stimulated D1 cells. 
In order to prepare 20 µl of reaction mix, 10 µl of SYBR Green JumpStart Taq Ready Mix 
(Sigma-Aldrich), 1µl forward primer (6.25pmol/µl) (Table 2.3), 1µl reverse primer (6.25pmol/µl) 
and 1µl of template and 7µl nuclease-free water (Sigma-Aldrich) were combined. However, in 
order to prevent differences in amount of cDNA added, a general master mix was prepared which 
was then used to prepare all PCR reactions. Each time 11µl of mix containing the Jump Start Taq 
Read Mix and template was combined with a mix containing 9µl of specific primers mixed with 
water. In all experiments expression levels of Gdnf or Bmp4 gene were compared to the 
expression levels of a reference gene, Gapdh (Table 2.3). In addition, a no-template control was 
included in each experiment to detect any contamination. For each PCR reaction duplicates of 
technical replicates were performed. All mixes were
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spun down before transferred to a Rotor-Gene 3000 centrifugal real-time cycler (Corbett 
Research, Australia) with Rotor Gene Software (Version 6). The conditions used to perform 
quantitative PCR reactions were set as described below. First in order to activate the DNA 
polymerase an initial incubation for 10 min at 95oC was performed, followed by 35 cycles 
consisting of 6 sec at 95oC for denaturation, then 30 sec at 62oC for annealing and finally 30 sec 
at 72oC for elongation. SYBR Green fluorescence was measured at the end of the each 72oC step. 
Initially, the amplicons were analysed using agarose gel electrophoresis (see section 2.9.6). 
However, additionally for each experiment a melting curve for each PCR reaction following the 
final cycle was generated, to assess the presence of non-specific products and primer dimers. The 
melting curve analysis was performed using the Rotor-Gene software. Accordingly the melting 
curve was generated between 72ºC and 95ºC with 1ºC rise per each step. 
2.10.8. Efficiency of the real-time polymerase chain reaction 
In order to quantify expression, efficiency of Gapdh, Gdnf and Bmp4 primers in the PCR 
reactions had to be determined. Accordingly, real-time PCR reactions were performed using 
serial dilutions of the template from E13.5 kidney rudiment and each primer pair. Serial dilutions 
of the template in water were prepared as follows: undiluted template, 1/5, 1/25, 1/125, 1/625 and 
1/3125. Triplicates of technical replicates were performed. The conditions for the real-time PCR 
were the same as above (see section 2.9.7). SYBR Green fluorescence was measured at the end of 
each elongation step. When a primer yields a 2-fold increase in the amount of PCR product in 
every cycle its efficiency is 2 thus the efficiency of the primers is 100%. In this study the 
determined efficiencies of the primers for Gapdh, Gdnf and Bmp4 were 1.95, 1.7 and 1.9 
respectively. The Rotor-Gene software was used for analysis. 
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2.10.9. Quantification of real-time polymerase chain reaction 
Suitability of SYBR green for quantitative PCR was demonstrated before (Simpson et al. 2000). 
During the exponential phase of the real time PCR reaction, the increase in fluorescence emitted 
from SYBR Green bound to double-stranded DNA is also exponential. The cycle threshold (Ct) 
value indicates the start of the exponential phase and depends on the number of copies of target 
sequence initially present in the PCR mix. If a particular cDNA is highly abundant then the Ct 
value will be low as the exponential phase is reached sooner than for a less abundant template. 
The Rotor-Gene software was used to determine Ct values in all experiments. Subsequently 
Pfaffl method (Pfaffl 2001) was used to quantify relative expression levels between unstimulated 
and NKC CM stimulated-D1 cells. In this method a relative expression ratio is established based 
on PCR efficiency (E) and the crossing point (CP) at which the fluorescence was detected to raise 
above the background fluorescence, i.e., the Ct value (Pfaffl 2001). The Pfaffl’s equation is 
shown below.  
 
As demonstrated in the equation, the relative expression ratio of a target gene is normalised with 
the expression of an endogenous reference gene transcript. The Etarget is the real-time PCR 
efficiency of target gene transcript whereas the Eref is the real-time PCR efficiency of a reference 
gene transcript. The ∆Cttarget is the Ct difference of control – sample of the target gene transcript 
and the ∆Ctref is the Ct difference of control – sample of reference gene transcript. In the current 
study the ratio was calculated based on the E and the Ct difference of the target genes Gdnf or 
Bmp4 in unstimulated D1 cells versus NKC CM stimulated D1 cells and the E and the CP 
ratio = 
(Etarget)∆Cttarget(control-sample) 
(Eref)∆Ctref(control-sample) 
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difference of Gapdh of the unstimulated D1 cells versus NKC CM stimulated cells.  
2.11. Statistical analysis 
Statistical analysis was performed using Student’s t-test. Differences between samples were 
expressed as mean of standard error. P<0.05 was considered as significant. 
2.12. Culture media and buffers 
2.12.1. Culture media 
Standard culture medium  
• High glucose Dulbecco’s Modified Eagle Medium (DMEM) (Sigma-Aldrich) 
• 10% (v/v) foetal calf serum (FCS) (PAA Laboratory)   
• 2mM L-glutamine (Invitrogen) 
• 1% (v/v) penicillin/streptomycin (Sigma-Aldrich) 
MEF culture medium  
• High glucose DMEM (Sigma-Aldrich) 
• 10% (v/v) FCS (PAA Laboratory)   
• 2mM L-glutamine (Invitrogen) 
• 1% (v/v) penicillin/streptomycin (Sigma-Aldrich) 
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• 1% (v/v) non-essential amino acids (Sigma-Aldrich) 
• 0.01% (v/v) 50mM 2-mercaptoethanol (Invitrogen)  
ESC culture medium  
• High glucose DMEM (Sigma-Aldrich) 
• 10% (v/v) FCS (PAA Laboratory)   
• 2mM L-glutamine (Invitrogen) 
• 1% (v/v) penicillin/streptomycin (Sigma-Aldrich) 
• 0.15% (v/v) 100mM monothioglycerol (Sigma-Aldrich) 
• 1000U/ml leukaemia inhibitory factor (LIF) (Chemicon) 
Adipogenic inductive medium  
• High glucose DMEM (Sigma-Aldrich) 
• 10% (v/v) FCS (PAA Laboratory)   
• 2mM L-glutamine (Invitrogen) 
• 1% (v/v) penicillin/streptomycin (Sigma-Aldrich) 
• 1nM dexamethasone (Sigma-Aldrich) 
• 5µg/ml insulin (Sigma-Aldrich) 
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• 0.5µM 3-isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich) 
• 50µM indomethacin (Sigma-Aldrich) 
Osteogenic inductive medium  
• High glucose DMEM (Sigma-Aldrich) 
• 10% (v/v) FCS (PAA Laboratory)   
• 2mM L-glutamine (Invitrogen) 
• 1% (v/v) penicillin/streptomycin (Sigma-Aldrich) 
• 20mM β-glycerol phosphate (Sigma-Aldrich) 
• 0.5µM L-ascorbic acid sodium (Sigma-Aldrich) 
• 1nM dexamethasone (Sigma-Aldrich) 
• 50ng/ml thyroxine (Sigma-Aldrich) 
Chondrogenic inductive medium  
• High glucose DMEM (Sigma-Aldrich) 
• 2mM L-glutamine (Invitrogen) 
• 1% (v/v) penicillin/streptomycin (Sigma-Aldrich) 
• 500 ng/ml bone morphogenetic protein 6 (R and D) 
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• 10 ng/ml transforming growth factor β-3 (R and D) 
• 0.1nM dexamethasone (Sigma-Aldrich) 
• 50µg/ml L-ascorbic acid sodium (Sigma-Aldrich)  
• 40µg/ml proline (Sigma-Aldrich)  
• 1x ITS+3 liquid media supplements comprising: insulin, transferring, selenious acid, 
bovine serum albumin, linoleic acid and oleic acid (Sigma-Aldrich) 
• 100µg/ml sodium pyruvate (Sigma-Aldrich) 
2.12.2. Buffers and solutions 
0.1% (w/v) gelatine solution 
• 1g porcine gelatine type A (Sigma-Aldrich) 
• 1L distilled H20 
The solution was autoclaved before use. 
4% (w/v) paraformaldehyde 
• 4g PFA (Sigma-Aldrich) 
• 100ml PBS 
The solution was heated to 60-70ºC and ultimately the pH was adjusted to 7.4-7.6. 
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0.5% (w/v) Oil Red O solution  
• 0.5g Oil Red O (Sigma-Aldrich) 
• 100ml isopropanol (Sigma-Aldrich) 
The solution was filtered using Whatman paper and diluted 3:2 in H20 before use. 
2% (w/v) Alizarin Red S solution 
• 2g Alizarin Red S (Sigma-Aldrich) 
• 100ml distilled H2O 
The solution was filtered using Whatman paper and the pH adjusted to 4.1-4.3 with 5% 
ammonium hydroxide.  
15% (w/v) sucrose solution 
• 15g sucrose (Sigma-Aldrich) 
• 100ml PBS 
The solution was autoclaved before use. 
Subbing solution  
• 2.5g porcine gelatine type I (Sigma-Aldrich) 
• 500ml distilled H2O 
• 0.25g CrKSO4x12H2O (Sigma-Aldrich) 
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1% (w/v) Alcian Blue solution  
• 1g Alcian Blue (Sigma-Aldrich) 
• 100ml 0.1N HCl pH 1 (Invitrogen) 
The solution was filtered using Whatman paper before use.  
Phosphate buffered saline  
• 6mM Na2HPO4 (Sigma-Aldrich) 
• 2mM KCl (Sigma-Aldrich) 
• 0.137M NaCl (Sigma-Aldrich) 
The pH was adjusted to 7.4.  
TAE buffer (50x) 
• 40mM Tris base (Sigma-Aldrich) 
• 20mM glacial acetic acid (AnalarR) 
• 0.5M EDTA (Sigma-Aldrich) 
• up to 1L distilled H20 
The pH was adjusted to 8.0. Before use the buffer was diluted.  
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Gel loading buffer (6x) 
• 3ml glycerol (Sigma-Aldrich) 
• 25mg bromophenol blue (Sigma-Aldrich) 
• 10ml distilled H20 
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Chapter 3: Differentiation potential of mesenchymal stem cells and their 
labelling methods 
3.1. Introduction 
The aim of the study is to investigate the potential of MSC to contribute to kidney development 
in an in vitro model of nephrogenesis. Accordingly, the capacity of MSCs to become integrated 
into developing renal structures and their subsequent differentiation into specific kidney 
phenotypes will be tested. The objective of the first part of the chapter is therefore to demonstrate 
multilineage differentiation potential of MSCs employed in this study by performing adipogenic, 
osteogenic and chondrogenic differentiation assays. The ability of MSCs to undergo in vitro 
adipogenesis, osteogenesis and chondrogenesis upon stimulation with appropriate inductive 
medium is widely used for identification and characterisation of MSC populations (Pittenger et 
al. 1999; Peister et al. 2004). Nevertheless, different MSC populations might differ substantially 
in their differentiation potential (Peister et al. 2004; Anjos-Afonso and Bonnet 2007). It has been 
described that MSCs isolated from various mouse strains have different abilities to differentiate 
(Phinney et al. 1999; Peister et al. 2004). It was demonstrated that bone marrow-derived MSCs 
isolated from Bl/6 mice more readily undergo osteogenic differentiation than from BALB/c mice 
which in turn have higher adipogenic potential. MSCs isolated from Bl/6 and BALB/c have also 
lower chondrogenic potential in comparison with MSCs derived from FVB/N and DBA1 mice 
(Peister et al. 2004). In addition, over time the number of broad flattened and slowly growing 
cells increases over rapidly expanding spindle-shaped cells in the MSC culture (Digirolamo et al. 
1999). It has been shown that different morphologies relate to dissimilar differentiation potential 
of the cells. Cultures harbouring thin spindle-shaped MSCs differentiate more readily towards 
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adipocytes, whereas cultures composed of wider spindle-shaped cells have greater chondrogenic 
potential (Sekiya et al. 2002). Even cells derived from the same MSC colony can vary in their 
differentiation potential (Digirolamo et al. 1999; Pittenger et al. 1999). Moreover the 
differentiation capability and expansion potential of the cells decreases with increasing passage 
number (Digirolamo et al. 1999). Finally, the proliferation and differentiation abilities of bone 
marrow-derived MSCs depend also on the age of the donor and tend to decline with increasing 
age of donor (Kretlow et al. 2008). Infrequently, MSCs have been described to spontaneously 
differentiate. For instance, osteogenic differentiation was observed in high passage human MSC 
cultures in the absence of inductive medium (Digirolamo et al. 1999). In current study a clonal 
multipotent stromal stem cell line called D1 and human primary MSCs were employed. D1 were 
demonstrated previously to undergo adipogenic, osteogenic and chondrogenic differentiation 
(Diduch et al. 1993; Juffroy et al. 2009). Similarly human MSCs were demonstrated to have 
adipogenic, osteogenic and chondrogenic differentiation potential (Prockop 1997). 
The second part of this chapter is aimed at establishing the most appropriate method for labelling 
of MSCs. This is important as the renogenic potential of the MSCs will be investigated by 
incorporating the cells into mouse kidney rudiments to generate kidney chimeras. It is therefore 
necessary to use a labelling method that will enable MSCs to be distinguished from the kidney 
cells. There exists a range of labelling methods available for imaging cells. When choosing 
appropriate fluorophores for staining, some important aspects such as brightness or resistance to 
photobleaching of the particular fluorophore need to be taken into consideration, as the properties 
among different fluorophores can vary significantly (Schroeder 2008). To date, MSCs have been 
successfully labelled with a number of transient labels, including fluorescent dyes such as the 
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green cell tracer carboxyfluorescein diacetate succinimidyl ester (CFDA SE) which reacts with 
intracellular amines (Togel et al. 2005), and the red fluorescent cell linker PKH26 that is 
incorporated into the cell membrane (Morigi et al. 2010), or nanoparticles such as quantum dots 
(QDs) (Rosen et al. 2007) and superparamagnetic iron oxide nanoparticles (SPIONs) (Jendelova 
et al. 2004). It has been also possible to introduce fluorescent proteins into MSCs by genetically 
modifying the cells to stably express fluorescent proteins, like the green fluorescent protein 
(GFP) (Fukui et al. 2009). Finally, staining using species-specific antibodies can be used for 
detecting human MSCs in some experimental settings (Azizi et al. 1998; Jeong et al. 2009). For 
this study, the following labelling methods for mouse MSCs will be investigated for their 
suitability; namely, transient labelling using CFDA SE or QDs, and permanent labelling using 
genetically encoded GFP. For human MSCs, the suitability of post-staining using a species 
specific antibody to a human nuclear antigen will be evaluated.  
CFDA SE (carboxyfluorescein diacetate succinimidyl ester) is a non-fluorescent membrane-
permeant dye, which in the intracellular environment, becomes fluorescent 5-(and-6)-
carboxyfluorescein succinimidyl ester, due to removal of acetate groups by esterases. This 
molecule is not only less membrane permeant than the CFDA SE, but also reacts with 
intracellular amine groups, forming a range of fluorescent conjugates. CFDA SE can be used for 
tracking non-dividing cells over a long period of time; however, its intensity in proliferating cells 
is reduced after each cell division (Parish 1999). Nevertheless, several groups have successfully 
used CFDA SE for tracking MSCs (Togel et al. 2005; Kucerova et al. 2007; Fiorina et al. 2009).   
QDs are fluorescent nanocrystals that are synthesised from semiconductor materials. They have 
proven to be ideal probes for sensitive fluorescent imaging. As QDs are highly photostable, they 
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are resistant to photobleaching, whereas the high fluorescence intensity of the nanoparticles 
enables sensitive detection. Furthermore QDs show broad absorption but narrow emission 
spectra, which facilitates simultaneous detection of multiple colours (Pinaud et al. 2006; Solanki 
et al. 2008). QDs have been used for imaging a variety of cell types, including HeLa cells 
(Jaiswal et al. 2003), cardiac myocytes (Koshman et al. 2008) and embryonic stem cells (Lin et 
al. 2007). Human MSCs labelled with commercially available QDs were shown to maintain their 
normal rate of proliferation, and their multilineage differentiation potential. Importantly, the 
stained cells were able to retain the label up to 8 weeks (Rosen et al. 2007). Further, Moioli et al 
showed that human MSCs labelled with bioconjugated QDs maintain multilineage differentiation 
potential. Additionally, no difference in viability and proliferation of the cells following the 
staining was noticed (Shah et al. 2007). Another study using commercially available QDs 
demonstrated high labelling efficiency with minimal cytotoxic effects on rat MSCs (Muller-Borer 
et al. 2007). Similarly as for CFDA SE, progressive loss of QDs from QD-labelled cells was 
demonstrated (Rosen et al. 2007; Pi et al. 2010).  
In contrast to fluorescent dyes and nanoparticles, GFP labelling requires some genetic 
modification in order to achieve stable expression of fluorescent protein. As a consequence, no 
loss of signal due to cell division occurs (Schroeder 2008). It has been reported that 
hematopoietic stem cells have been successfully modified to express GFP without any noticeable 
effects on their characteristics, such as long-term multilineage potential (Tao et al. 2007). MSCs 
isolated from GFP transgenic animals have been shown to display the same features as cells 
isolated from non-transgenic animals (Raimondo et al. 2006; Ripoll and Bunnell 2009). Ripoll 
and Brunnell, who used MSCs isolated from enhanced GFP transgenic mice, showed that 
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expression of GFP in the cells did not alter their adipogenic and osteogenic potential. Similarly, 
the surface expression marker profile of GFP MSCs remained unchanged (Ripoll and Bunnell 
2009). Apart from cells that can be directly isolated from GFP transgenic mice, MSCs can be 
transfected with GFP encoding plasmids to trigger GFP expression (Min et al. 2002; Song and 
Tuan 2004). Such cells have been subsequently used for in vivo tracking of MSCs in injured 
porcine myocardium (Min et al. 2002) or in vitro studies on transdifferentiation potential of 
MSCs (Song and Tuan 2004). Another method of introducing GFP into MSCs takes advantage of 
viral transduction: here, the cells are infected with a virus encoding GFP (Lu et al. 2005; Yang et 
al. 2009). For example, this method of labelling has been used for imaging MSCs in a spinal cord 
injury model (Lu et al. 2005). Finally, although GFP expression was not described to affect 
multilineage differentiation potential of MSCs, GFP presence was found to have some adverse 
effects on the kidney, as a GFP transgenic mouse strain was shown to display renal defects (Guo 
et al. 2007). An earlier study showed also that expression of enhanced GFP or GFP fusion 
proteins lead to suppression of NF-κB and JNK signalling pathways in the HEK2934-T cells, a 
human embryonic kidney cell line (Baens et al. 2006).  
Finally, staining for human specific antigens can be used for detection of human primary MSCs. 
Previously such staining was performed to track human bone marrow–derived MSCs in rat brain 
(Azizi et al. 1998) and in rat degenerated tailbone disc (Jeong et al. 2009). In this way cells do 
not undergo modifications that could cause loss of differentiation potential, as the 
immunostaining is performed at the end of the assay. Also, no progressive loss of the label can 
occur during culture period. However, confirmation of the specificity of the antibody is crucial 
for effective detection. 
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The aim of this chapter is to confirm the multilineage potential of the MSC used in this study and 
to determine the most appropriate labelling method for further experiments. In order to study the 
potential of MSC to differentiate into kidney-specific cell types in the kidney chimeras, first the 
multipotency of MSCs will be confirmed to ensure that employed cells have the potential to 
differentiate. Accordingly, the adipogenic, osteogenic and chondrogenic capacity of MSCs will 
be assessed using standard differentiation protocols. In order to examine the contribution of 
MSCs to developing kidney structures, MSCs will require labelling to discriminate them from 
kidney cells. Several labelling methods can be used for labelling of MSCs, as described above. 
To elucidate the most appropriate labelling method for MSCs, labelling with CFDA SE, QDs, 
GFP and staining with species-specific antibody will be performed.  
3.2. Results 
In this chapter, the adipogenic, osteogenic and chondrogenic differentiation potential of MSCs 
used throughout this study is investigated, in order to ensure that the cells display typical MSC 
multipotency. Furthermore, different MSC labelling methods are evaluated to identify which 
methods are likely to be appropriate for identifying MSCs within the chimeric kidneys. Transient 
labelling using CFDA SE or QDs, permanent labelling using genetically encoded GFP and 
staining with species-specific antibody are compared.  
3.2.1. The multilineage differentiation potential of the mouse D1 MSC line 
In order to prevent problems caused by contamination with hematopoietic cells and the 
heterogeneity of mouse MSC cultures, a clonal multipotent stromal stem cell line called D1 has 
been employed in this study. This line was derived from the bone marrow of the BALB/c mice 
and displays common MSC features (Diduch et al. 1993). D1 have the typical spindle-shaped 
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morphology and demonstrate characteristic adipogenic, osteogenic and chondrogenic 
differentiation potential (Diduch et al. 1993; Juffroy et al. 2009). D1 cells have been used before 
in stem cell-based applications aimed at bone formation (Shen et al. 2002; Juffroy et al. 2009). 
The cells form uniform, adherent monolayer cultures with cells displaying characteristic spindle-
shaped morphology, as demonstrated in Figure 3.1. 
 
Figure 3.1 Morphology of D1 cells, a mouse bone marrow-derived MSC line.  
To confirm the differentiation potential of the D1 cells used in this study, subconfluent D1 
cultures were stimulated for two weeks with adipogenic and osteogenic inductive media, as 
described before by Peister et al (Peister et al. 2004). Unstimulated cultures were treated 
identically, except that they were plated in complete culture medium. After approximately 1 week 
of stimulation with adipogenic inductive media, lipid vacuoles become visible inside some of the 
100µm 
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induced D1 cells, indicating the start of adipogenic differentiation. Subsequent staining with Oil 
Red on day 14 confirmed the presence of lipid vacuoles, as shown in Figure 3.2a. Meanwhile, the 
unstimulated D1 cells did not show any vacuole formation (Figure 3.2b).  
As depicted in Figure 3.2c, the stimulation with osteogenic inductive medium for 14 days 
resulted in characteristic extracellular calcium deposits in the cultures visualized with Alizarin 
Red, confirming the osteogenic potential of D1 cells. No deposits were detected in cultures of 
unstimulated cells maintained in normal growth medium for 14 days (Figure 3.2d). 
To achieve chondrogenic differentiation, MSCs were cultured as a micromass in the presence of 
chondrogenic inductive media, as described previously (Peister et al. 2004). In brief, D1 cells 
were spun down to form a pellet and subsequently cultured at the bottom of a 15ml tube in the 
presence or absence of inductive media for 14 days. An important feature of chondrogenic 
differentiation is the production of extracellular proteoglycans which can be detected with Alcian 
Blue solution (Karlsson et al. 2007). In order to detect chondrogenic differentiation Alcian Blue 
staining was performed on 10 µm frozen sections prepared from fixed micromass cultures. 
Proteoglycans, visualised by blue staining, were detected in the periphery of the pellet formed 
with the stimulated D1 cells, as shown in Figure 3.2e. No significant staining occurred in sections 
of control pellets cultured in the absence of inductive media (Figure 3.2f). In addition, it was 
found that the micromass culture induced with chondrogenic medium was noticeably larger than 
control. The difference in size can be observed with the representative micromass section (Figure 
3.2e and f). 
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Figure 3.2 Confirmation of multilineage differentiation potential of D1 cells following stimulation with 
inductive media. (a) Following 14 days culture in adipogenic inductive medium, D1 cells displayed lipid 
vacuoles that stained positively with Oil Red. (b) Oil Red staining of control D1 culture (D1 cells cultured 
in standard culture medium) showed that no lipid vacuoles had formed. (c) Following 14 days culture in 
osteogenic inductive medium, Alizarin Red staining showed the presence of extracellular calcium deposits 
in D1 culture. (d) Alizarin Red staining of control D1 cells showed that no calcium deposits were present 
in the culture. (e) Following 14 days of micromass culture in chondrogenic inductive medium, Alcian 
Blue staining of frozen sections showed positive staining in the periphery of the pellet (arrows), indicating 
that cartilage proteoglycans were present. (f) Alcian Blue staining of control micromass sections showed 
no evidence of cartilage proteoglycans.  
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In summary, D1 cells demonstrated adipogenic, osteogenic and chondrogenic differentiation 
potential in vitro. The multipotency of D1 cells was therefore confirmed.  
The multilineage differentiation potential of human MSCs 
Bone marrow-derived human primary MSCs depleted of hematopoietic cells were purchased 
from Lonza. An important concern regarding primary human MSCs is the loss of multipotency of 
the cells following prolonged in vitro culture (Digirolamo et al. 1999). It has been shown that 
human MSCs can reach senescence after several passages (Baxter et al. 2004). In order to avoid 
problems associated with prolonged culture, in this study human MSCs were used only at low 
passage numbers. Human cells were cultured and subsequently differentiated towards adipogenic 
and osteogenic lineages according to instructions provided by the supplier. In standard culture 
conditions human MSCs displayed the same characteristic spindle shaped morphology despite 
being larger than the mouse MSC (Figure 3.3).  
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Figure 3.3 Morphology of human bone marrow-derived MSCs.  
In order to confirm the adipogenic differentiation potential of these cells, confluent human MSCs 
(passage 4) were stimulated with adipogenic inductive medium for 3 days followed by 
stimulation with adipogenic maintenance medium for 1-3 days. Three cycles of stimulation with 
inductive and subsequently maintenance medium were performed. Finally, the cells were cultured 
one week in adipogenic maintenance medium. The cells not subjected to adipogenic induction 
were cultured in adipogenic maintenance medium for the same period of time. As shown in 
Figure 3.4a, following 20 days of culture, staining with Oil Red confirmed the presence of lipid 
vacuoles in the stimulated human MSCs. No vacuole formation occurred in controls that were 
cultured in maintenance medium only (Figure 3.4b). 
To confirm the osteogenic potential of the human MSC, the cells were cultured for 14 days in 
osteogenic inductive medium, following which they were stained with Alizarin Red to detect the 
100µm 
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presence of calcium deposits. Human MSCs cultured in the inductive medium demonstrated 
evidence of calcium deposits (Figure 3.4c), whereas no deposits were detected in controls that 
were cultured in normal growth medium for 14 days (Figure 3.4d). 
Accordingly human MSCs were shown to display adipogenic and osteogenic differentiation 
capacity in vitro. No chondrogenic assay was performed for human MSCs. Herewith the 
differentiation potential of mouse and human MSCs was confirmed.  
3.2.2. Identification of suitable labelling method for tracking of MSCs 
As mentioned in the introduction, several labelling methods can be utilized for imaging MSCs. 
For the purpose of this study, the suitability of the following methods has been assessed for 
detecting MSC following their incorporation into mouse kidney rudiment chimeras: (i) labelling 
with the vital cell tracker, CFDA SE; (ii) QD labelling; (iii) lentiviral transduction with GFP, (iv) 
staining with a species-specific antibody which was used only in conjunction with human MSCs.  
In the first instance, the suitability of two transient labelling methods was assessed, in order to 
avoid potential problems associated with genetic modification. To be effective, the labelling 
method would need to show high labelling efficiency and low cytotoxicity. Furthermore, as the 
concentration of non-genetically encoded fluorophores is reduced with each cell division 
(Schroeder 2008), it was important to find a labelling method that would enable  detection after 
several days of culture. A comparison was made between two transient labelling methods, CFDA 
SE and QDs, in order to elucidate their suitability for long term tracking. D1 cells were labelled 
with 10 µM CFDA SE or 10 nM QDs according to manufacturer’s instructions. 
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Figure 3.4 Confirmation of multilineage differentiation potential of human primary MSCs following 
stimulation with inductive media. (a) Stimulated with adipogenic inductive medium human MSCs after 3 
cycles of adipogenic induction and subsequent week of culture in maintenance medium accumulated lipid 
vacuoles that stained positively with Oil Red. (b) Oil Red staining in the absence of stimulation: no lipid 
vacuoles were present in human MSCs cultured in maintenance medium only for the same period of time. 
(c) Alizarin Red staining indicated the presence of extracellular calcium deposits in human MSC cultures 
stimulated with osteogenic inductive medium after 14 days of culture. (d) Alizarin Red staining in control 
MSCs maintained in standard culture medium showed that no calcium deposits were present after 14 days 
of culture. 
c d 
100µm 100µm 
200µm 200µm 
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No visible difference in labelling efficiency was detected when the cells were analyzed directly 
after staining. All cells were stained following labelling with either CFDA SE (Figure 3.5a and b) 
or QDs (Figure 3.5e and f). Since CFDA SE interacts with intracellular molecules upon labelling, 
a diffuse cytoplasmic staining was observed (Figure 3.5a and b), whereas QDs showed a patchy 
pattern as nanoparticles tend to be unequally distributed in the cells (Figure 3.5e and f). After 5 
days of standard culture no obvious cytotoxic effect was observed in any of the conditions. 
However, only the cells incubated with QDs remained labelled. As shown in Figure 3.5e-h QD 
staining remained intense, although in comparison to day 0 notably fewer cells were labelled with 
QDs. CFDA SE, on the other hand, was not detectable on the 5th day following labelling (Figure 
3.5c and d).  
Stable transduction or transfection with GFP is an efficient labelling method that should not lead 
to loss of signal over a period of time as the cells constitutively express the fluorescent protein 
that is used to detect them (Schroeder 2008). In this study, a lentivirus encoding enhanced GFP 
under control of the spleen focus-forming virus (SFFV) promoter has been used to induce 
expression of GFP in mouse MSCs. D1 cells were incubated for 24h with lentiviral particles 
carrying GFP (obtained from Sokratis Theocharatos, University of Liverpool). On the 3rd day 
following transduction, the cells were analyzed for GFP expression. No visible signs of 
cytotoxicity were observed. As shown in Figure 3.6a and b, although the levels of expression 
varied between cells, all D1 cells after 3 passages from initial labelling still expressed GFP, and 
maintained GFP expression at least for the next 20 passages.  
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Figure 3.5 CFDA SE- and QD-labelling of D1 MSCs. (a-d) D1 cells stained with CFDA SE. (a) Bright field and (b) 
fluorescent image of the D1 cells stained with CFDA SE directly after labelling. (c) Bright field and (d) fluorescent 
image of the D1 cells stained with CFDA SE after 5 days. (e-h) D1 cells stained with QDs. (e) Bright field and (f) 
fluorescent image of the D1 cells stained with QDs directly after labelling. (g) Bright field and (h) fluorescent image of 
the D1 cells stained with QDs after 5 days.  
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Figure 3.6 GFP labelling of D1 cells using lentiviral transduction. (a) Bright field and (b) fluorescent 
image of the D1 cells transduced with GFP.  
Although it has been demonstrated that GFP MSCs are not affected by the enforced expression of 
fluorescent proteins and maintain adipogenic and osteogenic potential as well surface expression 
marker profile (Ripoll and Bunnell 2009), there are reports describing adverse effects associated 
with GFP expression (Baens et al. 2006; Guo et al. 2007). For this reason, the differentiation 
potential of transduced D1 cells was verified. GFP D1 cells were induced to undergo 
adipogenesis and osteogenesis in the presence of the appropriate inductive media, as described 
earlier in section 3.2.1. It was found that the GFP D1 cells were able to undergo both adipogenic 
(Figure 3.7a-d) and osteogenic (Figure 3.8e-f) differentiation, as visualized by Oil Red and 
Alizarin Red staining, respectively, whereas no staining was detected in uninduced cultures. 
Above, three different labelling methods for tracking of D1 cells have been described. As the 
assessment of the renogenic potential of MSCs will require formation of kidney chimeras using 
mouse kidney cells, D1 cells, which are of mouse origin, could not be detected with a species-
specific antibody. Nevertheless, a species-specific antibody can enable discrimination between 
human MSCs and mouse cells. To test the suitability of a human anti-nuclear antibody, human 
MSCs were immunostained using the human anti-nuclei antibody and co-stained with DAPI 
100µm 100µm 
a b 
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(Figure 3.8a-c). No unspecific staining of human cells was detected when the primary antibody 
was omitted (Figure 3.8d-f). Further, the potential cross-reactivity of the antibody was tested on 
mouse cells. Using the protocol for formation of kidney chimeras described in the section 4.2.1 
mouse embryonic kidneys were disaggregated and obtained kidney cells re-aggregated to form 
new kidneys in the absence of human MSCs. The re-aggregated mouse kidneys containing only 
mouse cells were stained subsequently with an antibody identifying expression of a nuclear 
kidney marker Wt1 and the antibody detecting human nuclei. Accordingly expression of Wt1 was 
observed; however, no expression of human nuclear antigen was found in the re-aggregated 
mouse kidney (Figure 3.9a-c). Some unspecific signal was detected in cytoplasm of the kidney 
cells. 
In summary, several labelling methods were tested here for their suitability for imaging of MSCs, 
including labelling with CFDA SE, QDs, and GFP as well as staining with a species-specific 
antibody. For the purpose of this study labelling with QDs and viral transduction with GFP were 
identified as most suitable for tracking mouse MSCs. Furthermore the specificity of species-
specific antibody for human MSC detection was assessed and subsequently proven to be suitable 
for human MSC tracking. 
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Figure 3.7 Confirmation of multilineage differentiation potential of GFP D1 cells (a) Stimulated with 
adipogenic inductive medium GFP D1 cells accumulate lipid vacuoles inside after 14 days of adipogenic 
induction. (b) GFP expression in induced towards adipocytes GFP D1 cells (in green). (c) Stimulated with 
adipogenic inductive medium GFP D1 cells display lipid vacuoles stained with Oil Red. (d) Oil Red 
staining of GFP D1 cells cultured in standard culture medium showed that no lipid vacuoles had formed.  
(e) Stimulated with osteogenic inductive medium GFP D1 cells show extracellular calcium deposits 
visualized using Alizarin Red staining after 14 days of osteogenic induction. (f) Alizarin Red staining of 
GFP D1 cells cultured in standard culture medium showed that no calcium deposits were present. 
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Figure 3.8 Staining of human MSCs using an anti-human nuclei antibody. (a) Human MSCs labelled with anti-
human antibody. (b) Labelled human MSCs co-stained with DAPI. (c) Merged image of a and b indicates that all 
cells are labelled. (d) Human MSCs incubated only with appropriate secondary antibody; the anti-human 
antibody was omitted. (e) Human MSCs co-stained with DAPI (in blue). (f) Merged image of d and e.  
 
 
Figure 3.9 Assessment of specificity of anti-human nuclei antibody tested on mouse cells. (a) Staining using the 
antibody detecting human nuclei performed on the same re-aggregated kidney. (b) A re-aggregated mouse 
kidney stained with an antibody identifying expression of a nuclear kidney marker Wt1. (c) Merge. 
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3.3. Discussion 
In this chapter the multipotency of the mouse and human MSCs that will be used in renogenic 
assays performed in subsequent chapters has been confirmed and different labelling methods for 
MSCs have been assessed. Both mouse and human MSCs showed considerable multilineage 
differentiation potential. Furthermore, QD staining and GFP transduction were proven to be 
suitable methods for mouse MSCs labelling, similarly as antibody staining for human MSCs. 
3.3.1. The multilineage differentiation potential of MSCs 
The multilineage differentiation potential of mouse D1 MSCs and primary human MSCs was 
confirmed in standard assays for adipogenesis, osteogenesis and chondrogenesis. Following 
induction with adipogenic medium, MSCs started accumulating lipid vacuoles, a feature of 
adipogenic differentiation, whereas stimulation with osteogenic medium resulted in the 
appearance of calcium deposits, which are characteristic for osteogenic differentiation. No 
spontaneous differentiation of unstimulated cells occurred, neither towards the adipogenic, nor 
osteogenic lineage. Moreover, the adipogenic and osteogenic potential of both mouse and human 
MSCs has been confirmed. In addition, both stimulated and unstimulated D1 cells formed stable 
pellets in chondrogenic culture condition. Alcian Blue staining confirmed the presence of 
proteoglycans in stimulated cells, indicating chondrocyte differentiation of mouse MSCs. 
Nevertheless only a small amount of proteoglycans was detected. D1 cells are derived from bone 
marrow of BALB/c mouse and MSCs isolated from this mouse strain have been described to 
produce little proteoglycans in response to chondrogenic culture conditions (Peister et al. 2004). 
No chondrogenic differentiation was attempted for human MSCs in this study; however it has 
been shown previously that human MSCs efficiently undergo chondrogenesis in micromass 
 105 
culture. Accordingly human MSCs secrete proteoglycans and type II collagen and subsequently 
undergo hypertrophic differentiation, which is similar to the behaviour of chondrocytes in vivo 
(Mackay et al. 1998). Finally, another member of the laboratory, Laurence Glennon-Alty, 
demonstrated that human MSCs used in the current study are able to undergo chondrogenesis in 
the micromass culture condition (personal communication). In conclusion, MSCs employed in 
this study demonstrate genuine differentiation potential. 
3.3.2. The labelling methods of MSCs 
A number of labelling methods for MSCs was described in this chapter. Subsequently, D1 cells 
were labelled with CFDA SE, QDs and GFP, whereas human MSCs were stained with human 
specific antibody in order to elucidate the best labelling method for MSCs. All of the techniques 
have been employed previously in imaging of MSCs, as described in the introduction for this 
chapter. 
According to results presented here, QDs have proven to be a more persistent labelling agent than 
CFDA SE, since CFDA SE could not be detected in D1 cells with fluorescent microscopy after 5 
days of culture. CFDA SE loss of intensity, which led to exclusion of this labelling method from 
further experiments, has been demonstrated before in sheep MSCs after 8 days of culture (Weir et 
al. 2008). The loss of CFDA SE signal in D1 cells most likely occurred due to the high 
proliferation rate of the cells, as it was described that the intensity of this dye is reduced by half 
with every cell division (Lyons and Parish 1994).  
In contrast, cells labelled with QDs remained stained after 5 days of culture. The localisation of 
QDs within D1 cells was perinuclear. QDs were shown previously to localise around the nucleus 
in MSCs (Muller-Borer et al. 2007; Rosen et al. 2007). According to Muller-Borer et al QDs 
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found in the perinuclear region represent aggregated nanoparticles in endosomal vesicles (Muller-
Borer et al. 2007). Importantly, no loss of intensity of the QD-labelling occurred during the 
culture period. Nevertheless, fewer nanoparticles were detected inside the D1 cells after 5 days of 
in vitro culture than when observed directly after labelling. This is in agreement with Rosen et al, 
who showed progressive loss of QDs in human MSCs (Rosen et al. 2007). Loss of QD labelling 
was also reported in mouse embryonic stem cells (ESCs) (Lin et al. 2007; Pi et al. 2010) and 
mouse embryonic fibroblasts (MEFs) (Pi et al. 2010). In particular ESCs were demonstrated to 
rapidly lose the labelling within a few days of in vitro culture (Lin et al. 2007). MEFs are more 
likely to retain QD-labelling, since the decrease in the number of labelled cells over a period of 
time was smaller in MEFs than in ESCs (Pi et al. 2010). It was suggested that loss in QD-
labelling in ESCs is not due to cell division, as treatment with mitomycin C which inhibited the 
proliferation of the cells did not prevent loss of labelling. Accordingly other mechanisms such as 
degradation and excretion of QDs were proposed. At the same time inhibition of proliferation did 
help to retain the labelling in MEFs; implying that proliferation rate of the cells may be linked to 
loss of QD-labelling and that there exist different mechanisms for QDs loss in different cells (Pi 
et al. 2010). In contrast, human MSCs were shown to retain the QDs for up to 44 days in culture 
(Rosen et al. 2007). As QD-labelled human MSCs were observed to divide only a few times 
during this period of time (Rosen et al. 2007), the retention of QDs in human MSCs might be also 
attributed to lower proliferation rate of the cells. D1 cells used in this study seemed to lose QDs 
more rapidly than described by Rosen et al. human MSCs. Although no direct comparison 
between QD-labelled D1 cells and human MSCs was attempted, it might be possible that D1 cells 
lose QDs more quickly due to a higher proliferation rate. D1 cells used in this study were 
robustly proliferating and therefore passaged regularly every 2-3 days in comparison to primary 
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human MSCs used also in this study which displayed a much lower proliferation rate and 
accordingly were sub-cultured approximately once a week.  
An important issue regarding QDs is the potential transfer of nanoparticles from QD-loaded 
MSCs to other cells. It has been demonstrated that QDs can be transferred to other cells. 
Supernatants collected from the cultures of ESCs labelled with QDs were shown to contain QDs. 
Subsequently QDs derived from such supernatants were used to label MEFs in the presence of a 
labelling buffer (Pi et al. 2010). Nevertheless, Rosen et al. demonstrated that human MSCs 
labelled with QDs did not transfer QDs to unlabelled MSCs. Furthermore, no uptake of QDs by 
cardiac myocytes from mechanically disrupted QD-labelled human MSCs occurred (Rosen et al. 
2007). Another study on QD-labelled rat MSCs showed that QDs are not transferred when co-
cultured with cardiac myocytes (Muller-Borer et al. 2007). The transfer of QDs between the cells 
has not been addressed in this study.  
There are a number of reports describing the use of GFP-labelled MSCs (Min et al. 2002; Lu et 
al. 2005; Fukui et al. 2009). Transduction with GFP have been shown to be an ideal method for 
long term tracking of bone marrow-derived stem cells, namely hematopoietic stem cells (HSCs) 
(Tao et al. 2007) and MSCs (Lu et al. 2005). In the current study the D1 cells were transduced 
with lentiviral particles carrying enhanced GFP to induce constitutive GFP expression in MSCs. 
GFP D1 cells maintained labelling over a long period of time following many passages. 
However, GFP expression might have some adverse effects on the cells (Baens et al. 2006; Guo 
et al. 2007). It has been shown that expression of enhanced GFP or GFP fusion proteins inhibits 
NF-κB and JNK signalling pathways in a human embryonic kidney cell line (Baens et al. 2006). 
Furthermore GFP transgenic mouse expressing the fluorescent protein under the control of β-
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actin promoter were shown to display renal defects including increase in glomerular extracellular 
matrix, occasional mesangiolysis, and tubulointerstitial injury, which are accompanied by 
proteinuria. As it has been confirmed that the insertion of the transgene encoding GFP did not 
disrupt nor modify expression of adjacent genes, the authors suggested that high expression 
levels of GFP in the glomeruli might be responsible for the observed defects (Guo et al. 2007). In 
order to examine if stable GFP expression does not negatively affect D1 cells and hence alter 
their differentiation potential, GFP D1 cells were confirmed to undergo adipogenic and 
osteogenic degeneration in standard differentiation assays. The obtained results were in 
agreement with previous report showing that that expression of GFP in MSCs does not alter their 
adipogenic and osteogenic potential (Ripoll and Bunnell 2009). Nevertheless, it is difficult to 
speculate if GFP expression is going to influence D1 cells behaviour in the chimeric kidneys thus 
if GFP D1 cells will have similar differentiation potential towards kidney-specific phenotype as 
non-transduced cells. 
Another concern regarding GFP labelling of D1 cells is that the GFP expression might be 
downregulated when the labelled cells start to differentiae into kidney-like cells making the 
detection of D1 cells impossible. None of the GFP transgenic mice was shown to ubiquitously 
express GFP in all its tissues. Accordingly transgenic mice expressing GFP under the control of a 
human ubiquitin C promoter showed absence of GFP signal in the renal tissue (Swenson et al. 
2007). There is also a discrepancy in levels of GFP expression between different GFP transgenic 
mice in the same tissues. Different percentage of peripheral blood cells was detected to be 
positive for GFP in different transgenic mice (Swenson et al. 2007). It is therefore not clear if 
GFP D1 cells will not loss the expression when undergoing differentiation. In this study it was 
 109 
demonstrated that GFP expression is maintained upon adipogenic differentiation of D1 cells, 
which implicates that GFP D1 cell, might continue the express GFP when differentiating into 
renal structures. 
Finally, horizontal transfer of labels between cells via microvesicles should be taken in 
consideration. Microvesicles mediate intracellular communication by delivering proteins and 
mRNA between cells. Recently, it was demonstrated that microvesicles derived from human 
MSCs protect mice from tubular damage in glycerol-induced acute kidney injury (Bruno et al. 
2009). However, at the same time it has been shown that cultured tubular cells can take up 
microvesicles labelled with PKH-26 dye and subsequently become labelled with PKH-26 (Bruno 
et al. 2009). Therefore, there also exists the possibility that GFP mRNA can be transferred to 
kidney cells resulting in inaccurate GFP labelling of other cells than MSCs. 
In particular, for detection of human primary MSCs a staining for human antigen can be 
performed. It was demonstrated that human specific antibodies may be used for detection of 
human primary MSCs in fixed samples obtained from rats (Azizi et al. 1998; Jeong et al. 2009). 
Here the staining with human anti-nuclei antibody has been demonstrated as a suitable method 
for labelling human cells. 
In conclusion, QDs have proven to be better labelling agent than CFDA SE, although some loss 
of QD-labelling did occur during the in vitro culture period. Nevertheless, D1 cells labelled with 
QDs retained sufficient nanoparticles to be used for imaging, allowing sensitive detection over a 
period of 5 days. Therefore QDs can be used to investigate the renogenic potential of D1 cells in 
short-time experiments. Genetic modification using lentiviral transduction of D1 cells provided a 
long-term labelling method which did not result in loss of signal due to proliferation of the 
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cells. However, since it was described that GFP expression in the kidneys of transgenic mice led 
to renal defect it is unknown if GFP expression in this setting might not also influence the course 
of MSC differentiation. For this reason two labelling methods, QDs and GFP, were chosen for 
tracking D1 cells in the chimeric kidneys. For human MSCs antibody staining against human 
nuclear antigen will be used to track the cells. 
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Chapter 4: Potential of MSCs to contribute to metanephric development using 
the novel chimeric kidney system 
4.1. Introduction 
In the previous chapter, the multilineage potential of MSCs employed in this study was 
confirmed. Further, different labelling methods were established for tracking  the cells. In this 
chapter the potential of MSCs to contribute to metanephric development will be studied using an 
ex vivo model of mouse embryonic kidney development. As mentioned previously, direct 
injection of human MSCs into an in vitro developing kidney, widely used for other stem 
cell/progenitor populations, has proven to be insufficient to trigger MSC integration and 
subsequent differentiation towards nephron-like structures (Yokoo et al. 2005; Yokoo et al. 2006; 
Fukui et al. 2009). The sophisticated protocol developed by Yokoo et al. used to introduce MSCs 
into embryonic kidneys makes further investigation of their renogenic capacity difficult. The 
technique involves demanding experimental procedures such as injection of MSCs into 
intermediate mesoderm (IM) of an embryo, ex utero culture of the embryos with the transplanted 
cells, as well as altering the expression profile of the MSC by genetically modifying the cells so 
that they express GDNF (Yokoo et al. 2005; Yokoo et al. 2006; Fukui et al. 2009). Consequently 
no other reports have been published utilizing this particular methodology for differentiation of 
MSCs to kidney-specific cell types. Furthermore, therapeutic applications of engineered renal 
tissue comprising genetically modified MSCs would  not be feasible in the near future due to the 
potential  risks associated with viral insertion, such as the activation of proto-oncogenes (Mavilio 
and Ferrari 2008).  Recently, Unbekandt and Davies described a new approach, which permits ex 
vivo generation of chimeric embryonic kidneys. This uncomplicated method is based on 
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disaggregation and subsequent re-aggregation of mouse metanephroi. Similar to an intact, whole 
embryonic kidney, the re-aggregated kidneys display normal morphology and marker expression 
characteristic of normal developing kidneys. The technique has been used to integrate kidney 
progenitor cells with down-regulated Wt1 expression into a normal kidney rudiment in order to 
study nephron formation (Unbekandt and Davies 2010). Accordingly, this new methodology 
allows incorporation of cells from different origins into kidney rudiments and can be used to 
determine the contribution of MSCs to nephrogenesis in a controlled environment which mimics 
the metanephric development. As the protocol involves the disaggregation of the kidney 
rudiments, there are no problems with aggregation at the site of injection as observed previously 
by Yokoo et al. (Yokoo et al. 2005). In this chapter, the ability of MSCs to integrate into 
developing embryonic kidney structures will be evaluated using a modified chimeric kidney 
culture system based on the protocol of Unbekandt and Davies (Unbekandt and Davies 2010). 
However, before performing the chimeric kidney culture, in order to establish if any kidney 
related genes might be already expressed by MSCs used in this study, the expression profile of a 
panel of key genes involved in kidney development will be compared to that of  kidney rudiment 
cells. Expression of the following genes will be investigated: Wt1, Six2, Pax2, Sall1, Lim1, Gdnf, 
Osr1, Bf2 and Rarβ2. A brief description of the metanephric kidney markers used in this study is 
given below (see also Chapter 1). Both Wt1 and Six2 are found in the mesenchyme that gives rise 
to nephrons. Wt1 expression is associated with both condensing metanephric mesenchyme (MM) 
and developing nephrons but becomes restricted to the precursors of podocytes in the S-shaped 
bodies later on in development (Armstrong et al. 1993; Mundlos et al. 1993). Similarly, Six2 is 
expressed in the nephron progenitor population within the cap mesenchyme (Kobayashi et al. 
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2008). Pax2 shows a broader expression during metanephric development than Wt1 and Six2, as 
it is expressed in the ureteric buds (UBs), condensing mesenchyme and developing nephrons 
(Dressler et al. 1990; Dressler and Douglass 1992). Other essential genes in metanephric 
development include Sall1 and Lim 1. Sall1 is expressed during all stages of nephron formation 
(Nishinakamura et al. 2001) whereas Lim1 expression is found during nephron development and 
in UBs (Karavanov et al. 1998; Kobayashi et al. 2005). Glial cell line-derived neurotrophic 
factor (Gdnf) is a crucial gene expressed during early metanephric development, as it induces the 
initial outgrowth and subsequent branching of the UB. Accordingly, Gdnf is expressed by MM 
adjacent to UB (Vega et al. 1996; Sainio et al. 1997). Recently, Osr1-expression was associated 
with a precursor population in IM which gives rise to most cells found within the developing 
metanephros, including the collecting duct, nephrons and interstitial mesenchyme, mesangial and 
smooth muscle cells (Mugford et al. 2008). Finally, Bf2 (Foxd1) is expressed in stromal cells 
during metanephric kidney development (Hatini et al. 1996). Similarly, retinoid acid receptor β 2 
(Rarβ2) is expressed in kidney stromal cells (Mendelsohn et al. 1999). 
Ultimately, in order to examine the capacity of MSCs to become integrated into different renal 
structures in the chimeric kidneys, expression of Wt1 and Six2 as well as laminin and calbindin 
will be studied in the chimeras. Wt1 (Armstrong et al. 1993) and Six2 (Kobayashi et al. 2008) 
will be used as markers for nephrogenic MM. Subsequently, calbindin staining will be performed 
in order to discriminate UBs. Calbindin was demonstrated to be expressed in the developing 
collecting duct and in the most distal part of the renal tubules of emerging nephrons (Davies 
1994). Finally, laminin staining will be used to visualize both UBs and developing nephron-like 
structures in the chimeras. Laminin is detected in UBs and along the borders of comma-shaped 
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and S-shaped bodies (Ekblom 1981). 
Other cell types, namely a mouse embryonic stem cells (ESCs) line and mouse kidney progenitor 
cell line will be also tested using the chimeric kidney assay. Previously, ESCs and ESCs-
derivatives were detected in the tubular compartment of metanephric kidneys following injection 
into a kidney rudiment (Kim and Dressler 2005; Steenhard et al. 2005; Vigneau et al. 2007). 
Subsequently, kidney-derived progenitors have been demonstrated to harbour the potential to 
contribute to different compartments of the developing kidney, and were shown to give rise to 
both nephrons and the collecting system after injection into metanephroi (Challen et al. 2006; 
Maeshima et al. 2006; Ward et al. 2011). Accordingly, the kidney progenitors that will be 
employed in this study are a population of mouse neonatal kidney cells (NKCs) derived by at the 
University of Liverpool by Cristina Fuente Mora (Mora 2009). The NKC population used here 
expresses Wt1 and Gdnf, but not Pax2, and displays some heterogeneity in morphology 
suggestive of differentiation towards different renal-specific cell types. NKCs were also 
demonstrated to express a range of renal markers such as synaptopodin characteristic for 
podocytes, desmin found in mesangial cells, megalin and zona occludens-1 expressed in tubular 
cells (Mora 2009).  
The aim of the chapter is to assess renogenic potential of MSCs using a model of mouse 
embryonic kidney development. Ultimately the renogenic potential between MSCs, ESCs and 
NKCs will be compared using the same chimeric kidney assay and the results obtained here will 
be compared with existing evidence.  
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4.2. Results 
In this chapter the capacity of mouse and human MSCs to contribute to nephrogenesis was 
evaluated using the novel chimeric kidney culture system (Unbekandt and Davies 2010). Initially, 
prior to integration into the kidney rudiments, the expression profile of MSCs in regard to genes 
expressed during early kidney development was determined. The ability of the MSC to integrate 
into developing renal structures and differentiate into kidney-specific cell types was then tested 
by performing a chimeric kidney culture assay based on the protocol of Unbekandt and Davies 
(Unbekandt and Davies 2010). Subsequently, using the same assay, the renogenic potential of the 
MSCs was compared with other stem cell types.   
4.2.1. Chimeric kidney culture 
The first aim of this chapter was to confirm that the in vitro development of re-aggregated E11.5 
mouse kidney rudiments resembled that of intact rudiments. It is important because the purpose 
of this study is to assess the contribution of MSCs to nephrogenesis in an environment that 
closely mimics to the metanephric development. The re-aggregated kidneys were previously 
shown to display marker expression characteristic of normal developing kidneys, such as Wt1 
(Unbekandt and Davies 2010). Here the expression of Wt1, Six2, calbindin and laminin is 
investigated in intact and re-aggregated embryonic kidneys.  
Early stage mouse kidney rudiments can be obtained at embryonic day (E) 10.5 when the UB has 
just invaded the MM and no branching has occurred or at E11.5 when the UB has branched once. 
The rudiments are located close to the hind limb bud and can be distinguished by an opaque 
region of MM and the presence of the UB outgrowing from the Wolffian duct (Davies 2010). 
Figure 4.1a shows the localization of the metanephric kidney within a caudal part of an E11.5 
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embryo, and Figure 4.1b shows the morphology of the rudiments following dissection from the 
embryo.  
E11.5 metanephroi were dissected and following 4 days of in vitro culture stained for several 
markers of early nephrogenesis. As demonstrated in Figure 4.2a and g, Wt1 expression was 
detected using two different antibodies. Its expression was present in condensing MM and 
forming nephrons with the highest levels of Wt1 expression in nascent podocytes. Further, Six2 
was detected in condensing MM (Figure 4.2b). As shown in Figure 4.2d calbindin expression was 
found exclusively in UBs. Finally, laminin staining was evident in the basement membrane of the 
UBs and developing nephrons of the cultured metanephroi (Figure 4.2e). The undifferentiated 
MM or stroma did express neither laminin nor Wt1, Six2, calbindin. As demonstrated in Figure 
4.2c, f and h appropriate negative controls, in which primary antibody was omitted, showed only 
weak background staining. 
 
Figure 4.1 Morphology of mouse E11.5 kidney rudiment (bright field images). (a) Localization of mouse 
E11.5 metanephric kidney within the embryo (dashed line). Only the caudal part of an embryo is being 
shown. (b) Mouse E11.5 kidney rudiments after dissection consisting of T-shaped UB (u) and its 
surrounding MM (arrows). 
200µm 500µm 
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Figure 4.2 Expression of several markers of early nephrogenesis found in intact mouse metanephroi following 4 days of in vitro culture. Embryonic 
kidneys subsequent stained after for Wt1 (a and g), Six2 (b), calbindin (d) and laminin (e). Corresponding negative controls where the primary antibody 
was omitted are demonstrated: (c) Wt1 (in red), (h) Wt1 (in green), (c) Six2, (f) calbindin and (f) laminin. 
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Unbekandt and Davies developed a method which enables kidney chimeras to be re-formed from 
a suspension of individual kidney rudiment cells. In this method, following dissection, E11.5 
kidneys are disaggregated and the resultant single cell suspension of kidney rudiment cells is 
pelletted to promote re-aggregation. The re-aggregated kidney is then cultured under the same 
conditions as an intact E11.5 kidney rudiment (Unbekandt and Davies 2010). Figure 4.3a-f shows 
such re-aggregated kidney after 4 days of in vitro culture. As demonstrated, the re-aggregated 
metanephros displays normal kidney development. Wt1 staining is detected in condensing MM as 
well as in forming nephrons whereas the laminin was found in the basement membranes 
surrounding emerging nephrons and UBs (Figure 4.3a-c). Subsequently, Six2 staining is detected 
in condensing MM, whereas calbindin staining is found in UBs (Figure 4.3d-f). No Wt1, laminin, 
Six2 or calbindin staining was detected in the stroma surrounding condensing MM and UBs 
(Figure 4.3a-f). 
The presence of condensing MM around UB tips and early nephron formation demonstrates that 
kidney development was not disrupted by the disaggregation and re-aggregation protocol. This is 
also in accordance with data presented by Unbekandt and Davies (Unbekandt and Davies 2010). 
The re-aggregated embryonic kidney can act as a model for studying nephrogenesis in vitro and 
this model may be used to assess the renogenic potential of stem cells, similarly as the intact 
kidney.  
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Figure 4.3 A re-aggregated mouse embryonic kidney cultured in vitro for 4 days. The re-aggregated kidney rudiment shows characteristic features of 
embryonic development during the in vitro culture period: branching UBs (u), condensing MM (m) and developing nephrons (*) surrounded by stromal 
cells (s). (a-c) Wt1 and laminin staining of a re-aggregated kidney rudiment, (d-f) Six2 and calbindin staining of a re-aggregated kidney rudiment. 
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4.2.2. Renogenic potential of D1 cells 
Expression profile of D1 cells 
In order to establish if any of the kidney related genes might be already expressed by MSCs 
before introducing them into the embryonic kidney environment, D1 MSCs were investigated for 
the expression of important markers found during nephrogenesis. To investigate the expression 
profile of D1 cells in regard to genes involved in nephrogenesis, semi-quantitative polymerase 
chain reaction (PCR) was performed. The following genes were selected for initial assessment, as 
all have been shown to play a crucial role in kidney development (see Chapter 1): Pax2, Wt1, 
Six2, Sall1, Lim1, Gdnf, Osr1, Bf2 and Rarβ2. As demonstrated in Figure 4.4, the D1 cells 
displayed expression of several genes known to be important in the early stages of kidney 
development; namely, Sall1, Lim1, Gdnf and Osr1. Nevertheless, expression of other genes found 
during nephrogenesis like Pax2, Wt1 and Six2 was not detected (Figure 4.4). Additionally, 
expression of the stromal-specific genes, Bf2 and Rarβ2, was analyzed in D1 cells. Accordingly, 
D1 cells did not show expression of Bf2 or Rarβ2 (Figure 4.4). Glyceraldehyde 3-phosphate 
dehydrogenase (Gapdh) was used as a reference gene for all samples.  
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Figure 4.4 Gene expression profile of D1 cells (D1) compared with E13.5 kidney assessed using reverse 
transcription semi-quantitative PCR. D1 cells showed expression of several genes involved in kidney 
development. The reference gene is Gapdh. No template control was included (H2O). 
Chimeric kidney assay using D1 cells 
As described earlier, the technique developed by Unbekandt and Davies will be used to introduce 
MSCs into the embryonic kidney environment, in order to assess their renogenic potential. In 
brief, labelled MSCs or other stem cells will be recombined with kidney rudiment cells derived 
from disaggregated E11.5 mouse embryonic kidneys. Following the aggregation step the obtained 
re-formed kidneys will be subsequently cultured for 4 days and analysed using a combination of 
antibody staining. Figure 4.5 highlights the essential steps of the recombination protocol.  
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Figure 4.5 Schematic representation of the technique used to evaluate the contribution of stem cells to 
embryonic kidney development showing disaggregation of kidney rudiments and subsequent re-
aggregation in the presence of labelled stem cells followed by in vitro culture. 
D1 cells were recombined with kidney cells in all experiments in ratio of 1:5. Preliminary 
experiments performed with both mouse and human MSCs revealed that when lower ratios of 
MSCs were used for the recombination, such as 1:10, 1:20 and 1:100, only a few cells could be 
detected within the kidney chimeras (data not shown). For this reason a 1 to 5 ratio was chosen 
for the experiments. Since for each chimera a total of 100,000 cells was used, the approximate 
number of D1 cells recombined was 20,000. Upon the recombination MSCs were evenly 
distributed in the chimeras, mixing with rudiment kidney cells, hence no aggregates of MSCs 
were detected which could lead to impaired engraftment into renal structures (data not shown). In 
order to track D1 cells within the chimeric kidney the cells were labelled with either QDs or GFP, 
as described in section 3.2.3, and cultured for 4 days in vitro. The chimeras were then fixed and 
immunostained as demonstrated in section 4.2.1. Confocal microscopy was used to evaluate the 
localization of D1 cells within renal structures. After 4 days of chimeric kidney culture numerous 
laminin-positive structures were detected. This was accompanied by the expression of Wt1 in 
condensing MM (Figure 4.6). Some QD labelled cells were observed within the Wt1-positive 
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MM, hence the condensing MM, however most of the QD-labelled D1 cells were found in the 
Wt1- and laminin-negative compartment of developing chimeras, identified as stroma (Figure 
4.6a-d). Further, no QD-labelled D1 cells were detected in the large laminin-positive structures, 
identified as the UBs (Figure 4.6 a-d). These results were confirmed using GFP-labelled D1 cells. 
Some GFP D1 cells were found within condensing MM, whereas the majority of the cells were 
detected in the stroma, where they appeared to form cell clusters (Figure 4.6 e-h). 
In addition, it was observed that the integration of D1 cells might have a slight detrimental effect 
on the development of the chimeric kidneys. Chimeras harbouring D1 cells seemed to contain 
less condensing MM and nephrons in comparison with re-formed kidneys cultured in the absence 
of D1 cells. The negative effect on embryonic kidney development exerted by D1 cells will be 
investigated in more detail in Chapter 6. 
Taken together, these data show that MSCs express some genes involved in early kidney 
development, such as Gdnf, Sall1, Lim1 and Osr1 but do not express important genes, like Pax2, 
Six2 and Wt1. Furthermore, in the kidney chimeras D1 cells integrated into Wt1-positive 
condensing mesenchyme but not into laminin-positive structures, identified here as UBs. In 
addition, many recombined cells were found in the Wt1- and laminin-negative compartment of 
the chimeras where some clustering of the cells was observed. Finally, it is possible that the 
integration of D1 cells might have some negative effect on the development of the chimeras. 
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Figure 4.6 The contribution of D1 cells to nephrogenesis in chimeric kidneys after 4 days of in vitro culture. D1 cells were mainly found in stroma (s) 
and condensing MM of developing chimeras (m). No cells were found in UBs (u). Representative images of kidney chimeras are shown (at least 3 
independent experiments were performed using each labelling method). (a-d) Engraftment potential of QD D1 cells (in red) into developing renal 
structures stained with Wt1 and laminin. (e-h) Engraftment potential of GFP D1 cells (in green) into developing renal structures stained with Wt1 and 
laminin. 
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4.2.3. Renogenic potential of human MSCs 
Expression profile of human MSCs 
The use of mouse MSCs for regeneration of human renal tissue in the future is rather unlikely. 
Ultimately human cells would be used for a purpose of such regenerative therapy. Therefore it is 
essential to determine human MSCs renogenic potential. The above results showed that D1 cells 
expressed several genes involved in nephrogenesis, such as Osr1 and Sall1, but not Pax2 or Wt1 
(Figure 4.4). Before performing the chimera assay to determine the renogenic potential of the 
human MSCs, expression of several metanephric markers was investigated in human MSCs. 
Similarly to mouse MSCs, no expression of PAX2 or WT1 was detected in human MSCs (Figure 
4.7). As shown in the Figure 4.7 human MSCs did show expression of OSR1 which was also 
found in D1 cells. However, in contrast to D1 cells, human cells did not express SALL1 (Figure 
4.7). GAPDH was used as reference gene for all samples and human proximal tubular cells 
(PTC) were used as a positive control. 
 
 
 
 
 
Figure 4.7 Gene expression profile of human MSCs (hMSC) compared with human proximal tubular 
cells (PTC) assessed using reverse transcription semi-quantitative PCR. The reference gene is GAPDH. 
No template control was included (H2O). 
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Chimeric kidney assay using human MSCs 
In order to assess the renogenic potential of human MSCs, the same method described previously 
to generate chimeras harbouring D1 cells was utilized. Human MSCs were recombined with 
kidney cells in a ratio of 1 to 5. In order to track human MSCs within the chimeric kidney, the 
cells were immunostained with an anti-human nuclei antibody as described in section 3.2.3. 
After 4 days of chimeric kidney culture, some labelled cells were detected in the proximity of 
Wt1 positive structures, but never fully integrated into Wt1-expressing MM or developing 
nephrons. Human MSCs were predominantly found in the stromal compartment or outside the 
developing kidney, as shown in Figure 4.8a-c. It also appeared that human MSCs are mainly 
found in groups within the chimeras, similar to clusters of D1 cells, but less tightly packed 
(Figure 4.8a-c). As no staining for UBs was employed, the contribution of human cells to UB 
formation could not be assessed. 
In addition, the recombination with human MSCs appeared to have also some negative effect on 
the development of chimeric kidneys, similar to D1 cells. Chimeras harbouring human MSCs 
seemed to contain less condensing MM and nephrons in comparison with re-formed kidneys 
cultured in the absence of human cells. The remaining Wt1-expressing regions often seemed to 
be disorganised. The negative effect exerted by human MSCs is described in Chapter 6. 
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Figure 4.8 The contribution of human MSCs to nephrogenesis in chimeric kidneys after 4 days of in vitro culture. The cells were mainly found in stroma 
(s) and no integration occurred into Wt1-expressing condensing MM (m). A representative image of kidney chimera is shown (at least 3 independent 
experiments were performed). (a-c) Engraftment potential of human MSCs labelled with anti-human nuclei antibody (in green) into developing renal 
structures stained with Wt1. 
100 µm 
a b c 
m 
s 
Wt1 anti-human antibody merge 
 128 
In summary, human MSCs displayed similar expression profile to D1 cells, however they did not 
express SALL1. In the chimeric kidneys, numerous human cells were found in the Wt1- and 
laminin-negative compartment. Although some human MSCs were detected also in the proximity 
of Wt1-expressing structures, no definitive integration did occur. Finally, the integration of 
human MSCs might have some negative effect on the development of the chimeras similarly as 
observed for D1 cells. 
4.2.4. Renogenic potential of other progenitors 
In sections 4.2.2 and 4.2.3, the contribution to in vitro nephrogenesis of both mouse and human 
MSCs was assessed. Mouse MSCs could be found within the MM, which gives rise to nephrons, 
but the majority of the MSCs appeared to reside in the Wt1 and laminin-negative compartment, 
possibly the stromal compartment. Still, it is important to note that no marker for identifying the 
stromal compartment was employed in this study. Here the involvement of other stem 
cells/progenitors in the metanephric development was tested using the chimeric kidney culture 
system.  
Accordingly, mouse ESCs were labelled with QDs and recombined in 1:5 ratios with E11.5 
kidney rudiment cells to form chimeric kidneys. As shown in Figure 4.9a-h after 4 days of 
chimeric kidney culture QD-labelled ESCs were detected within Wt1-expressing condensing MM 
and laminin positive structures, possibly UBs. ESCs were also present in stroma but no cells were 
detected in nephron-like structures (Figure 4.9a-h).  
Also, a cell population derived from mouse neonatal kidney, here referred as neonatal kidney 
cells (NKCs), was introduced into metanephric environment using the described chimeric culture 
system. NKCs have been established from a Pax2 expressing cell population isolated from a 
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disaggregated neonatal mouse kidney. These cells were described to spontaneously differentiate 
in vitro to generate cells with different renal phenotypes characteristic for podocyte-, mesangial- 
and tubular-like cells (Mora 2009). Following a 4 day culture period, QD-labelled NKCs 
integrated into condensing MM and developing nephron-like structures, as demonstrated in 
Figure 4.10a-h. Integration into UBs was rarely observed.  
Finally, the integration of ESCs and NKCs did not appear to have an adverse affect on the 
chimeric kidney development. On the contrary, it seemed that more Wt1- and laminin-expressing 
structures were induced in the chimeras harbouring NKCs in comparison with the other stem 
cells tested.  
In conclusion, both ESCs and NKCs were found in the Wt1-expressing compartment of chimeric 
kidneys. Presence of NKCs in the developing nephron-like structures was detected. Some ESCs 
were also present in laminin-positive structures. Both ESCs and NKCs were detected as well in 
the Wt1- and laminin-negative stromal compartment. Ultimately, the integration of ESCs and 
NKCs appeared not to have any negative effect on the development of the chimeras. 
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Figure 4.9 The contribution of mouse ESCs to nephrogenesis in chimeric kidneys after 4 days of in vitro culture. ESCs were found in stroma (s), 
condensing MM (m) and UBs (u) of developing chimeras. Representative images of kidney chimeras are shown (at least 2 independent experimenters 
were performed). (a-d) Engraftment potential of QD ESCs (in red) into condensing MM stained with Wt1. (e-f) Engraftment potential of QD ESCs (in 
red) into UBs stained with laminin. 
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Figure 4.10 The contribution of mouse NKCs to nephrogenesis in chimeric kidneys after 4 days of in vitro culture. NKCs were found in stroma (s), 
condensing MM (m) and forming nephrons (*) of developing chimeras. Representative images of kidney chimeras are shown (at least 2 independent 
experimenters were performed). (a-d) Engraftment potential of QD NKCs (in red) into MM stained with Wt1. (e-f) Engraftment potential of QD NKCs 
(in red) into developing nephron-like structures stained with Wt1 and laminin.  
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4.3. Discussion 
In this chapter the potential of mouse and human MSCs to contribute to renal development was 
evaluated using a novel method of embryonic kidney culture. Although D1 cells showed 
expression of some genes associated with early nephrogenesis, they did not express important 
genes, like Pax2, Six2 and Wt1. In the chimeric kidney culture, D1 cells remained mainly within 
the Wt1- and laminin-negative compartment, although some D1 cells integrated into Wt1-
expressing condensing MM. Nevertheless, the presence of MSCs within developing nephrons 
was not detected. When compared with mouse embryonic stem cells and mouse neonatal kidney 
cells, mouse MSCs behave comparable to neonatal kidney cells. Similarly to mouse MSCs, 
human MSCs did not show expression of PAX2 and WT1. When recombined with embryonic 
kidney, they did not integrate into Wt1-exprssing condensing MM though several human cells 
were found in the proximity of Wt1 positive structures. Ultimately, the integration of mouse and 
human MSCs appeared to have some negative effect on the development of the chimeras. 
4.3.1. Expression profile of MSCs 
Expression of kidney related genes had previously been described in MSCs. Rat bone marrow-
derived MSCs were shown to start expressing aquaporin-1 when indirectly co-cultured with 
glycerol-injured rat kidney tissue (Qian et al. 2008). Similarly, indirect co-culture with injured 
cortical tubular epithelial cells induced expression of aquaporin-1 and kidney-specific cadherin in 
mouse MSCs (Singaravelu and Padanilam 2009). As demonstrated by Yokoo et al., human bone 
marrow-derived MSCs transduced with GDNF and integrated into kidney rudiments, acquire 
expression of several kidney-specific markers that were previously not expressed in the cells, 
such as the podocyte specific genes, nephrin, podocin and glomerular epithelial protein 1, as well 
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as the tubular epithelial cell-specific markers, aquaporin-1, 1α hydroxlyase, parathyroid hormone 
receptor 1 and HCO3- co-transporter (Yokoo et al. 2005; Yokoo et al. 2006). Moreover, human 
bone marrow-derived foetal MSCs were demonstrated to express aquaporin-1 and parathyroid 
hormone receptor 1 after infusion into rats with glycerol-induced acute renal failure. 
Subsequently these cells were found integrated into tubular structures (Qian et al. 2008).  
The expression of early embryonic kidney markers in MSC has not been thoroughly investigated 
until a recent paper from Lusis et al. identified a panel of embryonic kidney markers expressed in 
mouse MSCs (Lusis et al. 2010). Accordingly primary mouse bone-marrow-derived MSCs were 
shown to express Eya1, Six1, Six2, Osr1, Pax8, cadherin 11, Gdnf, Wnt4, megalin and Foxd1. In 
addition, no expression of Wt1, Sall1, Hoxa11, Pax2 and Lim1 was found in the cells. Moreover, 
human bone marrow-derived MSCs transfected with chicken Pax2 have been shown to express 
SALL1, WNT4, and EMX2. In addition, human MSCs over-expressing Pax2 were shown to 
acquire LIM1 expression after integration into Wolffian duct epithelia (Fukui et al. 2009). 
Finally, two kidney-related genes were detected in human MSCs prior the incorporation into 
kidney rudiments; namely, Kir6.1 and SUR2 (Yokoo et al. 2005). The expression pattern of 
abovementioned genes in metanephric kidneys during nephrogenesis was described in detail in 
Chapter 1, except for Emx2, Kir6.1 and SUR2. Accordingly, Emx2 was shown to be expressed in 
the ureteric buds and early epithelial structures derived from MM during mouse metanephric 
development (Pellegrini et al. 1997). Further, ATP-sensitive K+ channel subunits Kir6.1 and 
SUR2 were demonstrated to be expressed during early ureteric bud and nephron development and 
later in proximal tubules in rats (Braun et al. 2002).  
In the current study, the expression profile of MSCs in regard to embryonic kidney markers has 
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been evaluated. The analysis demonstrated that D1 cells express a number of genes important for 
metanephric development; namely, Osr1, Sall1, Lim1 and Gdnf. Mugford et al. showed that the 
Osr1-expressing progenitors give rise to the collecting duct epithelium, nephron and interstitial 
mesenchyme precursors (Mugford et al. 2008). Here, comparable expression levels of Osr1 were 
found in D1 cells and E13.5 kidney. Similarly, human MSCs were demonstrated to express 
OSR1. This is in agreement with Lusis et al. demonstrating Osr1 expression in mouse MSCs 
(Lusis et al. 2010). Furthermore, D1 cells were found to express Lim1, which is detected in UBs 
and at different stages of nephron formation during nephrogenesis (Karavanov et al. 1998; 
Kobayashi et al. 2005), and Sall1, which is present during all stages of nephron development 
(Nishinakamura et al. 2001). SALL1 was not detected in human MSCs though. Lim1 and Sall1 
expression has not been reported previously in mouse MSCs (Lusis et al. 2010). Further the 
Gdnf/Ret signalling plays important role in UB outgrowth and the branching morphogenesis and 
Gdnf is normally expressed by mesenchymal cells during metanephric development (Sainio et al. 
1997). D1 cells demonstrated expression of Gdnf, which is in accordance with previous results 
(Lusis et al. 2010).  
As demonstrated, D1 cells show expression of a range of markers found in embryonic kidney. 
However it is important to note that all mentioned genes are not exclusively expressed during 
nephrogenesis. Osr1 expression is found throughout limb and branchial arch development (So 
and Danielian 1999). Similar to Osr1, Sall1 is expressed during limb development but also during 
heart development (Sweetman and Munsterberg 2006). Gdnf is a neurotrophic factor, which is an 
important survival factors for central and peripheral neurons. Gdnf and its receptors are expressed 
in developing tooth, limbs and submandibular gland (Golden et al. 1999). Finally Lim1 
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expression was found during neurogenesis (Barnes et al. 1994). Therefore an expression of 
following genes in D1 cells may not necessary reflect their renogenic potential.  
According to the data provide here D1 cells do not express several genes essential for 
metanephric development, such as Pax2, Wt1 and Six2. Pax2 is found in UB but also in 
condensing mesenchyme and developing nephrons (Dressler et al. 1990; Dressler and Douglass 
1992). Similarly Wt1 expression is present in condensing mesenchyme and developing nephrons 
(Armstrong et al. 1993; Mundlos et al. 1993). Both D1 cells and human MSCs did not express 
Pax2 or Wt1, which is in agreement with previous results (Lusis et al. 2010). Furthermore, Six2, 
which is a maker for the nephron progenitor population (Kobayashi et al. 2008), was not 
expressed by D1 cells, although Six2 expression in mouse MSCs was described previously (Lusis 
et al. 2010). Finally, the stromal compartment of metanephric kidneys is characterised by the 
expression of  Bf2 (Hatini et al. 1996) and Rarβ2 (Abecassis et al. 2008). D1 cells did not express 
any of the markers, even though expression of Foxd1 (Bf2) in primary mouse MSCs was 
documented (Lusis et al. 2010).  
In conclusion, MSCs employed in this study express some early embryonic kidney genes. 
However there is a discrepancy between the expression profile of D1 cells and the profile 
described previously for mouse MSCs (Lusis et al. 2010). One explanation for this could be the 
fact that D1 cells used in this study are a cell line. For that reason their expression profile might 
slightly differ from primary MSCs used by Lusis and co-workers. Finally, there was also a 
difference in expression pattern of mouse and human MSCs which may influence their 
contribution to kidney development. It has been demonstrated that D1 cells express Sall1 whereas 
human MSCs do not. Similarly Lim1 expression was detected in D1 cells which was not found 
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previously in primary mouse and human MSCs (Fukui et al. 2009; Lusis et al. 2010). 
4.3.2. Renogenic potential of MSCs 
To be used for renal tissue engineering aimed at de novo nephrogenesis, MSCs should commit 
efficient and exclusively into kidney-specific cell types. Ideally, a large number of MSCs should 
be reprogrammed, as the random contribution of only a few cells would be insufficient for future 
regenerative purpose. Previously, only a sophisticated protocol was employed to introduce MSCs 
into embryonic kidneys (Yokoo et al. 2005), making further investigation of their renogenic 
capacity difficult. Here, in order to test the renogenic potential of MSCs, the cells were integrated 
into an embryonic kidney environment by performing chimeric kidney culture. Accordingly, 
mouse kidney rudiments obtained at E11.5 were disaggregated and re-aggregated in the presence 
of MSCs to form a chimeric embryonic kidney based on the novel chimeric kidney culture 
system described by Unbekandt and Davies (Unbekandt and Davies 2010). The chimeras were 
cultured similarly to intact metanephric kidneys and were confirmed to recapitulate normal 
kidney development, as described before (Unbekandt and Davies 2010). Both mouse and human 
MSCs were recombined with kidney cells in ratio 1:5, using a total of 100,000 cells, with each 
chimeric kidney containing approximately 20,000 MSCs. In comparison, in Yokoo`s 
experiments, only 1000 human MSCs were used (Yokoo et al. 2005). However, human MSCs 
were injected into rat intermediate mesoderm between the somite and lateral plate at the level of 
somite 29 which is a relatively small area (Yokoo et al. 2005). Following 4 days of in vitro 
culture, both QDs and GFP labelled D1 cells were found predominantly outside the developing 
chimeric kidney and in the laminin- and Wt1-negative compartment, identified here as stroma. 
Furthermore, some labelled cells were detected within condensing MM but they were not 
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observed in forming nephron-like structures. No labelled D1 cells were detected in laminin-
positive and Wt1-negative tubular structures, which can be described as the UBs. Similar results 
were obtained with human MSCs. Human MSCs appeared larger than mouse kidney cells in the 
chimeras. Labelled with anti-human antibody, MSCs were found mainly outside the developing 
chimeric kidney or in the putative stromal compartment. Some human cells were found in the 
proximity of Wt1 positive structures but did not engraft into MM, suggesting that human MSCs 
display even lower integration potential into MM than mouse MSCs. In addition, some human 
cells seemed to divide in the chimeras. Nevertheless, this has not been further verified. In 
conclusion, it has been demonstrated that MSCs have a rather low renogenic potential in the 
chimeric kidney assay. 
Previously it has been demonstrated by Yokoo et al. that MSCs can contribute to nephrogenesis 
integrating into both glomerular and tubular epithelium (Yokoo et al. 2005; Yokoo et al. 2006). 
These results differ from data obtained here using the chimeric kidney system. Nevertheless the 
absence of D1 cells from UBs is in accordance with earlier results showing that human MSCs are 
unable to fully contribute to development of the collecting duct system (Fukui et al. 2009). In 
previous experiments performed by Yokoo and co-workers, human MSCs over-expressing 
GDNF were injected into rat IM at the site of nephrogenesis before the initiation of metanephric 
development (Yokoo et al. 2005; Yokoo et al. 2006). In the system described in this study MSCs 
were recombined with embryonic kidneys that were isolated at the onset of metanephric 
development. Therefore, the embryonic signals that MSCs receive in this environment are 
different from signals found in IM. It has been shown that injection of human MSCs into an 
intact kidney rudiment is insufficient to trigger integration of MSCs. It is not clear however if 
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these cells were over-expressing GDNF (Yokoo et al. 2005). Moreover, human MSCs injected 
into intact metanephroi did not form any recognizable renal structures and remained aggregated 
(Yokoo et al. 2005). Similar results were found in this study, as the mouse MSCs appeared to 
form aggregates of cells within the chimeric kidney, even after they were recombined with a 
single cell suspension of kidney cells. These data confirm that the method by which MSCs are 
introduced into kidney, namely injection into intact metanephros or recombination with kidney 
cells is not essential for the integration of cells, but rather, the stage of metanephric development 
is important. Another reason for the low contribution of MSCs to nephron formation could be 
that the MSCs used here for creating the chimeras were not genetically modified to express high 
levels of GDNF. This modification has been demonstrated to be crucial for enhancing the number 
of integrated cells (Yokoo et al. 2005). It is also important to note that human MSCs were 
analyzed after 6 days of culture in Yokoo`s experiments (Yokoo et al. 2005) whereas the 
chimeric kidneys here were analysed after 4 days of in vitro culture. For this reason, cells 
observed in the condensing MM at this stage could possibly be found in developing nephrons 
later on. Nonetheless, as described in Chapter 6, no extensive nephron formation did take place 
after 7 days of chimeric kidney culture and subsequently no MSCs were found in nephron-like 
structures. Finally Yokoo et al. do not present an exact quantification of human MSC 
engraftment and differentiation (Yokoo et al. 2005); therefore, it is difficult to compare the 
number of cells integrated into different kidney compartments between the two protocols. 
As demonstrated, mouse MSCs do not express kidney stroma markers, like Bf2 and Rarβ2 in 
standard in vitro culture. However, many mouse and human MSCs were localised in the stroma 
of kidney chimeras upon recombination. The relatively high prevalence of the MSCs in the 
 139 
stroma of developing metanephroi, however, might not be too surprising, as both ESCs and 
NKCs that were used to form kidney chimeras were also found in high numbers in the stromal 
compartment of the developing chimeras. Further, it has been shown that even kidney-derived 
progenitors are to a great extent found in the stromal compartment (Challen et al. 2006; 
Maeshima et al. 2006; Lusis et al. 2010). Ultimately, it was not possible to conclude if cells 
remaining in the Wt1- and laminin-negative compartment are becoming stromal cells, due to lack 
of appropriate commercially available antibody. It might be also feasible that cells which were 
not found integrated into UBs or MM-derived structures remained undifferentiated. As no 
reliable marker for undifferentiated MSCs exists, it was not possible to investigate this option in 
chimeras harbouring MSCs. 
Furthermore, it is also difficult to conclude if the integrated D1 cells expressed Wt1 after 
integration into condensing MM. The data obtained with QDs indicate that D1 cells indeed did 
express some Wt1. Nevertheless Wt1 expression could not be confirmed using the GFP-labelled 
cells. One possibility explaining the discrepancy might be that GFP expression in the cells 
suppresses Wt1. It has been demonstrated that GFP expression interferes with activation of NF-
κB and JNK signalling pathways and stabilisation of p53 tumor suppressor in human embryonic 
kidney cells (Baens et al. 2006). Another possibility is that after labelling with QDs, some 
nanoparticles remain in the MSC cell suspension and during the recombination and a small 
fraction of kidney cells becomes labelled with these QDs. QDs might also be lost from D1 cells 
and subsequently transferred to kidney cells expressing Wt1 in the chimeras. Accordingly, it was 
shown that embryonic stem cells lose QDs and such QDs can be further utilized for labelling of 
other cells when additional labelling buffer is used (Pi et al. 2010). 
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In addition, both mouse and human MSCs had some detrimental effect on the development of 
chimeric kidneys. Kidneys harbouring MSCs appeared to contain less condensing MM and 
forming nephron-like structures in comparison with kidneys recombined in absence of MSCs or 
recombined with other cells, for example ESCs. The inhibited development of the chimeras might 
be responsible in part for poor integration of the cells. Ultimately the effect on metanephric 
development exert by MSCs is examined in Chapter 6. 
In summary, although MSCs express some of early embryonic kidney genes their integration 
potential into renal structures remains low in the kidney chimeras. High prevalence of MSCs has 
been observed in the stromal compartment of the chimeras. Also some negative effects on 
metanephric development were associated with the integration of MSCs. In order to contribute to 
renal development MSCs most likely require complex reprogramming, similar to the one 
described by Yokoo et al. Perhaps pre-conditioning before performing the chimeric assay could 
help the cells to increase their renogenic potential. 
4.3.3. Renogenic potential of other stem cells 
Here ESCs and NKCs have been used to perform embryonic chimeras using the same 
methodology as for MSCs in order to compare integration potential of MSCs with other stem 
cells. Previously, both ESCs and kidney progenitors have been introduced into the embryonic 
kidney environment with the aim to investigate their capability to differentiate towards renal like 
structures. However none of the aforementioned cell types had previously been recombined with 
kidney cells using the novel chimeric kidney culture technique (Steenhard et al. 2005; Challen et 
al. 2006; Maeshima et al. 2006). Accordingly, Steenhard et al. introduced undifferentiated mouse 
ESCs into E13 mouse kidney rudiments using microinjection. After 5 days of in vitro culture, 
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ESCs were detected in large tubule-like structures surrounded by basement membranes and 
displaying apical microvilli. In the injected metanephroi ESCs did not mix however with native 
kidney cells to create chimeric tubules. They also were rarely observed in glomerular structures 
(Steenhard et al. 2005). ESC-derived renal structures stained positively with Lotus 
tetragonolobus (LTA) lectin, a marker for proximal tubules, but were negative for Tamm-
Horsfall protein and Dolichos biflorus lectin, which are markers of distal tubule and collecting 
duct, respectively (Steenhard et al. 2005). Using the chimeric kidney system it was possible to 
demonstrate the presence of mouse ESCs in Wt1- and laminin-negative compartment, laminin 
positive tubular structures and condensing MM. No cells were detected among highly Wt1-
expressing cells of emerging glomeruli in the developing nephron-like structures. These results 
are partially in agreement with previous data, since the presence of ESCs in proximal tubules 
could not be confirmed using the chimeras. Finally, in chimeric kidneys ESCs were able to 
become integrated into emerging renal structures and not only contribute to structures formed 
entirely from ESCs, as described by Steenhard et al. (Steenhard et al. 2005).  
Apart from ESCs, various kidney progenitors have been demonstrated to contribute to in vitro 
kidney organogenesis. Among several types of renal progenitors, label-retaining tubular cells 
(LRTC) (Maeshima et al. 2006) and kidney site population (SP) (Challen et al. 2006) were 
demonstrated to have the capacity to integrate into metanephric kidney, thus contributing to 
embryonic kidney development. LRTC have been isolated from an adult rat kidney by using 
bromodeoxyuridine labelling method that enables identification of slowly dividing cells. They 
were shown to form tubule-like structures in three-dimensional culture conditions in the presence 
growth factors such as hepatocyte growth factor. After 5 days following the injection into E15 rat 
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kidney rudiment, the cells were found in the interstitium, ureteric buds, as well around ureteric 
buds and in tubules positive for LTA (Maeshima et al. 2006). Similarly, the SP population 
isolated by Challen et al. from adult mouse kidneys using the ability of some cells to efflux the 
Hoechst dye incorporated into the metanephric kidney. Following injection of the SP cells into 
mouse E12.5 metanephroi, the cells were detected in UB structures labelled with calbindin and 
Pax2 as well as in MM co-stained with Wt1 and Pax2 after 3 days of in vitro culture. Further, 
kidney cells which did not represent the capacity to efflux the dye did also engraft into UB and 
MM but at a much lower percentage than the SP population (Challen et al. 2006). Recently, 
human CD133/1+ kidney progenitors isolated from both papilla and cortex were shown to 
integrate into tubular compartment of metanephric kidney after 3 days of culture following 
injection into E.12.5 mouse kidney rudiments (Ward et al. 2011). Here a renal cell population, the 
NKCs, was introduced into metanephric environment using the described chimeric culture 
system. NKCs have been established from Pax2 expressing cell population isolated from 
disaggregated neonatal mouse kidney. The cells are not a clonal population and demonstrate in 
vitro different renal phenotypes characteristic for podocyte-, mesangial- and tubular-like cells 
(Mora 2009). Accordingly NKCs were found in Wt1- and laminin-negative compartment and 
Wt1- positive condensing MM of chimeric kidneys. Some NKCs were found in developing 
nephron-like structures. The cells were rarely detected in tubular laminin positive structures 
which can be associated with UBs. NKCs appear to share some similarities with cells of kidney 
side population which after injection into metanephric kidney were found in higher numbers in 
MM-derived structures in comparison with UBs (Challen et al. 2006). 
Recently it has been demonstrated using the same system described by Unbekandt and Davies 
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that human amniotic fluid stem cells (AFSCs) can form kidney chimeras. Accordingly AFSCs 
were contributing to nephron formation as well as ureteric bud structures during metanephric 
development. AFSCs represent a novel stem cell population which combine the features of 
embryonic and adult stem cells (De Coppi et al. 2007). Human AFSCs were recombined with 
E11.5 kidney cells in a 1 to 10 ratio and subsequently the kidney chimeras were cultured for 4 
days. The cells were detected in Pax2 and Wt1 positive structures. Further, this was accompanied 
by acquisition of expression of some important embryonic kidney markers, such as Pax2 (Siegel 
et al. 2010). Interestingly, a broader integration potential of human AFSCs encompassing both 
UBs and developing nephrons has been described using the chimeric kidney approach. Previously 
the cells were injected into E13 kidneys and found integrated into stroma and developing nephron 
structures after 5 days (Perin et al. 2007).  
In conclusion, it was shown that different progenitor types have different abilities to contribute to 
ex vivo kidney development in the chimeric kidneys. In the chimeric kidneys NKCs behave 
comparable to D1 cells as both progenitor types were found in the condensing MM and did not 
integrate into UBs. However, NKCs could be detected in structures resembling developing 
nephrons, which was not the case for MSCs. It appears also that AFSCs have the broadest 
integration potential in the chimeras since they have been described to integrate into both UBs 
and nephron-like structures (Siegel et al. 2010). As some D1 cells were detected in the 
nephrogenic mesenchyme, it can be suggested that mouse MSCs do possess some renogenic 
potential. The subsequent chapter describes an attempt to increase the presence of MSCs in the 
condensing MM, thus facilitating the integration of MSCs into nephron-like structures.  
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Chapter 5: Potential of MSCs to contribute to metanephric development after 
stimulation with conditioned medium from neonatal kidney cells 
5.1. Introduction 
In Chapter 4 the ability of MSCs to integrate into developing embryonic kidney structures was 
evaluated using a novel chimeric kidney culture system. As described previously, direct injection 
of human MSCs into a rodent kidney rudiment is insufficient to elicit MSC integration into 
nephron-like structures; instead, the MSCs tended to aggregate at the injection site (Yokoo et al. 
2005). For that reason, a new methodology developed by Unbekandt and Davies (Unbekandt and 
Davies 2010) was employed to determine the contribution of both mouse and human MSCs to 
nephrogenesis. As the protocol involved the disaggregation of the kidney rudiments and 
subsequent reformation of the kidney in the presence of stem cells, no aggregation at the site of 
injection could occur. Nevertheless, as demonstrated in the previous chapter, only infrequent 
engraftment of mouse MSCs into condensing metanephric mesenchyme (MM) was observed in 
the embryonic kidney chimeras. Furthermore, no human primary MSCs were found in the MM of 
the chimeras. This implies that in order to obtain full MSC incorporation into renal structures, 
MSCs require additional reprogramming, as demonstrated by Yokoo et al. (Yokoo et al. 2005). It 
appears that glial cell line-derived neurotrophic factor (GDNF) plays a crucial role in this process 
since it was shown that over-expression of GDNF in human MSCs before their introduction into 
the embryonic environment, considerably increases their integration potential into metanephric 
kidneys (Yokoo et al. 2005). GDNF is an important factor for ureteric bud (UB) outgrowth and 
branching (Vega et al. 1996; Sainio et al. 1997). The mechanism of action of GDNF involves 
activation of the tyrosine kinase receptor Ret, encoded by the Ret proto-oncogene (Trupp et al. 
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1996; Vega et al. 1996). In the subsequent chapter the possibility to induce a renal phenotype and 
subsequently improve the engraftment potential of MSCs into metanephric kidney will be 
investigated following pre-treatment of MSCs with conditioned medium obtained from kidney 
progenitor population.   
The use of conditioned medium to trigger differentiation of MSCs has been attempted before 
(Rivera et al. 2006; Pan et al. 2008; Baer et al. 2009; Schittini et al. 2010). Conditioned medium 
from cardiac explants was used as a potential source of factors to induce differentiation of MSCs 
into cardiomyocyte-like cells, as it has been demonstrated to contain cytokines, growth factors 
and myocardial and metabolism-related proteins. Accordingly, the conditioned medium was 
shown to elicit phenotypic changes in the MSCs so that their morphology and marker expression 
profiles resembled those of cardiomyocyte-like cells (Schittini et al. 2010). Further, foetal liver-
conditioned medium obtained from different developmental stages was assessed for induction of 
hepatic differentiation in MSCs: this study demonstrated that stimulation with conditioned 
medium from E13.5 liver culture was most effective in inducing morphological and functional 
changes in the MSCs, as well as changes in gene expression that were characteristic of hepatic 
differentiation (Pan et al. 2008). In addition, to induce a neuronal-like phenotype, MSCs were 
treated with conditioned medium derived from adult hippocampus, cortex or cerebellum, and 
muscle-derived conditioned medium was used as a negative control. All media tested, except the 
muscle-derived conditioned medium, induced a neuronal morphology and the expression of 
neuronal markers in MSCs (Rivera et al. 2006). Finally, conditioned medium from proximal 
tubular cells has been used to initiate differentiation of MSCs into epithelial-like cells. After 
incubation with the conditioned medium, changes in morphology and gene expression of the cells 
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occurred, indicating epithelialisation (Baer et al. 2009). In conclusion, these studies highlight that 
the fate of MSCs can be influenced by factors derived from various types of differentiated cells, 
and in most cases, the MSCs start to adopt the characteristics of the cells from which the factors 
are derived. 
In this chapter, conditioned medium from neonatal kidney cells (NKC CM) will be tested for its 
ability to increase the renogenic potential of MSCs. NKCs used for obtaining conditioned 
medium are a heterogeneous population displaying features of podocytes, mesangial and renal 
tubular cells (Mora 2009). As demonstrated in the previous chapter, NKCs contribute 
considerably to nephron development in chimeric kidneys by integrating into condensing MM 
and developing nephron-like structures. Accordingly, NKC CM will be used to initiate 
differentiation of MSCs towards a renal phenotype in order to subsequently increase the 
renogenic potential of the cells in the recombination assay. 
5.2. Results 
In order to enhance the potential of MSCs to engraft into developing nephron structures, NKC 
CM has been employed to pre-condition both mouse and human MSCs. Initially, the multilineage 
differentiation potential of D1 cells pre-treated with NKC CM was assessed, followed by 
expression analysis of kidney-specific genes. Finally, the ability of pre-treated D1 cells and 
human MSCs to integrate into developing renal structures and differentiate into nephron-specific 
cell types was tested by performing the chimeric kidney culture assay.  
5.2.1. The multilineage differentiation potential of D1 cells stimulated with NKC CM 
In an attempt to increase their renogenic potential, D1 cells were incubated for 4 days with a 1:1 
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mix of conditioned medium obtained from a confluent NKC culture (NKC CM), and standard 
culture medium. In Figure 5.1, bright field images of unstimulated and stimulated D1 cultures 
show that there is a slight difference in morphology of D1 cells incubated in  NKC CM compared 
to those cultured in standard culture medium: i.e., following stimulation with NKC CM, MSCs 
appeared more aligned than when cultured in standard medium.  
 
Figure 5.1 Morphology of D1 cells after stimulation with NKC CM. Representative images are shown 
(observed for more than 3 independent cultures). (a) Bright field image of the D1 cells cultured for 4 days 
in standard culture medium. (b) Bright field image of the D1 cells cultured in NKC CM. 
To verify how the stimulation with NKC CM affects the multipotency of D1 cells, subconfluent 
D1 cultures were induced for two weeks to undergo adipogenic, osteogenic and chondrogenic 
differentiation using appropriate inductive media, as described in section 3.2.1. Figure 5.2 shows 
the adipogenic, osteogenic and chondrogenic potential of MSC stimulated with NKC CM 
compared to those cultured in standard medium. 
Following induction with adipogenic medium, Oil Red staining on day 14 confirmed the presence 
a 
100µm 
b 
100µm 
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of lipid vacuoles in D1 cells that had been stimulated with NKC CM, and those cultured in 
standard medium, whereas in the absence of adipogenic medium, there was no evidence of lipid 
vacuoles (Figure 5.2a-d). It appeared, however, that D1 cells stimulated with NKC CM (Figure 
5.2c) had a slightly lower adipogenic potential compared to controls, as fewer cells accumulated 
lipid vacuoles in comparison with unstimulated D1 cells (Figure 5.2a).  
Further, 14 days following induction with osteogenic medium, Alizarin Red staining showed that 
both the control D1 cells and those stimulated with NKC CM were able to undergo osteogenesis 
(Figure 5.2e and g). Interestingly, under osteogenic conditions, some NKC CM-stimulated cells 
displayed vacuoles that appeared similar to lipid vacuoles found during adipogenesis, and these 
cells did not stain for Alizarin Red (Figure 5.2g insert). In the absence of osteogenic medium, no 
staining was detected in control cultures or in those stimulated with NKC CM (Figure 5.2f and 
h).  
Finally, in order to confirm the chondrogenic differentiation potential of MSCs, a chondrogenic 
culture condition was employed, as described in section 3.2.1. Both unstimulated and NKC CM-
stimulated D1 cells formed stable pellets and showed the presence of proteoglycans in the 
periphery of the pellet, as indicated by Alcian Blue staining (Figure 5.2i and k). No Alcian Blue 
staining was detected in pellets cultured in the absence of chondrogenic medium (Figure 5.2j and 
l). 
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Figure 5.2 Confirmation of multilineage differentiation potential of D1 cells treated with NKC CM for 4 
days and subsequently induced with adipogenic, osteogenic and chondrogenic induction media. 
Representative images are shown. (a) After 14 days of stimulation with adipogenic inductive medium D1 
cells displayed lipid vacuoles that stained positively with Oil Red. (b) Oil Red staining of D1 cells 
cultured in standard culture medium showed no lipid vacuole formation. (c) D1 cells pre-treated with 
NKC CM for 4 days and subsequently stimulated with adipogenic inductive medium for additional 14 
days displayed lipid vacuoles. (d) In the absence of adipogenic medium, Oil Red staining demonstrated no 
lipid vacuole formation in cells pre-treated with NKC CM. (e) After 14 days of culture in osteogenic 
inductive medium, Alizarin Red staining showed the presence of extracellular calcium deposits in D1 
cultures. (f) Alizarin Red staining of control D1 cells showed that no calcium deposits were present. (g) 
D1 cells pre-treated with NKC CM for 4 days and subsequently stimulated with osteogenic inductive 
medium show Alizarin Red staining detecting presence of calcium deposits. Occasionally some pre-
treated D1 cells also displayed vacuoles comparable to lipid vacuoles found during adipogenesis (insert). 
(h) In the absence of osteogenic medium, Alizarin Red staining demonstrated no evidence of calcium 
deposits in cells pre-treated with NKC CM. (i) After 14 days of micromass culture in chondrogenic 
inductive medium, Alcian Blue staining showed positive staining in the periphery of the pellet, indicating 
cartilage formation. (j) In the absence of chondrogenic medium, Alcian Blue staining of D1 micromass 
sections showed no evidence of cartilage proteoglycans. (k) After 14 days of micromass culture in the 
presence of chondrogenic medium, NKC CM pre-treated of D1 cells showed evidence of cartilage 
formation at the periphery of the pellet, as indicated by Alcian Blue staining (arrow). (l) In the absence of 
chondrogenic medium, no Alcian Blue staining was detected in micromass sections of D1 cells pre-treated 
with NKC CM. 
In summary, pre-treatment with NKC CM of D1 cells did not result in substantial morphological 
changes of the cells. Further, upon stimulation the cells maintained also their multilineage 
potential, as demonstrated in the adipogenic, osteogenic and chondrogenic assays. 
5.2.2. Renogenic potential of D1 cells stimulated with NKC CM 
Expression profile of D1 cells following treatment with NKC CM 
Before performing chimeric kidney rudiment culture, the expression profile of D1 cells 
stimulated with NKC CM was assessed. D1 cells were stimulated with a mix of NKC CM and 
standard culture medium for 4 days, and subsequently, the expression of important early kidney 
markers was evaluated using semi-quantitative PCR. As demonstrated in Figure 5.3, stimulated 
D1 cells continued to express several genes essential for metanephric development, such as Gdnf, 
Sall1, Lim1 and Osr1. Moreover, Gdnf expression appeared to be up-regulated in NKC CM-
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stimulated cells in comparison with unstimulated MSCs. Furthermore, a slight downregulation of 
Sall1 and Lim1 expression was noted in NKC CM-stimulated cells. The incubation of D1 cells 
with NKC CM did not induce Pax2, Wt1 or Six2 expression. Expression of those genes was also 
not detected in unstimulated D1 cells (Figure 5.3). Interestingly, NKC CM-stimulated D1 cells 
did show weak expression of Bf2 which was not detected in unstimulated cells (Figure 5.3). 
Rarβ2 was not detected in either NKS CM-stimulated cells or unstimulated control D1 cells. 
 
Figure 5.3 Comparison of gene expression related to metanephric development between D1 cells cultured 
in standard culture conditions and D1 cells following 4 days culture in NKC CM assessed using reverse 
transcription semi-quantitative PCR. E13.5 kidney was included as a positive control. Gapdh was used as 
reference gene. No template control was included (H2O). 
As the data obtained using semi-quantitative PCR showed up-regulation in Gdnf expression after 
KSC CM stimulation, quantitative PCR was performed to determine the extent of the up-
regulation. Figure 5.4a shows a significant up-regulation of Gdnf expression after stimulation 
with NKC CM for 4 days in comparison to unstimulated cells (p<0.01, n=6). Further, Gdnf 
remained at significantly higher levels in the cells 24h after the NKC CM was changed to 
standard culture medium (p<0.05, n=3) (Figure 5.4b). Nevertheless, the increase in Gdnf 
expression in stimulated cells 24h after  changing the medium to standard culture medium was 
less than that observed in MSCs cultured in the presence of NKC CM  (Figure 5.4a and b). All 
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experiments were performed using Gapdh as a reference gene. 
 
Figure 5.4 Comparison of Gdnf expression levels in unstimulated and NKC CM-stimulated cells using 
reverse transcription quantitative PCR. The reference gene is Gapdh and the error bars represents SE of 
the mean. (a) There was a significant increase in Gdnf following culture in NKC CM (t-test, p<0.01, n=6). 
(b) Up-regulation in Gdnf expression was also present in D1 cells 24 h following withdrawal of NKC CM 
(t-test, p<0.05, n=3). 
As the stimulation with NKC CM resulted in a significant increase in Gdnf expression, it was 
investigated if Gdnf expression in D1 cells could be further enhanced by applying concentrated 
conditioned medium onto the cells. D1 cells were stimulated for 4 days with different 
concentrations of NKC CM. In order to obtain 1x, 2x or 10x NKC CM concentration in media 
used for stimulation, the conditioned medium was concentrated using a Vivaspin centrifugal 
concentrator and diluted with standard culture medium to reach the appropriate concentration. 
The expression levels after stimulation with concentrated NKC CM were compared to the 
expression levels found in unstimulated D1 cells. Gdnf expression was also evaluated in cells 
stimulated with the corresponding concentration of standard culture medium. The 1x condition, 
which was equivalent to a 1:1 mix of NKC CM and standard culture media, used in previous 
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experiments, elicited an increase in Gdnf expression after 4 days of stimulation (Figure 5.5). 
However, as demonstrated in Figure 5.5a, the use of concentrated NKC CM did not lead to any 
further increase in Gdnf levels in D1 cells. Furthermore, Gdnf expression following stimulation 
with 2x and 10x concentrated standard culture medium for the same period of time as with NKC 
CM, appeared to slightly up-regulate Gdnf expression levels in D1 cells (Figure 5.5b).  
To investigate if CM derived from other cell types can induce Gdnf expression in D1 cells, the 
cells were cultured in a 1:1 mix of conditioned medium obtained from mouse embryonic 
fibroblasts derived from E11.5-E12.5 embryos (MEF CM) and standard culture media for 4 days. 
As shown in Figure 5.6a, the stimulation with MEF CM had a similar effect on Gdnf expression 
as NKC CM. 
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Figure 5.5 Comparison of Gdnf expression levels in unstimulated and KSC CM-stimulated D1 cells after 
4 days using reverse transcription quantitative PCR. The following culture media were used: standard 
culture medium, 1x NKC CM in standard medium - an equivalent to 1:1  mix or 1x standard medium (1x), 
2x NKC CM in standard medium or 2x standard medium in standard medium (2x), 10x NKC CM in 
standard medium or 10x standard medium in standard medium (10x). Gapdh was used as reference gene. 
(a) No further increase in Gdnf expression was detected when more concentrated NKC CM was applied, 
although D1 cells stimulated with different concentrations of NKC CM showed up-regulation of Gdnf in 
comparison to unstimulated cells. (b) D1 cells stimulated with correspondingly 10x concentrated standard 
culture medium showed also some up-regulation of Gdnf in comparison to unstimulated cells. 
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Figure 5.6 Comparison of Gdnf expression levels in unstimulated, MEF CM- and NKC CM-stimulated 
D1 cells using reverse transcription quantitative PCR. D1 cells stimulated with MEF CM showed similar 
up-regulation in Gdnf expression as with NKC CM. Gapdh was used as reference gene. 
Finally, it has been described that stimulation with Gdnf results in induction of Gdnf expression 
in kidney-derived MSCs (Shi et al. 2008). The lowest concentration of Gdnf described to induce 
Gdnf expression in MSCs was 20ng/ml (Shi et al. 2008). Accordingly, in order to test if Gdnf 
expression may be induced by the presence of Gdnf in NKC CM or MEF CM, D1 cells were 
stimulated with different concentration of Gdnf (1ng/ml, 10ng/ml, and 50ng/ml) for 4 days. 
Exogenous Gdnf induces UB branching in metanephric kidney cultures (Vega et al. 1996; Sainio 
et al. 1997). Therefore the activity of Gdnf used for stimulation was confirmed by stimulating 
E11.5 kidney with 50ng/ml Gdnf for 4 days. Subsequently the UBs were visualized using 
calbindin staining (Davies 1994). Accordingly, kidneys stimulated with Gdnf demonstrated 
increased branching morphogenesis in comparison with unstimulated rudiments confirming that 
Gdnf used in this study is active (Figure 5.7a). However, as demonstrated in Figure 5.7b none of 
the Gdnf concentrations tested was able to elicit Gdnf up-regulation in D1 cells. It appeared 
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that D1 cells do not express Ret gene, which encodes the Ret receptor that is important in Gdnf 
signalling (Vega et al. 1996). Figure 5.7c demonstrates expression of Ret in E13.5 kidneys and its 
absence in D1 cells. 
 
Figure 5.7 Comparison of Gdnf expression levels in unstimulated, NKC CM-stimulated D1 cells and D1 
cells stimulated with different concentrations of Gdnf using reverse transcription quantitative PCR and 
subsequent analysis of Ret expression in D1 cells. Gapdh was used as reference gene for all experiments. 
(a) Increase in UB branching in E11.5 kidney after stimulation with Gdnf for 4 days demonstrating that 
Gdnf used for stimulation of D1 cells is active. Calbindin staining is visualising the UBs. (b) D1 cells 
stimulated with 1ng/ml, 10ng/ml and 50ng/ml of Gdnf showed no up-regulation in Gdnf expression in 
comparison with stimulated cells with NKC CM. (c) No expression of Gdnf receptor Ret was detected in 
D1 cells using semi-quantitative PCR. E13.5 kidney was used as a positive control and no template 
control was included (H2O). 
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Chimeric kidney assay using D1 cells stimulated with NKC CM 
Next, D1 cells stimulated with NKC CM were assessed for their renogenic potential using the 
chimeric kidney culture system, described previously in Chapter 4. Both unstimulated and NKC 
CM-stimulated D1 cells were recombined with E11.5 kidney cell suspension in a 1 to 5 ratio. 
After 4 days of chimeric kidney culture, confocal microscopy was used to evaluate the 
localization of both unstimulated and stimulated QD-labelled D1 cells within renal structures. 
Although many labelled cells were still found in the Wt1- and laminin-negative compartment, 
incubation with NKC CM considerably improved the engraftment of QD-labelled D1 cells into 
condensing MM stained for Wt1, as demonstrated in Figure 5.8a-h.  
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Figure 5.8 The contribution of QD-labelled D1 cells to nephrogenesis following treatment with NKC CM for 4 days in chimeric kidney rudiment assay. 
Considerably more stimulated D1 cells were found in Wt1-expressing mesenchyme in comparison with unstimulated cells after 4 days of culture. 
Representative images of kidney chimeras are shown (performed in at least in 3 independent experiments). (a-d) Engraftment potential of QD-labelled D1 
cells cultured in standard medium into renal structures stained with Wt1 and laminin. Arrow indicates a D1 cell that has integrated into condensing 
mesenchyme. (e-h) Engraftment potential of NKC CM-stimulated QD-labelled D1 cells into renal structures stained with Wt1 and laminin. Arrows 
indicate NKC CM-stimulated D1 cells that have integrated into condensing mesenchyme. 
a 
25 µm 
25 µm 
b c d 
e f g h 
QD D1 cells 
QD D1 cells 
laminin Wt1 merge 
laminin Wt1 merge 
 u
n
stim
ulated
 
 stim
ulated
 
 159 
In order to quantify the difference in incorporation rates into renal structures between stimulated 
and unstimulated QD D1 cells, a total number of cells counted in five random fields was assessed 
and compared against the number of cells found in different kidney compartments in the same 
five fields for both conditions. The following compartments have been considered: the Wt1-
positive compartment representing the Wt1-expressing condensing MM; the laminin-positive 
compartment representing the UBs; the Wt1- and laminin-positive compartment representing the 
nephrons; and, finally, the Wt1- and laminin-negative compartment representing the stroma. 
Three separate experiments were performed for both conditions. As depicted in Figure 5.9a, most 
of the D1 cells in both conditions were localised in the Wt1- and laminin-negative compartment. 
Both unstimulated and NKC CM-stimulated D1 cells were also present to some extent in the 
Wt1-expressing compartment; however, more stimulated cells were found in the condensing 
MM. On average, 3.75% of all counted cells that were pre-treated with NKC CM before 
recombination, were found within Wt1-expressing mesenchyme, in comparison with only 1.18% 
for unstimulated D1 cells (Figure 5.9a). Occasionally both unstimulated and NKC CM-stimulated 
D1 cells were detected in the Wt1- and laminin-positive compartment (Figure 5.9a). There was 
also little engraftment into laminin-positive structures detected in both conditions (Figure 5.9a). 
Taken together, the integration rate of QD D1 cells into all Wt1-positive compartments, the 
condensing mesenchyme and nephron-like structures, upon stimulation with NKC CM increased 
significantly (i.e., up to 3.6 fold) (p<0.05, n=3) (Figure 5.6 b). 
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Figure 5.9 Statistical analysis of integration rate of unstimulated versus NKC CM-stimulated QD-labelled 
D1 cells into different compartments of chimeric kidney after 4 days of culture. (a) Percentage of 
unstimulated versus stimulated QD-labelled cells found in different kidney compartments counted in 3 
separate experiments (b) QD D1 cells showed 3.6 fold increase in engraftment into condensing 
mesenchyme and nephron-like structures after 4 days of preconditioning with NKC CM in comparison 
with  unstimulated QD D1 (t-test, p<0.05, n=3).  
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The recombination experiments were repeated with D1 cells labelled with GFP in order to 
confirm the results obtained with QD-labelled cells. Figure 5.10e-h shows that GFP D1 cells 
stimulated with NKC CM demonstrated considerable engraftment potential into the Wt1-positive 
MM. Occasionally, the presence of laminin around condensing mesenchyme harbouring pre-
treated GFP-labelled cells was observed, indicating the possible start of nephron formation 
(Figure 5.10h arrowheads). In comparison, cells not stimulated with NKC CM displayed a lower 
integration potential into Wt1-positive MM, as shown in Figure 5.10a-d. In order to further 
confirm the presence of D1 cells within chimeric kidney structures, immunostaining was 
performed for Six2, which is expressed in nephron progenitor populations (Kobayashi et al. 
2008), and calbindin, found mainly in ureteric buds (Davies 1994) (Figure 5.10a-h). 
Consequently, NKC CM-stimulated GFP D1 cells were found in higher numbers in Six2 positive 
MM than unstimulated cells, as shown in the Figure 5.11e-h. In both conditions, there was no 
engraftment into ureteric buds, stained for calbindin, confirming previous observations (Figure 
5.11a-h).  
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Figure 5.10 The contribution of GFP-labelled D1 cells to nephrogenesis following treatment with NKC CM for 4 days in chimeric kidney rudiment 
assay. Considerably more stimulated D1 cells were found in Wt1-expressing mesenchyme in comparison with unstimulated cells after 4 days of culture. 
Representative images of kidney chimeras are shown (performed in at least in 3 independent experiments). (a-d) Engraftment potential of GFP D1 cells 
not stimulated with NKC CM into developing renal structures stained with Wt1 and laminin. (e-h) Engraftment potential of GPF D1 cells stimulated with 
NKC CM into developing renal structures stained with Wt1 and laminin. Arrowheads indicate presence of laminin staining around Wt1-expressing region 
harbouring GFP cells.  
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Figure 5.11 The contribution of GFP-labelled D1 cells to nephrogenesis following treatment with NKC CM in chimeric kidneys assay. It appeared that 
more stimulated D1 cells were found in Six2 expressing mesenchyme in comparison with unstimulated cells after 4 days of culture. No integration into 
calbindin positive ureteric buds was detected in any condition. Representative images of kidney chimeras are shown (performed in at least in 2 
independent experiments). (a-d) Engraftment potential of GFP D1 cells not stimulated with NKC CM into developing renal structures stained with Six2 
and calbindin. (e-h) Engraftment potential of GPF D1 cells stimulated with NKC CM into developing renal structures stained with Six2 and calbindin. 
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Accordingly, incorporation rates between NKC CM-stimulated and unstimulated D1 cells were 
evaluated. Similarly as for QD-labelled cells, a total number of GFP D1 cells counted in five 
random fields was assessed and compared against the number of GFP cells found in different 
kidney compartments in both conditions in three separate experiments (Figure 5.12a and b). Most 
GFP-labelled cells remained in the Wt1- and laminin-negative compartment of chimeric kidneys, 
as demonstrated in Figure 5.12a. On average, 13.29% of NKC CM-stimulated GFP D1 cells and 
3.37% unstimulated GFP D1 cells was found within Wt1-expressing compartment in the kidney 
chimeras (Figure 5.12a). No integration into laminin-positive or Wt1- and laminin-positive 
structures was counted in any of the conditions (Figure 5.12a). As demonstrated in Figure 5.12b, 
the integration rate of GFP D1 cells into condensing mesenchyme upon stimulation increased up 
3.9 fold. However the increase was not statistically significant (p>0.05, n=3).  
In addition, it appeared that chimeric kidneys harbouring NKC CM-stimulated D1 cells 
developed better than kidneys that were reformed using unstimulated D1 cells. There were 
considerably more Wt1-positive regions as well as developing nephron-like structures in 
chimeras harbouring stimulated D1 cells. Accordingly, effects exerted by stimulated D1 cells on 
metanephric development are described in detail in the subsequent chapter. 
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Figure 5.12 Statistical analysis of integration rate of unstimulated versus NKC CM-stimulated GFP-
labelled D1 cells into different compartments of chimeric kidney after 4 days of culture. (a) Percentage of 
unstimulated versus stimulated GFP-labelled cells found in different kidney compartments counted in 3 
separate experiments. (b) Stimulated GFP D1 cells showed considerable increase in engraftment into 
condensing mesenchyme after 4 days of culture, however this difference was not statistical significant (t-
test, p>0.05, n=3).  
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In summary, the stimulation with NKC CM increased in D1 cells the expression of Gdnf, an 
important factor for UB development. It was demonstrated that the use of concentrated NKC CM 
does not induce any further increase in Gdnf expression in stimulated cells. Furthermore, 
exogenous Gdnf was not able to induce Gdnf up-regulation in D1 cells. Finally, conditioned 
medium derived from MEFs can similarly to NKC CM, increase expression of Gdnf in D1 cells 
after 4 days of stimulation. In addition, it has been demonstrated that stimulation of D1 cells for 4 
days with NKC CM facilitates their integration into condensing MM in the chimeric kidney 
rudiment culture. However, there is a discrepancy in the number of integrated cells depending on 
the labelling method. Accordingly, 13.29% of NKC CM-stimulated D1 cells labelled with GFP 
were present in the condensing MM in the kidney chimeras after 4 days of culture in comparison 
with only 4.5% of NKC CM-stimulated D1 cells labelled with QDs.  
5.2.3. Renogenic potential of human MSCs stimulation with NKC CM 
In order to assess if human MSCs respond to NKC CM treatment in the same way as D1 cells, 
human MSCs were cultured in the presence of NKC CM for 4 days prior to the integration 
experiment. Figure 5.13a-h shows that stimulation with NKC CM had no effect on human MSC 
integration potential. Human MSCs did not integrate into condensing MM and developing 
nephron-like structures. Similarly as described in the previous chapter, recombination with 
human MSCs appeared to have a negative effect on the development of the chimeric kidneys, 
irrespective of whether the cells had been previously cultured in standard, or NKC CM media. 
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Figure 5.13 The contribution of human MSCs to nephrogenesis following treatment with NKC CM in chimeric kidney rudiment assay. Both 
unstimulated and NKC CM- stimulated human MSCs were mainly found in the Wt1 negative compartment of developing chimeras after 4 days of 
in vitro culture. Representative images of kidney chimeras are shown. (a-c) Engraftment potential of human MSCs labelled with anti-human nuclei 
antibody into developing renal structures stained for Wt1. (d-f) Engraftment potential of labelled human MSCs stimulated with NKC CM into 
developing renal structures stained for Wt1. 
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Taken together, pre-treatment with NKC CM could not increase the integration rate of human 
MSCs into chimeric kidney structures. The stimulation with NKC CM could not avert the 
negative effects exerted by human MSCs on metanephric development, although it seemed to 
prevent the detrimental action in mouse MSCs.  
5.3. Discussion 
Stimulation with conditioned medium from a particular culture can trigger changes in 
morphology and expression profile of MSCs and hence induce them to differentiate (Rivera et al. 
2006; Pan et al. 2008; Baer et al. 2009; Schittini et al. 2010). In this chapter, mouse and human 
MSCs were stimulated with NKC CM in order to see if this treatment could induce a renal 
phenotype and subsequently increase their contribution to metanephric development. NKC CM-
treated D1 cells maintained multilineage differentiation potential and similarly to D1 cells 
cultured in standard culture condition, expressed a number of MM-specific genes. In addition, the 
stimulation with NKC CM resulted in up-regulation in Gdnf expression in stimulated D1 cells. 
The pre-conditioning with NKC CM considerably increased the engraftment potential of D1 cells 
into the condensing MM and developing nephron-like structures of chimeric kidneys. In addition, 
stimulated D1 cells did not appear to have any detrimental effect on metanephric development of 
the chimeras. In contrast, stimulation with NKC CM did not facilitate integration of human 
MSCs into the developing structures of chimeric kidneys. 
5.3.1. Characteristics of D1 cells stimulated with NKC CM 
In this study, D1 cells were incubated with conditioned medium from a kidney cell population, in 
order to enhance their renogenic potential. As described by Baer et al., stimulation with 
conditioned medium from human renal proximal tubular cells can initiate epithelial 
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differentiation in human adipose-derived MSCs. After 12 days of incubation with conditioned 
medium obtained from renal cells, human MSCs changed their morphology to become epithelial-
like and started to express an early epithelial marker - cytokeratin 18 (Baer et al. 2009). After 4 
days of stimulation with NKC CM, no change to epithelial-like morphology was observed in D1 
cells. However, stimulated D1 cells appeared more aligned than unstimulated D1 cells. Further, 
D1 cells maintained multipotency after stimulation with NKC CM. Both unstimulated and 
stimulated D1 cells showed adipogenic, osteogenic and chondrogenic potential which is 
characteristic for MSC populations (Peister et al. 2004). However, fewer cells after NKC CM 
seemed to accumulate lipid vacuoles in comparison with unstimulated D1 cells. Following the 
osteogenic induction, both unstimulated and stimulated cells displayed calcium deposits. 
Unexpectedly, in this condition, some cells stimulated with NKC CM also exhibited lipid 
vacuoles, similar to those found during in vitro adipogenesis. However it is important to note that 
these vacuoles have not been stained to confirm the presence of lipids. Adipocytes and 
osteoblasts originate from a common mesenchymal progenitor and the presence of 
dexamethasone in inductive medium is modulating adipogenesis and osteogenesis in MSCs 
(Mikami et al. 2010). A similar but converse situation was described for adipose-derived human 
MSCs: adipose-derived MSCs at later passages were shown to form both lipid vacuoles and 
calcium deposits when induced with adipogenic medium (Wall et al. 2007).  
5.3.2. Expression profile of D1 cells stimulated with NKC CM 
In the previous chapter, the expression of embryonic kidney markers such as Osr1, Sall1, Lim1 
and Gdnf was described in D1 cells. D1 cells continued to express the aforementioned genes after 
stimulation with NKC CM. Further, no expression of Wt1, Pax2 and Six2 was induced by the pre-
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conditioning. Similarly, no expression of Rarβ2 has been induced in stimulated D1 cells. 
Nevertheless some weak expression of Bf2 has been observed in NKC CM pre-treated cells. Bf2 
is expressed in stromal cells found around the condensing MM and at the periphery of the kidney 
rudiment (Hatini et al. 1996). This could suggest that the stimulated cells are triggered to become 
kidney stromal cells and consequently will more likely integrate into the stromal compartment of 
metanephric kidney. However, Bf2 expression during embryogenesis is not restricted to the 
kidney. Bf2 has been found also in the neuroepithelium during development of the central 
nervous system (Hatini et al. 1994). NKC CM-stimulated D1 cells showed also a significant up-
regulation in Gdnf expression. Gdnf over-expression was shown to enhance the integration 
potential of human MSCs into metanephric kidney (Yokoo et al. 2005). Therefore it is possible 
that the stimulation with NKC CM could increase the engraftment potential of MSCs in the 
chimeric kidney rudiment assay.  
Further, stimulation with concentrated NKC CM did not result in additional increase in Gdnf 
expression in D1 cells. Still, the expression remained higher than in unstimulated D1 cells. 
Surprisingly, stimulation with concentrated standard culture medium had also some positive 
effect on Gdnf expression. As a consequence, Gdnf expression in D1 cells following stimulation 
with 2x and 10x NKC CM was to some extent downregulated when Gdnf expression levels were 
compared against Gdnf expression levels found in cells stimulated with the corresponding 
concentration of standard culture medium for the same period of time. This could imply that 
standard culture medium already contains factors that are responsible for Gdnf up-regulation. 
Furthermore, conditioned medium derived from mouse embryonic fibroblasts had a similar effect 
on Gdnf expression as medium derived from NKCs. This medium, however, has not been used 
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for pre-conditioning of MSCs in the chimeric kidney assay.  
It is not clear which factors present in the conditioned media induce Gdnf up-regulation in D1 
cells. As it was shown that exogenous Gdnf triggers expression of Gdnf in kidney-derived MSCs 
(Shi et al. 2008), it was investigated if one of the factors inducing Gdnf expression could be Gdnf 
present in the conditioned medium. Accordingly, different concentrations of Gdnf were used to 
stimulate D1 cells for 4 days; however Gdnf was not able to induce Gdnf expression in the cells, 
irrespective of the concentration used, suggesting that the mechanism of Gdnf induction remains 
different in D1 cells than in kidney-derived MSCs. 
5.3.3. Renogenic potential of MSCs stimulated with NKC CM 
It has been demonstrated earlier by Yokoo et al. that MSCs can be reprogrammed to differentiate 
during metanephric development into the glomerular and tubular epithelium (Yokoo et al. 2005). 
Using the chimeric kidney rudiment system introduced in Chapter 4, D1 cells were shown only to 
contribute to nephrogenesis to a limited extent. In an attempt to increase the integration potential 
of MSCs, before performing the recombination assay, MSCs were stimulated with a mix of NKC 
CM and standard culture medium for 4 days. This was followed by 4 days of in vitro chimeric 
kidney culture. Consequently, the preconditioning with NKC CM improved the engraftment 
potential of D1 cells into condensing MM, characterised by the expression of Wt1 or Six2. At the 
same time, D1 cells pre-treated with NKC CM were also infrequently found in developing 
nephron-like structures characterised.  
In addition, using the calbindin staining to visualise ureteric buds it has been possible to confirm 
that neither unstimulated nor stimulated GFP D1 cells integrate into the ureteric buds of chimeric 
kidneys. This is in accordance with previous data (Fukui et al. 2009). It has been 
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demonstrated that human bone marrow-derived MSCs expressing chicken Pax2 transplanted into 
a chicken embryo, can migrate along the elongating Wolffian duct and integrate into the Wolffian 
duct epithelia but do not engraft into the ureteric bud (Fukui et al. 2009).  
Furthermore, the presence of numerous D1 cells in Wt1- and laminin-negative compartment was 
detected in both conditions. However, due to a lack of availability of an appropriate stromal 
marker, it was impossible to conclude if D1 cells found in this compartment are differentiating 
into stroma or rather represent a fraction of undifferentiated D1 cells. No study was also 
attempted to elucidate if cells found in the Wt1- and laminin-negative compartment are 
proliferating, which might explain the high numbers of D1 cells in the compartment.  
Some human MSCs that were injected into rat embryos according to Yokoo`s protocol were 
expressing Wt1 when integrated into metanephric kidneys (Yokoo et al. 2005). Using QD-
labelled D1 cells, it was possible to detect in the chimeric kidneys some D1 cells that expressed 
Wt1. However, the expression could not be confirmed using GFP labelling. Upon stimulation 
with NKC CM, the GFP cells did not acquire Wt1 expression, although stimulated QD-labelled 
cells were still found to be Wt1 positive when integrated into Wt1 expressing regions. There are 
several possibilities explaining this result which were discussed in the previous chapter (section 
4.3.2).  
Surprisingly, the stimulation with NKC CM did not facilitate integration of human MSCs. One 
explanation of this fact could be that the human MSCs are not able to respond to factors found in 
the conditioned medium obtained from mouse kidney cells. For instance, it has been described 
that mouse and human bone marrow cells differently respond to feeder layers from patients with 
acute granulocytic leukaemia. Accordingly, mouse marrow colony growth was stimulated by 
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the feeder layer while no colony growth occurred in normal human marrow (Lind et al. 1974). 
Another possibility is that the human cells require a different set of factors to trigger their 
engraftment than mouse MSCs, which possess some initial integration potential. 
In conclusion, these data suggest that the pre-conditioning of D1 cells helps to increase the 
integration rate of the cells into condensing mesenchyme in the chimeric kidney model. In 
contrast, stimulation with NKC CM is insufficient to trigger engraftment of human MSCs. 
Accordingly, the difference in incorporation rates between stimulated and unstimulated D1 cells 
was evaluated and the outcomes of this analysis are discussed below. 
5.3.4. Analysis of integration potential of D1 cells stimulated with NKC CM 
In order to analyse the difference in incorporation between stimulated and unstimulated D1 cells, 
integration of the cells into different kidney compartments was assessed in three independent 
recombination experiments. Following stimulation with NKC CM, most D1 cells remained in the 
Wt1- and laminin-negative compartment of chimeric kidneys, similar to unstimulated cells. The 
second largest compartment, where stimulated D1 cells were localised upon recombination, was 
the Wt1-expressing MM. However, there is a discrepancy in the number of integrated cells 
depending on the labelling method used. On average, 3.75% of stimulated QD D1 cells and 
1.18% of unstimulated QD D1 cells were found in the Wt1-positive compartment, whereas 
13.29% of stimulated GFP D1 cells and 3.37% of unstimulated GFP D1 cells was localised 
within Wt1-positive compartment. This implies a 3.54-fold increase in the number of counted 
stimulated GFP cells versus stimulated QD cells, and a 2.86-fold increase in the number of 
counted unstimulated GFP cells versus unstimulated QD cells. One explanation for this result 
could be that some QDs were lost during the in vitro 4 day culture period. A quick loss of QD 
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labelling has been described in mouse embryonic stem cells (ESCs) and mouse embryonic 
fibroblasts (MEFs) (Pi et al. 2010). Also for human MSCs, a loss of QD labelling has been 
observed over a long period of time (Rosen et al. 2007). Indeed in section 3.2.1 it was 
demonstrated that D1 cells labelled with QDs remained stained in vitro for 5 days but fewer QDs 
were detected inside the cells on day 5 than directly after labelling. However, no quantification of 
D1 cells maintaining the labelling after 5 days of culture was attempted. Although a difference in 
the integration potential of D1 cells labelled with the two techniques was observed, both QD and 
GFP labelled D1 cells stimulated with NKC CM demonstrated a similar raise in engraftment into 
condensing mesenchyme, suggesting that if loss of labelling occurred it had to be similar in all 
cells.  
A discrepancy between the integration rate of QD and GFP labelled D1 cells into laminin positive 
compartments highlights also the problems associated with labelling. While neither unstimulated 
nor stimulated GFP-labelled cells were detected in laminin positive tubular structures, both 
unstimulated and stimulated QD D1 cells were found in this compartment. Additionally, an 
increase in integration of stimulated QD cells versus unstimulated was detected in the laminin-
positive compartment. In general, the renogenic potential of D1 cells seems to differ considerably 
depending on the labelling method used. While QD D1 cells show broad engraftment potential 
including stroma, condensing MM, nephron-like structures and UBs, GFP labelled cells display 
only integration potential into condensing MM. One explanation for those observations could be 
the fact that QDs can be excreted from D1 cells or remain in the structures after the cells 
underwent apoptosis, giving a false positive signal. Another possibility includes the transfer of 
QDs to kidney cells. It was shown that QDs found in the supernatant of labelled cells can be 
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further utilized for labelling of other cells (Pi et al. 2010). An additional labelling method should 
be considered to confirm the data using QD and GFP cells. Some other labelling methods for 
MSCs could include labelling with the lipophilic membrane dye Dil (Challen et al. 2006), sex 
chromosome staining (Morigi et al. 2004), as well as labelling with the analogue 5-bromo-
2’deoxyuridine (BrdU) which only can be incorporated by proliferating cells (Kunter et al. 2006). 
Although the integration of GFP-labelled cells increased upon stimulation, differently as for QD-
labelled cells, the increase was not statistically significant. When reforming the embryonic 
kidneys some variability among the chimeras is observed that could lead to differences in 
integration rate. For example, the chimeras often have slightly different sizes as some cells are 
lost during the transfer onto the filter. Also since metal grids supporting the filter have to some 
extent different dimensions, differences in volume of culture medium used for culturing chimeras 
occur that can affect the growth of chimeras. As the number of samples used for the integration 
statistics was small, more experiments using D1 cells labelled with both techniques should be 
performed in order to confirm the statistical significance.  
Finally, a difficulty in interpreting the integration results is the lack of information on apoptosis 
and proliferation of the cells in the chimeras. It has been suggested by Yokoo et al. that human 
MSCs in the kidney rudiments are undergoing cell division (Yokoo et al. 2005). It is possible that 
stimulated D1 cells in MM proliferate faster than unstimulated cells and this causes higher 
prevalence of stimulated D1 cells in the MM. Therefore the ratios obtained in these experiments 
do not reflect exact numbers of integrated cells but rather describe a trend in integration and 
cannot be used to fully describe the behaviour of the cells in chimeric kidneys.  
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5.3.5. Renogenic potential of D1 cells stimulated with NKC CM compared with other stem 
cells 
It is difficult to compare the number of integrated stimulated D1 cells using the recombination 
method with the integration described by Yokoo et al. since no exact quantification of MSC 
engraftment was provided (Yokoo et al. 2005). However, it is possible to make some comparison 
in integration capability into different renal compartments between stimulated D1 cells and 
kidney cells. Challen et al. injected mouse kidney-derived cells into mouse E12.5 metanephroi 
followed by 3 days of in vitro culture, in order to evaluate their differentiation potential in the 
metanephric development (Challen et al. 2006). For the kidney side population, a renal progenitor 
population, 29% of cells were found in MM stained with Wt1, whereas 14% of the cells 
incorporated into UBs stained with calbindin. Further, 9% of cells derived from adult kidneys, 
which did not display the kidney side population characteristics, were detected in MM and 1% of 
these cells was present in the UBs (Challen et al. 2006). D1 cells, both unstimulated and 
stimulated with NKC CM, therefore have a lower engraftment potential into Wt1-expressing 
mesenchyme than kidney progenitors. Nevertheless, D1 cells stimulated with NKC CM possess a 
higher potential to integrate into Wt1-expressing mesenchyme when compared with adult kidney 
cells, according to the data obtained with GFP D1 cells. Since no quantitative analysis using 
calbindin was performed in the kidney chimeras it is difficult to directly compare the integration 
of D1 cells and kidney progenitors into UBs. However, according to the data obtained with 
calbindin staining and GFP labelled D1 cells, D1 cells have no potential to contribute to UB 
formation.  
In addition, there exists also limited data on the extent of ESC integration into developing renal 
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structures. Steenhard et al. described that after injecting undifferentiated mouse ESCs into E13 
mouse kidney rudiments, ESCs were forming tubules. By day 2, over 50% of all structures 
containing ESCs were identified as tubules, whereas the remaining cells were characterised as 
single cells, clusters of cells or dying cells (Steenhard et al. 2005). Further, it has been described 
that mouse ESC-derived cells injected into E12.5 kidney cultured for 4 to 5 days can be found in 
the tubules, the interstitium and peripheral mesenchyme. The percentage of surface area occupied 
by ESC-derived cells in the metanephroi was 60% and 40% for non-tubular and tubular 
structures, respectively (Kim and Dressler 2005). In comparison, mouse ESC-derived cells 
stimulated with nephrogenic factors exclusively formed tubular structures (Kim and Dressler 
2005). Finally, no quantification of integration potential of amniotic fluid stem cells (AFSCs) into 
different kidney compartments was provided until now. However a recent report showed that 
modulation of mTOR activity in AFSCs decreases their ability to contribute to renal structures in 
the chimeric kidney assay (Siegel et al. 2010).  
Finally, in the chimeric kidneys, both unstimulated and stimulated D1 cells were found frequently 
outside the MM, MM-derived structures and UBs. An important question remains: is this a 
feature of MSCs, or do all other stem cell types preferentially localise outside renal structures? 
The statistical data on integration of kidney progenitors and kidney-derived cells into MM and 
UBs demonstrated by Challen et al. implicates that both populations are mainly found within the 
Wt1- and calbindin-negative compartment of injected metanephroi (Challen et al. 2006), perhaps 
the stromal compartment. Furthermore, results obtained with label retaining tubular cells (LRTC) 
isolated from rat kidneys demonstrated that 60% of LRTC injected into E15 rat embryonic 
kidneys were localized in the interstitium after 5 days of culture (Maeshima et al. 2006). Also a 
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mouse embryonic renal stem cell population characterised by Lusis et al. was described to mostly 
reside in the interstitium of mouse embryonic kidneys after a similar experiment to formation of 
chimeric kidneys was performed using these cells (Lusis et al. 2010). Accordingly these data 
suggest that the high prevalence of D1 cells in the stroma and outside the renal structures in the 
metanephric kidney is not a unique feature of MSCs.  
5.3.6. Mechanism of increased renogenic potential of D1 cells following preconditioning 
As discussed above, the culture of D1 cells in NKC CM for 4 days prior to the integration assay 
increases the engraftment potential of the cells into MM of developing chimeric kidneys. 
However, it is not clear how the conditioned medium mediates this effect. Human MSCs 
transduced with an adenovirus to transiently over-express human Gdnf that were injected at the 
site of nephrogenesis prior to the start of kidney development were found in metanephroi to a 
greater extent than MSCs not transduced with Gdnf. Accordingly, transduction with Gdnf has 
been shown to lead to an approximately 6-fold increase in the incorporation rate. Ultimately, 
almost 30% of cells found in such developing kidneys were human MSCs over-expressing GDNF 
(Yokoo et al. 2005). Why GDNF expression increases the integration potential of human MSCs 
is not evident. Yokoo and co-workers state in their report only that GDNF is expressed in MM 
and takes part in epithelial-mesenchymal signalling (Yokoo et al. 2005). In the current study the 
pre-conditioning with NKC CM lead to a significant up-regulation in Gdnf expression in D1 
cells. Subsequently, after the NKC CM was changed to standard culture medium, the increase in 
Gdnf expression was still detectable and significantly higher in comparison with unstimulated D1 
cells. The up-regulation in Gdnf expression was accompanied by a higher integration rate in the 
chimeric kidney assay. These results suggest that pre-conditioning with NKC CM indeed may 
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help MSCs to incorporate into metanephric kidneys, acting similarly as transient transduction 
with Gdnf, and further corroborates the role of Gdnf in enhancing the integration potential of 
MSCs.  
If Gdnf is increasing the renogenic potential of MSCs it is not clear if the up-regulation in Gdnf 
expression after stimulation with NKC CM is entirely responsible for the raise in incorporation 
rate. It might be possible that the increase in Gdnf expression only accompanies other 
mechanism. Still the factor that induces D1 to increasingly engraft has to be present in the NKC 
CM. One possibility to confirm the importance of Gdnf would be to knock-down its expression 
following stimulation and subsequently evaluate the integration ability of the stimulated cells. 
Another option could be to transiently over-express Gdnf in D1 cells and compare the effect of 
over-expression on engraftment potential of the cells with the effect exerted by NKC CM 
stimulation. Even if the up-regulation in Gdnf expression would be fully responsible for the 
improvement in integration potential of D1 cells, again it is difficult to assess which factors 
present in the NKC CM trigger the up-regulation. In this study in order to concentrate 
conditioned medium derived from NKCs Vivaspin centrifugal ultra-filtration device with 5kDa 
molecular weight cut off was used. In this way macromolecules with higher molecular weights 
dissolved in CM, such as growth factor, were retained in the concentrated CM, while salts and 
water passed through. For that reason it is difficult to speculate which factor present in both CM 
and concentrated CM is responsible for the increase in Gdnf expression and the enhanced 
engraftment. Nevertheless, elevated Gdnf expression has been shown to persist in cells stimulated 
with NKC CM that was concentrated. However, as the increase in concentration of NKC CM did 
not induce further increase in Gdnf, it can be assumed that a quasi optimal concentration of the 
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inducing factor has been reached already in the 1 to 1 mix. It is important to note that no analysis 
on diluted instead of concentrated NKC CM has been performed. Surprisingly, both concentrated 
culture media used for D1 and MEF CM induced also to some extent an increase in Gdnf. This 
suggests that the existence of factors responsible for Gdnf induction is not restricted to media 
derived from kidney cells. Nevertheless these results have not been quantified. Finally the 
possibility that Gdnf present in the NKC CM might induce Gdnf expression in D1 cells was 
evaluated, as MSCs were shown to increase Gdnf expression upon stimulation with Gdnf (Shi et 
al. 2008). Accordingly, no up-regulation in Gdnf expression in D1 cells has been achieved after 
Gdnf stimulation, possibly due to lack of expression of the Ret receptor. However, it is important 
to note that Gdnf can signal independently of Ret receptor (Popsueva et al. 2003), which might 
explain slight downregulation of Gdnf expression following Gdnf treatment.  
Finally, in this study it was not possible to perform any analysis of Gdnf expression on protein 
level. All approaches aimed at detection of Gdnf at protein level, namely the use of commercial 
available anti-Gdnf antibody for immunofluorescence staining/Western blot analysis as well as 
the use of commercial available enzyme-linked immunoadsorbent assay (ELISA) detecting Gdnf, 
failed (data not shown). However, problems with detection of Gdnf have been reported before 
(Liu et al. 2001). 
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Chapter 6: Effects of MSCs on metanephric kidney development 
6.1. Introduction 
Bone marrow-derived MSCs were described to improve renal function in different experimental 
models of acute kidney injury (Herrera et al. 2004; Morigi et al. 2004; Togel et al. 2005; Kunter 
et al. 2006). Notably, the paracrine activity of MSCs appears to play an important role in 
achieving the enhanced recovery from kidney injury (Togel et al. 2005; Bi et al. 2007; Imberti et 
al. 2007; Semedo et al. 2007; Togel et al. 2007; Togel et al. 2009). Togel et al. demonstrated that 
administration of rat bone marrow-derived MSCs improved renal function in the model of 
ischemia-reperfusion acute renal failure, although only few MSCs were detected in the injured 
kidneys. Accordingly, 24h after administration of rat MSCs, injured kidneys  showed  reduced  
expression of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and 
interleukin-1β,  and an increase in expression of the anti-inflammatory molecule, interleukin-10 
(Togel et al. 2005). These results have been confirmed by another group which also demonstrated 
a change in cytokine expression following administration of rat MSC in the ischemia-reperfusion 
injury model (Semedo et al. 2007). Bone marrow-derived MSCs were also shown to have a 
protective effect in cisplatin-induced acute renal failure (Morigi et al. 2004; Bi et al. 2007). Later, 
it was demonstrated that administration of conditioned medium derived from mouse MSCs is 
able to decrease kidney injury in the cisplatin-induced acute renal failure in a similar manner as 
the injection of the cells (Bi et al. 2007). These results were also repeated in an in vitro model 
where conditioned medium derived from mouse MSCs was shown to increase the survival of 
immortalized mouse proximal tubule cells treated with cisplatin (Bi et al. 2007). Collectively, 
these results suggest that the beneficial action of MSCs during renal injury is mediated through 
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paracrine factors secreted by the cells. 
Togel and co-workers subsequently showed that MSCs express various factors, such as fibroblast 
growth factor 2 (Fgf2), transforming growth factor-α (TGF-α), insulin-like growth factor-1 (IGF-
1) and different members of vascular endothelial growth factor (VEGF). In addition, the presence 
of VEGF-A, IGF-1 and TGF-β1 was confirmed in the conditioned medium from MSCs (Kunter 
et al. 2006; Togel et al. 2007). Ultimately, it has been described that inhibition of VEGF 
expression in bone marrow-derived rat MSCs prior to their administration in the ischemia-
reperfusion kidney failure model results in reduced functional renal recovery (Togel et al. 2009). 
Similarly, IGF-1 was demonstrated to mediate the beneficial effects of MSC administration in the 
cisplatin-induced kidney injury (Imberti et al. 2007). Accordingly, Imberti et al. demonstrated 
that bone marrow-derived mouse MSCs do not protect from renal function deterioration when 
IGF-1 expression has been blocked. In addition, MSCs expressing IGF-1 were shown to induce 
proliferation of cisplatin-damaged proximal tubular epithelial cells in vitro. The inhibition of 
IGF-1 expression in MSCs resulted in reduced proliferation of cisplatin-damaged tubular cells 
(Imberti et al. 2007). A recent report, however, describes no protective action of porcine MSCs in 
the ischemia-reperfusion acute renal failure model despite the fact that cells were shown to 
secrete VEGF-A and IGF-1. From this study, it was concluded that porcine MSCs might produce 
other factors, like the pro-inflammatory interleukin-6, during kidney injury which do not induce 
functional improvement of kidneys (Brunswig-Spickenheier et al. 2010). Similar results were 
obtained with mice lacking the alpha3-chain of type IV collagen, a chronic kidney disease model. 
In the aforementioned study, although MSCs were shown in vitro to express VEGF, weekly 
administrations of mouse MSCs did not protect the animals from renal failure. Nevertheless 
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MSCs were described to reduce renal fibrosis in this model (Ninichuk et al. 2006).  
In previous chapters, the contribution of MSC to nephrogenesis has been evaluated using the 
chimeric kidney model. Accordingly, D1 cells were shown to integrate infrequently into 
condensing metanephric mesenchyme (MM). Subsequently the engraftment potential was 
increased after pre-conditioning of the cells with conditioned medium derived from neonatal 
kidney cells (NKC CM). However, throughout the experiments it appeared that MSCs negatively 
affected the metanephric development of the chimeras. It also became evident that the stimulation 
with NKC CM may play a role in decreasing the negative action of D1 cells. Although the cells 
appeared to have a negative effect on the development of the chimeric rudiments, this was not 
directly investigated in previous chapters. If MSCs indeed negatively influence the metanephric 
development, their use in regenerative approaches aimed at recapitulating nephrogenesis would 
be very limited. The aforementioned results demonstrate that the renoprotective effect exerted by 
MSCs observed in experimental models of kidney injury can be mediated indirectly via a 
paracrine action of the cells. It is therefore likely that paracrine factors secreted by MSCs can 
affect chimeric kidney development. The aim of this chapter is to determine the effect of D1 cells 
on metanephric development and to investigate the mechanism of their action. 
6.2. Results 
In this chapter the effects exerted by MSCs on embryonic kidney development were examined. 
Accordingly, the outcome of recombination of D1 cells on chimeric kidney development was 
assessed and the putative mechanism of action is discussed. 
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6.2.1. Effect of integration of D1 cells and human MSCs on metanephric development 
following chimeric kidney culture 
In previous experiments, the renogenic potential of MSCs was investigated following the 
recombination of MSCs with E11.5 kidney rudiment cells to form kidney chimeras. As 
mentioned in Chapter 4 and 5, some detrimental effect on metanephric kidney development in 
chimeras harbouring either D1 cells or human MSCs was observed which was not present in 
kidneys reformed in the absence of stem cells. Figure 6.1 and 6.2 highlight the differences 
between reformed embryonic kidneys in the absence and presence of MSCs. While the reformed 
kidneys in the absence of D1 cells contained aggregates of Wt1-expressing condensing 
mesenchyme and developing nephron-like structures (marked by high expression of Wt1) (Figure 
6.1a-c), some regions of chimeric kidneys harbouring D1 cells entirely lacked condensing 
mesenchyme and nephron-like structures (Figure 6.1d-g).  
 185 
Figure 6.1 D1 cells impair the development of chimeric kidney after 4 days of culture. Representative images of chimeras are shown (from at least 3 
independent experiments). (a-c) Re-aggregated kidney in the absence of D1 cells stained for Wt1 and laminin showed normal development characterised 
by condensation of mesenchyme (m) around UBs (u) and nephron-like structure formation (*). (d-g) Chimera recombined in the presence of QD-labelled 
D1 cells stained for Wt1 and laminin lacking condensing mesenchyme and developing nephrons. 
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A comparable impairment of development was observed in chimeras harbouring human MSCs. 
As shown in Figure 6.2b-d, chimeras harbouring human MSCs displayed disorganization of Wt1-
expressing MM and lacked nephron-like structures. In comparison, reformed kidneys developing 
in the absence of human cells showed aggregates of Wt1-expressing condensing mesenchyme as 
well as highly Wt1-positive nephron-like structures (Figure 6.2a). 
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Figure 6.2 Human MSCs impair the development of chimeric kidney after 4 days of culture. Representative images of chimeras are shown (from at least 
3 independent experiments). (a) Re-aggregated kidney in the absence of human MSCs showed normal development which is characterised by regions of 
condensing mesenchyme (m) expressing medium levels of Wt1 and nephron-like structures (*) expressing high levels of Wt1. (b-d) Chimera recombined 
in presence of human MSCs labelled with anti-human antibody and stained for Wt1 showing disorganization of condensing mesenchyme.  
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As described in the previous chapter, the stimulation with NKC CM increased the integration 
potential of D1 cells into condensing mesenchyme of rudiment chimeras after 4 days of culture. 
At the same time, it also appeared that the stimulation had some beneficial effect on chimeric 
kidney development. In Figure 6.3 the difference in overall development between reformed 
embryonic kidneys in the absence of stem cells, the presence of D1 cells and the presence of 
NKC CM pre-treated D1 cells is presented. Some inhibition in metanephric development 
characterised by reduction of condensing mesenchyme and fewer forming nephron-like structures 
occurred in chimeras harbouring D1 cells (Figure 6.3d-g). However, the development of kidneys 
recombined with D1 cells that were pre-treated with NKC CM (Figure 6.3h-k) and kidneys re-
aggregated in the absence of D1 cells (Figure 6.3a-c) was similar. Both kidneys displayed Wt1-
expressing condensing MM and nephron-like structures characterised by high expression of Wt1 
and the presence of laminin. 
In order to assess if stimulated D1 cells can exert long-term beneficial effects on kidney 
development, E11.5 kidney cells were recombined with unstimulated or NKC CM stimulated D1 
cells in the same 1 to 5 ratio and cultured for 7 days. GFP-labelled D1 cells were used for this 
experiment as there was the risk that considerable number of cells might lose QDs after 7 days. It 
was demonstrated in section 3.2.1 that some D1 cells lost QD-labelling after 5 days of in vitro 
culture. Accordingly, the reduction of the D1-induced negative effect on metanephric 
development was detectable in chimeric kidneys containing NKC CM stimulated D1 cells after 7 
days. As shown in Figure 6.4e-h, chimeras harbouring stimulated D1 cells appeared to contain 
more Wt1-exepressing mesenchyme in comparison with unstimulated D1 cells (Figure 6.4a-d). 
Surprisingly, no further increase in nephron development seemed to occur during this period of 
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time in any of the conditions. Ultimately, NKC CM stimulated D1 cells were found to a greater 
extent integrated into the Wt1-expressing condensing mesenchyme than unstimulated cells, 
confirming the previous experiment performed at day 4 (Figure 6.4a-h). 
In summary, both D1 cells and human MSCs appear to exert a negative effect on chimeric kidney 
development. The pre-treatment of D1 cells with NKC CM seems to prevent the detrimental 
action of the cells in short- and long-term cultures. 
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Figure 6.3 D1 cells impair the development of chimeric kidney after 4 days of culture; however, the pre-treatment with NKC CM for 4 days before the recombination 
experiment can avert this effect. Representative images of chimeras are shown (from at least 3 independent experiments). (a-c) Re-aggregated kidney in the absence of 
MSCs stained for Wt1 and laminin demonstrating presence of condensing mesenchyme around UBs and nephron-like structure formation. (d-g) Chimera recombined 
in presence of QD labelled D1 cells and stained for Wt1 and laminin appears to display less condensing mesenchyme and developing nephrons. (h-k) Chimera 
recombined in presence of QD labelled D1 cells pre-treated with NKC CM and stained for Wt1 and laminin demonstrates presence of condensing mesenchyme and 
developing nephrons. 
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Figure 6.4 The pre-treatment of D1 cells with NKC CM can prevent loss of condensing mesenchyme in chimeras harbouring D1 cells after 7 days of 
culture. Representative images of chimeras are shown (from 2 independent experiments). (a-d) Chimera recombined in presence of GFP labelled D1 cells 
and stained for Wt1 and laminin appears to display less Wt1-positive mesenchyme. (e-h) Chimera recombined in presence of GFP labelled D1 cells pre-
treated with NKC CM and stained for Wt1 and laminin demonstrates presence of Wt1-expressing condensing mesenchyme (m) and enhanced integration 
of the GFP cells.  
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6.2.2. Effect of conditioned medium derived from D1 cells on the development of intact 
kidney rudiments 
To reduce condensation of metanephric mesenchyme or nephron formation in the chimeras, D1 
cell have to either directly or indirectly interact with kidney cells. It is anticipated that the 
protective action and enhanced recovery in kidney injury models are achieved through the 
paracrine activity of MSCs (Togel et al. 2005; Togel et al. 2007; Bruno et al. 2009). In order to 
examine if MSCs may exert an indirect effect on chimeras by secreting paracrine factors that 
inhibit kidney development, ex vivo development of whole E11.5 rudiments in the presence of 
conditioned medium derived from D1 cells was assessed (MSC CM). Subsequently, the 
development of rudiments cultured with MSC CM was compared against kidneys cultured in 
standard culture medium and in conditioned medium from NKC CM stimulated D1 cells (sMSC 
CM), as it has been observed that pre-conditioning of D1 cells with NKC CM may reduce the 
negative effect on the development of reformed kidneys. Accordingly, E11.5 kidney rudiments 
were cultured for 3 days in the presence of standard culture medium mixed 1:1 with MSC CM or 
sMSC CM. In order to ensure that no NKC CM was present in the sMSC CM, the conditioned 
medium collection took place 24h after the medium had been changed to standard culture 
medium. Also, MSC CM was collected 24h after a medium change to maintain similar 
experimental conditions. To determine the influence of MSCs on the development of kidneys, 
branching morphogenesis was evaluated by staining with calbindin which is expressed in UBs 
(Davies 1994). A schematic representation of the experiment is presented in Figure 6.5. As 
demonstrated in Figure 6.6a-c, kidneys incubated with MSC CM, have impaired branching when 
compared with kidneys cultured in standard medium or sMSC CM. Moreover, the number of 
counted UB tips was similar in kidneys incubated in standard culture medium and in medium 
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from sMSC CM but was significantly reduced by MSC CM (p<0.05, n=3) (Figure 6.6d).  
 
Figure 6.5. Schematic representation of an experiment elucidating the indirect effect of D1 cells on ex 
vivo development of intact E11.5 rudiments. D1 cells were cultured in standard culture medium (SCM) (a) 
or NKC CM (b) for 4 days. Subsequently the medium was changed to SCM for 24h in both conditions. 
Finally E11.5 kidney rudiments were cultured for 3 days in the presence of conditioned medium derived 
from D1 cells, either unstimulated (MSC CM) or previously stimulated with NKC CM (sMSC CM). 
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Figure 6.6 D1 cells exert an indirect negative effect on metanephric development and the pre-treatment of 
D1 cells with NKC CM can prevent this effect. Representative images showing whole E11.5 kidneys 
cultured in the presence of normal medium (a), medium from D1 cells (MSC CM) (b) and medium from 
stimulated D1 cells with NKC CM (sMSC CM) stained for calbindin after 3 days of in vitro culture. (d) 
UB tips count performed after 3 days on three different kidney rudiments cultured in normal medium, 
MSC CM and sMSC CM showing that the number of UB tips is significantly reduced in kidneys treated 
with  MSC CM (t-test, p<0.05, n=3).  
It has been shown that stimulation of E11.5 mouse kidney rudiments with exogenous bone 
morphogenetic protein 4 (Bmp4) inhibits branching of UB and condensation of MM (Miyazaki et 
al. 2003). As Bmp4 might be one of the factors implicated in inhibition of development in 
chimeras harbouring D1 cells, expression of Bmp4 in D1 cells was evaluated. In Figure 6.7a, D1 
cells were shown to express increased levels of Bmp4 in comparison with E13.5 kidney (p<0.01, 
n=4). Furthermore, following stimulation with NKC CM, the expression levels of Bmp4 in D1 
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cells were to some extent reduced.  
 
Figure 6.7 Comparison of Bmp4 expression level in unstimulated and stimulated with NKC CM D1 cells 
using quantitative PCR. The reference gene is Gapdh and the error bars represent SE of the mean. In 
comparison with E13.5 kidney cells D1 cells showed higher expression of Bmp4 (t-test, p<0.01, n=4). 
Expression of Bmp4 was not significantly different in D1 cells stimulated with NKC CM from E13.5 
kidney (t-test, p>0.05, n=4). 
In conclusion, it was found that conditioned medium from D1 cultures has a negative effect on 
development of intact kidney rudiments, suggesting that inhibition of metanephric development 
in chimeras observed in previously experiments is indirectly mediated by MSCs. Further, D1 
cells affect metanephric development possibly by secreting factors like Bmp4, which inhibit UB 
branching and condensation of MM. 
6.3. Discussion 
In this chapter the negative effect of recombination of MSCs on chimeric kidney development 
has been described. At the same time the stimulation with NKC CM was shown to prevent the 
detrimental effect on embryonic kidney development exerted by D1 cells. In order to examine if 
D1 cells influence kidney development in an indirect manner, intact metanephroi were cultured in 
the presence of conditioned medium derived from D1 cultures. It was found that conditioned 
medium from D1 cultures negatively affected the ex vivo development of intact kidney 
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rudiments. Finally, expression of Bmp4, a gene encoding a factor that inhibits nephrogenesis, was 
found to be highly expressed in D1 cells. 
6.3.1. Effects exerted by MSCs on kidney development 
So far it has been investigated if MSCs can contribute to nephrogenesis in vitro. The renogenic 
capacity of MSCs was determined by examining their integration potential into different 
compartments of chimeric kidneys. In this chapter, the effect of MSC recombination on 
metanephric development of the kidney chimeras was described. Accordingly, the chimeric 
kidneys were analysed for the presence of condensing mesenchyme and nephron formation. It 
appeared that chimeras harbouring either D1 cells or human MSCs displayed fewer areas of 
condensing mesenchyme or nephron-like structures in comparison with kidneys reformed in the 
absence of MSCs. This could be to some extent explained by the fact that chimeras reformed 
using MSCs contained fewer embryonic kidney cells. In the absence of MSCs the reformed 
kidneys were comprised only of kidney cells, whereas the chimeras harbouring MSCs were 
mixed in 1 to 5 ratios. Nevertheless, no such effect was observed when ESCs or NKCs were 
mixed in 1 to 5 ratios (see Chapter 4). Furthermore, chimeric kidneys harbouring D1 cells 
stimulated with NKC CM seemed to display similar levels of condensing mesenchyme and 
nephron-like structures when compared with kidneys without stem cells. It is not clear what 
factor in the NKC CM is responsible for the inhibition of detrimental effect on chimeric 
development in D1 cells upon stimulation. One option could be that NKC CM contains an 
inhibitor or an enzyme that inactivates a detrimental factor produced by MSCs. For example, it 
has been shown that matrix metalloproteinase-9 (MMP-9) secreted by embryonic kidneys are 
involved in UB branching (Lelongt et al. 1997). Nevertheless, MMP-9 can also induce epithelial 
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mesenchymal transition in tubular cells contributing to renal fibrosis (Tan et al. 2010). There 
exists a natural inhibitor of MMP-9, namely the tissue inhibitor of metalloproteinase 1, which is 
able to block the action of MMP-9 (Lelongt et al. 1997). NKC CM might contain such inhibitor. 
Together these results suggest that MSCs may have some negative impact on metanephric 
development in kidney chimeras.  
In order to determine if the negative effect was due to paracrine factors secreted by MSCs, the 
action of D1 cells on intact E11.5 kidney rudiments was evaluated. MSCs were previously 
described to secrete various factors such as vascular endothelial growth factor (VEGF) and 
insulin growth factor-1 (IGF-1) in vitro (Kunter et al. 2006; Togel et al. 2007). Furthermore, it 
was shown that the paracrine factors released by MSC play a crucial role in enhancing recovery 
from kidney injury in animal models (Togel et al. 2005; Bi et al. 2007; Imberti et al. 2007; Togel 
et al. 2007; Togel et al. 2009). However, despite their positive role in renal injury models, it is 
possible that some of the paracrine factors secreted by D1 cells inhibit the emergence of 
condensing mesenchyme and formation of nephrons during kidney development. The inhibitory 
role of D1 paracrine factors was confirmed by showing that conditioned medium derived from 
D1 cells reduced UB branching of in vitro cultured intact E11.5 kidney rudiments. Interestingly, 
the incubation of kidney rudiments in medium derived from stimulated D1 cells sustained normal 
branching in the intact kidneys.  
Together these results demonstrate that D1 cells can secrete factors that negatively influence 
metanephric development. Although it cannot be excluded that there might be some direct 
interaction between MSCs and kidney cells that contributes to observed negative effects on 
chimeric development, it is most likely the paracrine factors derived from MSCs that inhibit 
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nephrogenesis in the kidney chimeras. Furthermore, pre-treatment of D1 cells with NKC CM is 
able to avert this effect, probably by changing again the milieu of secreted factors. Yokoo et al. 
did not report any detrimental effect on kidney development when integrating human MSCs into 
rodent metanephroi (Yokoo et al. 2005). However there are reports describing toxic effects of 
conditioned medium derived from MSCs on hippocampal tissue in vitro (Horn et al. 2009; Horn 
et al. 2010). Accordingly, conditioned medium from rat bone marrow-derived MSCs was shown 
to induce reactive oxygen species formation and inflammation in organotypic cultures of rat 
hippocampus (Horn et al. 2010). 
6.3.2. Putative mechanism of detrimental action of D1 cell on kidney development 
Inductive interactions play a crucial role in early kidney morphogenesis (Horster et al. 1999; 
Dressler 2006). It is possible that MSCs interfere with these interactions and as a result, inhibit 
kidney development. One of the most important inductive interactions takes place when UB 
invades the MM and starts to branch and this is mediated through Gdnf signalling. Gdnf secreted 
by MM binds to the Ret receptor at the tips of UB inducing growth and branching of the UB 
(Vega et al. 1996; Sainio et al. 1997). D1 cells were shown to express Gdnf; however, no 
extensive UB branching was observed in chimeras harbouring D1 cells. On the contrary, it was 
observed that the conditioned medium derived from D1 cells reduced branching in the intact 
kidney rudiments. An explanation for this effect could be that although D1 cells express Gdnf, 
they do not secret the protein or that Gdnf secreted by D1 is not fully functional. In this study it 
has not been possible to measure Gdnf levels in supernatants obtained from D1 cell culture (data 
not shown). However, it has been reported that MSCs are able to produce and secrete Gdnf (Ye et 
al. 2005). Another possibility would be that D1 cells secrete simultaneously other factors or 
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molecules that inhibit Gdnf signalling in kidney cells. For example it has been reported that 
heparan sulphates are required to activate Ret receptor; nevertheless, exogenous heparan 
sulphates inhibit receptor activation and hence suppress Gdnf signalling (Barnett et al. 2002). 
Interestingly, D1 cells stimulated with NKC CM which do express higher levels of Gdnf than 
unstimulated D1 cells, do not induce impairment in branching morphogenesis. This can suggest 
that high expression of Gdnf may at least help sustain the number of UB tips. Blocking of Gdnf 
expression in stimulated cells would help to better understand the mechanism of protective action 
of D1 cells following treatment with NKC CM. Ultimately, the presence of Gdnf in the 
conditioned medium from stimulated cells has not been confirmed.  
A range of factors has been described to modulate kidney development (Horster et al. 1999). 
Different members of transforming growth factor-β (TGF-β) superfamily such as TGF-β1, 
activin, and bone morphogenetic protein 2 or 4 were described to negatively act on growth and 
branching of UBs (Bush et al. 2004). Accordingly, bone morphogenetic protein 4 (Bmp4) might 
be one of the factors responsible for the inhibition of development in kidney chimeras harbouring 
MSCs or intact rudiments cultured in the presence of D1 derived conditioned medium. During 
metanephric development, Bmp4 is expressed in mesenchymal cells surrounding the Wolffian 
duct when the UB starts invading the MM. Later, Bmp4 expression is observed in stromal 
mesenchymal cells around the stalk of the UB and the smooth muscle layer around the 
developing ureter (Miyazaki et al. 2000). Although in vitro Bmp4 is able to promote survival of 
isolated MM in the absence of inducer tissue, the stimulation of E11.5 mouse kidney rudiments 
with Bmp4 for 48h results in inhibition of UB branching and MM condensation (Miyazaki et al. 
2003). This is accompanied by down-regulation of expression of such markers like Gdnf, Wt1 
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and Pax2 (Raatikainen-Ahokas et al. 2000; Miyazaki et al. 2003). In this chapter it has been 
confirmed that D1 cells express Bmp4. This is in accordance with previous data demonstrating 
Bmp4 expression in mouse bone marrow-derived MSCs (Kondo et al. 2005). In addition, D1 cells 
were shown to express higher Bmp4 levels than E13.5 mouse kidney rudiment. It is possible that 
release of additional Bmp4 by D1 cells results in development inhibition similarly to the one 
achieved by exogenous Bmp4 in in vitro experiments mentioned earlier. However, it has not been 
attempted in this study to determine the expression levels of Bmp4 protein in D1 cells. 
Nevertheless, the stimulation with NKC CM did result in slight down-regulation of Bmp4 
expression in D1 cells.  
It is also likely that other members of TGF-β superfamily are implicated in the inhibition of the 
development of the chimeras or intact rudiments. Rat kidney rudiments treated with TGF-β1 for 5 
days have demonstrated a reduced number of UB tips (Bush et al. 2004), whereas mouse 
embryonic kidneys cultured for 9 days in the presence of TGF-β2 were demonstrated to develop 
only rudimentary glomeruli (Sims-Lucas et al. 2010). Conditioned media from MSCs was shown 
to contain TGF-β1 (Salazar et al. 2009). Accordingly TGF-β1 derived from MSCs was described 
to be responsible for mediating immunosuppressive effects characteristic for these cells (Nemeth 
et al. 2010). Similarly, expression of TGF-β2 was also confirmed in MSCs (Sun et al. 2011). 
Moreover, inactivation of Wnt signalling in ureteric bud cells also impairs branching of UB 
during nephrogenesis and consequently leads to lower numbers of nephrons and collecting ducts 
in kidneys of new born mice (Bridgewater et al. 2008). It has been demonstrated that a secreted 
glycoprotein Dickkopf-1 (Dkk-1) is able to suppress Wnt signalling, inducing in vitro impairment 
of UB branching in E13.5 mouse kidneys (Iglesias et al. 2007). Human MSCs have been shown 
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to express Dkk-1 and accordingly, inhibit the Wnt pathway in tumor cells (Qiao et al. 2008; Zhu 
et al. 2009). Consequently it is possible, that kidney development inhibition may also be 
mediated by the secretion of other factors than Bmp4, such as TGF-β1, TGF-β2 or Dkk-1. 
However, the expression of factors has been investigated neither in D1 cells nor human MSCs in 
this study. 
It is likely that MSCs may not only act on kidney development by secreting factors that inhibit 
UB or nephron development but also by facilitating stroma emergence. E11.5 mouse kidney 
rudiments treated with a mix of Bmp4 and fibroblast growth factor 2 (Fgf2) for 2 days showed 
expansion of stromal compartment at the periphery which was accompanied by the inhibition of 
MM condensation (Miyazaki et al. 2003). As mentioned before, D1 cells express Bmp4. It has 
been also demonstrated that Fgf2 is among the most prominent factors found in the supernatant of 
human bone marrow-derived MSCs (Schinkothe et al. 2008). A similar effect to Bmp4 and Fgf2 
in metanephric kidney has been observed with bone morphogenetic protein 7 (Bmp7) and Fgf2 
(Dudley et al. 1999). E11.5 kidney rudiments treated for 2 days with Bmp7 demonstrate impaired 
nephron formation. Consequently some UB tips remain surrounded by condensed MM but lack 
developing nephrons. The combination of Bmp7 and Fgf2 resulted in severe impairment in 
nephron formation which was accompanied by emergence of additional peripheral mesenchyme 
positive for the stromal marker Bf2 (Dudley et al. 1999). In addition, Weller et al. showed that 
epidermal growth factor (EGF) promotes emergence of interstitial cells in isolated MM. 
Treatment of intact E12 mouse embryonic kidneys with EGF led to formation of fewer epithelial 
structures and expansion of mesenchymal tissue (Weller et al. 1991). Unfortunately the 
expression of Bmp7 and EGF has not been investigated in MSCs.  
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Finally it is also possible that MSCs by secreting factors like TGF-β2 can induce renal cells to 
differentiate towards other cell types not found during normal nephrogenesis in the kidney. It has 
been shown that stimulation with TGF-β2 for 6 days induces two types of mesenchymal cells in 
mouse metanephroi which neither expressed the MM-specific markers Wt1 and Pax2, nor the 
stromal marker, Foxd1. Furthermore, in the presence of TGF-β2, some kidney cells started to 
resemble chondrocytes as they were expressing collagen found in the cartilage and after 9 days of 
culture, stained with Alcian blue. Another mesenchymal population induced by TGF-β2 was 
located at the periphery of the kidneys. These cells were positive for α-smooth muscle actin and 
did not stain for Alcian blue (Sims-Lucas et al. 2010). 
In conclusion, D1 cells affect kidney development by secreting various factors. Possibly some of 
the factors may support development and at the same time, different sets of factors may act 
antagonistically on nephrogenesis. D1 cells express both Gdnf, which induces UB branching 
(Vega et al. 1996), and Bmp4, described to suppress UB branching and MM condensation 
(Miyazaki et al. 2003). In addition, D1 cells may secrete simultaneously several factors that 
negatively act on kidney morphogenesis, such as Bmp4 and Fgf2. The combination of Bmp4 and 
Fgf2 may induce not only inhibition of MM condensation but as well expansion of the stromal 
compartment in the chimeras harbouring D1 cells as described for mouse kidney rudiments 
(Miyazaki et al. 2003). Finally, NKC CM stimulation of D1 cells helps to prevent the observed 
negative effects, possibly by modulating the expression profile of the cells.  
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Chapter 7: Final discussion 
There exist several approaches to renal regeneration in patients with kidney injury, which may 
involve stem cells or progenitor cells. One possibility would be to stimulate endogenous 
progenitors to induce more rapid renal regeneration following the injury. Another option would 
be to transplant exogenous stem cells/progenitors to enhance the functional and structural 
recovery of the injured kidneys. In patients with severely damaged kidneys that require a renal 
transplant, the above mentioned treatment options, however, would not be feasible. In this case, 
stem cells might be used to generate de novo renal tissue for transplantation (Little 2006). 
Previous research suggests that MSCs can be considered as potential candidates for therapies 
aimed at renal tissue regeneration. Along with renoprotective effects in different acute kidney 
injury models, occasional integration of MSCs into tubules of injured kidneys was observed 
(Herrera et al. 2004; Morigi et al. 2004; Qian et al. 2008; Li et al. 2010). Some reports have also 
described in vitro acquisition of kidney specific phenotypes by MSCs (Singaravelu and 
Padanilam 2009; Matsushita et al. 2010). Finally, MSCs were demonstrated to contribute to 
kidney development by integrating into glomeruli and tubules of metanephric kidneys (Yokoo et 
al. 2005). The purpose of the current study was to examine the renogenic potential of mouse and 
human MSCs using a novel approach that involves formation of mouse embryonic kidney 
chimeras. The study was also intended to compare the renogenic capacity of MSCs and other cell 
types as well as to evaluate the possibility of increasing the ability of MSCs to contribute to renal 
development. In addition, an attempt was made to elucidate the action of MSCs on metanephric 
development. Accordingly, using the kidney chimeras, MSCs were demonstrated to have low 
renogenic potential. In addition, their incorporation into metanephric kidneys led to inhibited 
kidney development. Subsequently, incubation of embryonic kidneys with conditioned 
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medium obtained from mouse MSCs culture was demonstrated to decrease branching 
morphogenesis of the kidney rudiments, suggesting that MSCs have indeed a detrimental effect 
on metanephric development. Pre-conditioning of mouse MSCs with medium derived from 
mouse neonatal kidney cells facilitated their engraftment into developing renal structures and 
prevented the negative action of the cells on kidney development. In addition, the renogenic 
potential of MSCs was compared to the renogenic potential of embryonic stem cells and neonatal 
kidney cells using the same approach. Consequently all objectives of the study have been 
addressed. In this chapter the outcomes of the study are summarised and discussed in view of 
existing evidence. 
Chimeric kidney assay 
Previously, human MSCs were demonstrated to contribute to kidney development by integrating 
into renal structures and expressing kidney-specific markers (Yokoo et al. 2005). Consequently 
metanephroi with integrated MSCs were shown to produce fluid similar to urine following 
transplantation into the omentum of recipient animals (Yokoo et al. 2006). Nevertheless, in order 
to achieve integration of human MSCs into metanephric kidneys, a sophisticated protocol had to 
be developed, as direct injection of MSCs into the kidney rudiment was demonstrated to be 
insufficient to trigger their integration. The protocol involved demanding experimental 
procedures, like injection of MSCs into the intermediate mesoderm of rat embryos and 
subsequent ex utero culture of the embryos (Yokoo et al. 2005; Yokoo et al. 2006). In order to 
accurately evaluate the suitability of MSCs for renal tissue generation a much simpler and more 
reproducible protocol is required. In the current study, a modified procedure developed by 
Unbekandt and Davies which involves disaggregation of mouse metanephroi followed by re-
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aggregation of kidney cells to form de novo kidney rudiments was used to assess renogenic 
potential of MSCs (Unbekandt and Davies 2010). It was shown previously that the re-formed 
kidney rudiments display features of developing metanephroi, with the same morphology and 
marker expression observed in intact rudiments, thus mimicking normal metanephric 
development (Unbekandt and Davies 2010). The suitability of re-aggregated kidney to act as a 
model of nephrogenesis was also confirmed here. In order to make kidney chimeras, kidney 
rudiments were disaggregated and subsequently re-aggregated in the presence of labelled MSCs, 
creating chimeras containing both kidney rudiment cells and MSCs. Recently, this protocol was 
used to incorporate human amniotic fluid stem cells (AFSCs) into embryonic kidneys in order to 
test their contribution to kidney development. Subsequently, the cells were detected in Pax2 and 
Wt1 positive renal structures (Siegel et al. 2010). Ultimately, an alternative chimeric kidney 
assay for testing MSCs contribution to kidney structures could be employed. A recent report 
describes the use of a similar technique to integrate embryonic renal stem cells, derived from 
dissociated E12.5 mouse kidney rudiments and subsequently cultured as nephrospheres, into 
metanephric kidneys. Accordingly, the cells were mixed with a suspension of kidney cells 
obtained from disaggregated E12.5 mouse kidney rudiments, subsequently pelletted and cultured 
in the presence of NIH3T3 cells expressing Wnt4 on a collagen IV coated filter. After 4 days of 
culture, embryonic renal stem cells were found to a great extent in the interstitium of the 
developing chimeras; however, some cells were detected in tubular structures (Lusis et al. 2010).  
Renogenic potential of MSCs 
In the first part of this study, the multilineage potential of the employed MSCs was confirmed 
and the most appropriate labelling methods for further experiments were determined. The 
 206 
adipogenic, osteogenic and chondrogenic capacity of MSCs was assessed using standard 
differentiation protocols (Peister et al. 2004) and both mouse and human cells were shown to 
undergo adipo- and osteogenesis. In addition, mouse MSCs were also confirmed to undergo 
chondrogenesis. Previously, it has been demonstrated that transient labelling with QDs, GFP 
transduction and staining with species-specific antibodies are suitable for MSCs labelling (Azizi 
et al. 1998; Lu et al. 2005; Muller-Borer et al. 2007). Subsequently, all abovementioned methods 
were confirmed to be appropriate for tracking MSCs, hence investigating their integration into 
chimeric kidneys. 
Before introducing MSCs into the embryonic kidney environment, the cells were analysed for 
their expression of early kidney development markers. Mouse MSCs showed expression of some 
genes involved in metanephric development, such as Gdnf, Sall1, Lim1 and Osr1; however, they 
did not express Pax2 and Wt1. At the same time Lusis et al. demonstrated that primary bone 
marrow-derived MSCs do not express markers like Sall1 and Lim1. A discrepancy observed 
between the expression profile of mouse MSCs employed in this study and the profile described 
previously for bone-marrow derived mouse MSCs (Lusis et al. 2010) might be explained by the 
fact that the mouse cells used in current study were a MSC line derived from BALB/c mice in 
comparison to the primary MSCs isolated form C57BL/6 mice used by Lusis et al.. Also, a 
difference between the expression profile of mouse MSC line and human primary MSCs was 
observed, as human MSCs were shown not to express SALL1 detected earlier in mouse cells. 
Similarly to mouse cells, human MSCs did not express PAX2 and WT1. 
Finally, in the current study, MSCs were recombined with a kidney cell suspension derived from 
mouse embryonic kidneys at the onset of metanephric development at E11.5. After 4 days of 
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culture the chimeras were analysed. Mouse MSCs were found integrated into condensing 
metanephric mesenchyme (MM) but not into ureteric buds (UBs). Despite the fact that some 
MSCs were detected in the condensing mesenchyme, no cells were found in developing nephron-
like structures. Regarding the human MSCs, they were found in the proximity of condensing MM 
or developing nephron-like structures, but no definitive integration was detected. Those result are 
contradictory to the observation made by Yokoo and co-workers showing integration of human 
MSCs into nephrons of rat metanephric kidneys (Yokoo et al. 2005). One of the main differences 
between this study and Yokoo et al is that MSCs were integrated into kidney rudiments at the 
onset of metanephric development and not prior to the start of nephrogenesis, as described before 
(Yokoo et al. 2005). In addition, it was demonstrated that high expression of GDNF in human 
MSCs is essential for enhancing the number of integrated cells (Yokoo et al. 2005). Gdnf is an 
important factor for outgrowth and branching of UBs during metanephric development (Vega et 
al. 1996; Sainio et al. 1997). Nevertheless, the mouse and human MSCs employed in this study 
did not over-express Gdnf. Finally, the absence of MSCs from UBs is with agreement with 
previous results showing lack of integration of human MSCs into the developing colleting duct of 
embryonic kidneys (Fukui et al. 2009). 
Moreover, the integration of mouse and human MSCs also had some negative effect on the 
development of the chimeras. The presence of MSCs affected the condensation of MM and 
subsequent nephron formation in the kidney chimeras, as fewer areas of condensing mesenchyme 
and nephron-like structures were formed in chimeras harbouring MSCs in comparison with 
kidneys reformed in the absence of MSCs. The inhibitory role of MSCs was confirmed in intact 
kidney rudiments. Accordingly, it was demonstrated that conditioned medium derived from 
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mouse MSCs decreased UB branching of in vitro cultured intact E11.5 kidney rudiments. 
Apparently others did not observe any detrimental effect on kidney development when 
integrating human MSCs (Yokoo et al. 2005; Yokoo et al. 2006; Fukui et al. 2009), although 
there exists reports demonstrating negative effects of conditioned medium derived from MSCs on 
hippocampal tissue (Horn et al. 2009; Horn et al. 2010). It is not clear which factors secreted by 
MSCs are responsible for this effect. Possibly, high expression of Bmp4 in MSCs can mediate the 
developmental inhibition in the chimeras and intact kidney rudiments. Bmp4 was shown to 
inhibit in vitro UB branching and MM condensation in mouse kidney rudiments (Raatikainen-
Ahokas et al. 2000; Miyazaki et al. 2003). In conclusion, despite the fact that MSCs secrete 
paracrine factors that play a crucial role in enhancing recovery from kidney injury (Imberti et al. 
2007; Togel et al. 2007; Togel et al. 2009), they exert an indirect negative effect on metanephric 
development.  
Ultimately, embryonic stem cells (ESCs) and neonatal kidney cells (NKCs) were integrated into 
chimeric kidneys in order to compare renogenic potential of MSCs with other cells. A previous 
study has shown that undifferentiated mouse ESCs were found in large tubule-like structures 
surrounded by basement membranes following injection into embryonic kidneys (Steenhard et al. 
2005). Using the chimeric kidney, in the current study, mouse ESCs were detected in both 
laminin positive tubular structures, possibly confirming previous results, and within condensing 
MM, but not in the developing nephron-like structures. When compared with MSCs, ESCs 
seemed to have a broader integration potential. In addition, no negative effect on metanephric 
development was noted. However, both stem cells types were absent from forming nephrons 
despite their presence in the condensing MM. In contrast, NKCs were rarely found integrated into 
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laminin positive structures in the chimeric kidneys. Accordingly, they were present in condensing 
MM and to some extent in developing nephron-like structures. Behaviour of NKCs in the 
chimeric kidneys was similar to the adult kidney progenitor populations, namely the side 
population, which after injection into metanephric kidney was detected in MM-derived structures 
rather than UBs (Challen et al. 2006). When compared with MSCs, NKCs seemed to have a 
similar integration potential, as both MSCs and NKCs were found in condensing MM but not in 
the laminin positive structures. However, the main difference between MSCs and NKCs was that 
the latter were also found in developing nephrons, marked in those experiments by presence of 
laminin and Wt1. Finally, NKCs did not appear to have any detrimental effect on kidney 
development. ESCs and NKCs were also present to a great extent in the stroma of developing 
chimeras, similar to MSCs. 
Increasing renogenic potential of MSCs  
Several studies demonstrated that MSCs can adopt the characteristics of the particular cell 
population following stimulation with conditioned medium derived from this population (Rivera 
et al. 2006; Pan et al. 2008; Baer et al. 2009; Schittini et al. 2010). Accordingly, the conditioned 
medium derived from cardiac explants, foetal liver culture, adult neural tissue, proximal tubular 
cells were demonstrated to induce phenotypic changes in the MSCs (Rivera et al. 2006; Pan et al. 
2008; Baer et al. 2009; Schittini et al. 2010). In order to enhance the contribution of MSCs to 
kidney development, conditioned medium from NKCs (NKC CM) was used to increase the 
renogenic potential of MSCs in the chimeric kidneys. After 4 days of stimulation with NKC CM, 
the cells were recombined with kidney cell suspension to form chimeric kidneys. In comparison 
with cells not pre-treated with the conditioned medium, the engraftment into condensing MM of 
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stimulated mouse MSCs increased significantly. The integration into Wt1-expressing 
compartment of chimeric kidneys was almost four times higher for stimulated mouse MSCs.  
The mechanism of action of conditioned medium on mouse MSCs is not clear. However, it was 
demonstrated that the stimulated cells significantly up-regulated Gdnf expression. In Yokoo`s 
experiments, transduction with GDNF has been shown to lead to an approximately 6-fold 
increase in the incorporation rate of human MSCs into metanephroi following injection into 
intermediate mesoderm (Yokoo et al. 2005). Possibly the pre-conditioning with NKC CM 
facilitates the incorporation of mouse MSCs into condensing MM by inducing high levels of 
Gdnf.  
Importantly, these results could not be replicated with human MSCs, as stimulation with NKC-
derived conditioned medium did not result in an increase of integration of human MSCs. 
Accordingly, human MSCs do not express SALL1 and, differently from mouse cells, were not 
integrating into any renal structures before pre-conditioning which may explain why human 
MSCs did not respond to NKC CM stimulation. Other possibility could be that human MSCs 
were not able to respond to factors found in the conditioned medium since they were derived 
from mouse cells. 
Interestingly, the pre-treatment of mouse MSCs with NKC conditioned medium prevented any 
negative effect on the development of the chimeras. In the presence of stimulated MSCs, 
condensation of MM and subsequent nephron formation in the chimeric kidneys occurred in the 
same way as in kidneys reformed in the absence of MSCs. Consequently, it was demonstrated 
that conditioned medium derived from stimulated cells did not inhibit UB branching of in vitro 
cultured intact E11.5 kidney rudiments. As mentioned earlier, the stimulation with NKC CM 
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led to an increase in Gdnf expression in the cells. In addition, some downregulation of Bmp4 
expression was also detected following the pre-treatment with NKC CM. These results indicate 
that the stimulation with NKC CM might change the secretion profile of mouse MSCs preventing 
the detrimental effects on metanephric kidneys.  
In this study it was possible to increase the engraftment potential of mouse MSCs using the NKC 
CM.  Nevertheless, still only a very small number of MSCs was found in the nephron-like 
structures in the chimeras. Therefore in order to obtain engraftment of MSCs into nephrons it 
might be necessary to permanently change the expression profile of MSCs, similarly as it was 
shown by Yokoo and co-workers (Yokoo et al. 2005). One idea would be to transduce MSCs 
with Wt1. AFSCs which expressed Wt1 before the recombination with embryonic kidney cells 
have been shown to readily integrate into developing renal structures in the chimeric kidney 
assay (Siegel et al. 2010). Also, NKCs which integrated into condensing mesenchyme and 
nephron-like structures were demonstrated to express Wt1 (Mora 2009). On the other hand, 
permanent expression of Wt1 could become problematic later in the development. In addition, for 
both mouse and human bone marrow-derived MSCs, subpopulations with higher plasticity exist 
(D'Ippolito et al. 2004; Kucia et al. 2006; Anjos-Afonso and Bonnet 2007). Their engraftment 
potential could be determined using the chimeric kidney assay as possibly these cells would more 
efficiently contribute to chimeric kidney development. 
Future directions 
In this study it was demonstrated that the chimeric kidney culture assay is a useful tool for 
investigating the renogenic potential of MSCs. This approach can be also used to assess 
renogenic potential of other cells like ESCs or kidney progenitors. In the long term perspective, 
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the chimeric kidneys could be utilized as a scaffold for generating renal tissue with the help of 
exogenous stem cells. Recent advances in kidney rudiment culture may be used to improve the 
kidney chimera culture. For instance, despite the emergence of forming nephrons and UB 
branching, no distinct cortical and medullary zones were observed in the chimeras performed in 
this study. Lately, it has been shown that culture of mouse metanephroi in a low volume of 
medium facilitates the development of cortico-medullary zones in the kidney rudiments, dividing 
the kidneys into cortex containing the glomeruli and ureteric bud tips, and medulla containing 
collecting ducts and the loops of Henle (Sebinger et al. 2010). Furthermore, in order to generate 
fully functional renal tissue from chimeric kidneys, a blood supply is required. To allow 
vascularisation, chimeras could be transplanted into host animals, for example under the renal 
capsule of a host rat (Rogers et al. 1998; Rosines et al. 2007). Previously, it has been attempted to 
transplant intact embryonic kidneys (Rogers et al. 1998) or in vitro engineered kidney rudiments 
consisting of recombined T-shaped UB and uninduced MM (Rosines et al. 2007). 
As discussed here, ESC, NKC and MSC populations have different abilities to contribute to 
kidney development. These observations can have crucial implications in approaches aimed at de 
novo generation of renal tissue. According to data presented in this study and by others, MSCs do 
not have a potential to contribute to the duct system (Yokoo et al. 2005; Fukui et al. 2009). For 
that reason it is rather unlikely that MSCs will be used in the future for generation of collecting 
ducts. On the contrary, kidney progenitors (Challen et al. 2006; Maeshima et al. 2006) or AFSCs 
(Perin et al. 2007; Siegel et al. 2010) were demonstrated to engraft into UBs and accordingly they 
might be used for this purpose. Numerous stem cell/progenitor types were demonstrated to 
engraft into MM-derived structures (Kim and Dressler 2005; Steenhard et al. 2005; Yokoo et al. 
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2005; Challen et al. 2006; Maeshima et al. 2006; Perin et al. 2007; Vigneau et al. 2007; Siegel et 
al. 2010). Nevertheless, it is difficult to decide which would be the most appropriate for de novo 
nephron formation as different methodologies were used to characterise the engraftment and 
subsequent differentiation towards kidney-like phenotype. So far no common standard has been 
established to evaluate performance of the various stem cells and progenitors in the metanephric 
environment, either following injection into the rudiment or following recombination with 
embryonic kidney cells. Accordingly, the following areas require standardization in order to 
effectively assess renogenic potential of stem cells and progenitors in the future: (i) labelling 
methods for detecting integrated cells; (ii) methods of calculating the number of engrafted cells 
into renal structures; and (iii) methods for determining their subsequent differentiation towards 
both renal phenotypes and non-renal phenotypes.  
Many reports showing a contribution of different cell types to nephrogenesis in vitro, including 
MSCs, do not use more then one labelling method to confirm the observations. Accordingly, this 
may result in misleading statements regarding their renogenic potential.  
As demonstrated in this study, a discrepancy between integration potential of QD- and GFP-
labelled MSCs into chimeric kidneys was observed. While QD-labelled cells showed broad 
engraftment potential encompassing all compartments found in the chimeric kidney, GFP-
labelled cells were found mainly in stroma and condensing MM. Also, the number of integrated 
cells into condensing MM differed depending on the labelling method, with less QD-labelled 
MSCs being engrafted into the condensing MM in comparison with GFP-labelled cells. It is 
likely that QD signal detected in some structures was not genuine. Some QDs might be also lost 
from cells in the condensing MM due to cell death or transferred to other cells. It is also possible 
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that GFP expression prevents MSCs integration in some compartments but facilitates the 
presence of MSCs in the condensing MM. All scenarios might be possible as loss of QD labelling 
has been described in different cell types, including MSCs (Rosen et al. 2007; Pi et al. 2010). 
QDs were also demonstrated to have some potential to transfer to other cells, as it was possible to 
use supernatants collected from labelled ESCs to label other cells again (Pi et al. 2010). 
Similarly, GFP labelling could have some effect on MSCs, since GFP expression was shown to 
negatively affect kidney cells by inducing renal defects in vivo and interfering with common 
signalling pathways in vitro (Baens et al. 2006; Guo et al. 2007). In conclusion, the number of 
observed integrated cells and their location may strongly depend on the labelling method. 
Further, using the GFP and species-specific antibody it became also clear that the majority of the 
MSCs were forming different sized clusters inside of chimeric kidneys, despite the fact that the 
cells were homogonously distributed at day 0, which could not be observed using QDs. Taken 
together, it is crucial to identify better labelling methods that give consistent results when 
assessing renogenic potential of cells in the future. Possibly, more than one tracking method 
should be employed to evaluate results. 
In order to be used for renal tissue engineering, a sufficient number of stem cells/progenitor cells 
would need to engraft and subsequently commit into kidney-specific cell types. Sporadic 
contribution of some cells would be unlikely to generate de novo renal structures. Although 
Yokoo et al. described contribution of human MSCs to glomeruli and tubules (Yokoo et al. 
2005), no quantification was provided, which could imply rather infrequent engraftment. 
Similarly, in the report of Siegel et al. which used the same chimeric kidney system to test 
renogenic potential of AFSCs, no quantification of the engraftment was shown (Siegel et al. 
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2010), which may again suggest only occasional integration of the cells. In the current study it 
was shown that following NKC CM pre-treatment, on average, 13% of GFP-labelled mouse 
MSCs were found engrafted into condensing MM. In addition, it appeared that stimulated mouse 
MSCs have a similar integration potential into Wt1-expressing mesenchyme as the neonatal 
kidney cells used in this study, and adult kidney cells (Challen et al. 2006). The engraftment into 
MM, however, does not implicate that all the cells initially found in this compartment will 
become integrated into developing nephron-like structures. On the contrary, in this study it was 
demonstrated that despite a high integration rate of GFP mouse MSCs into condensing MM, only 
occasionally the cells were found in the nephron-like structures at day 4 and no integration into 
nephron-like structures was detected on day 7 of chimeric kidney culture. This result can also be 
interpreted as a lack of proliferation of engrafted MSCs. Finally, one of the limitations of this 
study, but also other studies elucidating renogenic potential of stem cells, is the lack of a negative 
control, namely a population of cells that should not harbour any renogenic potential which could 
be used to compare the renogenic potential of MSCs. Ultimately, a suitable positive control 
should be established to elucidated renogenic potential of all stem cells and progenitors. In 
conclusion, in order to accurately assess the renogenic potential of different stem 
cells/progenitors, including MSCs, more quantitative studies should be performed in the future. 
Satisfactory levels of engraftment should be determined beforehand, in order to allow accurate 
analysis of renogenic potential of different cells types. 
Another important issue regarding the putative renogenic capacity of stem cells/progenitors is the 
acquisition of expression of kidney markers upon integration into kidney rudiment structures. The 
acquisition of expression of such markers by the engrafted cells suggests their differentiation 
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towards kidney phenotype. Previously, human MSC were demonstrated to express Wt1 when 
integrated into metanephric kidneys (Yokoo et al. 2005). In this study, QD-labelled mouse MSCs 
appeared to be stained with Wt1 when integrated into the condensing MM of chimeric kidneys 
implying that mouse MSCs might differentiate into MM-like cells that give rise to nephron. No 
expression of Wt1 was, however, detected when GFP-labelled MSCs were used instead of QD-
labelled cells. Again, it could be claimed that GFP expression prevents the Wt1 expression in the 
engrafted cells. One aspect that was not considered previously is the fusion potential of MSCs. 
Accordingly, mouse MSCs could infrequently fuse with kidney cells, which might explain the 
acquisition of renal markers by the QD-labelled cells. Nevertheless, in a model of folic acid 
induced kidney injury in mice, no conclusive evidence was found for fusion between bone 
marrow-derived cells and kidney cells (Fang et al. 2005). In addition, human MSCs were 
demonstrated to possess multilineage transdifferentiation potential in vitro. Accordingly they 
were shown to differentiate into osteoblasts but upon adipogenic or chondrogenic induction they 
could reverse their phenotype and become adipocytes or chondrocytes, respectively (Song and 
Tuan 2004). The transdifferentiation potential of engrafted MSCs as well as other stem cells 
needs to be considered in studies on renogenic potential. In conclusion, the expression of given 
renal markers may depend on the labelling method or other factors, like possible fusion events. 
For this reason, acquisition of renal expression should not be the only criterion for differentiation 
of engrafted cells. Long-term follow up studies should be performed to assess the commitment of 
the cells to renal lineages.  
MSCs, ESCs and NKCs were found predominantly in the stroma of the chimeric kidneys. These 
results are in accordance with some data from experiments with adult kidney-derived progenitors 
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injected into metanephric kidney which were shown to reside to a great extent in the stromal 
compartment (Challen et al. 2006; Maeshima et al. 2006). Similarly embryonic renal progenitors 
were shown to mainly localise in the interstitium following a similar recombination experiment 
involving chimeric kidney formation (Lusis et al. 2010). These results demonstrate that apart 
from MSCs, other stem cells/progenitors can be found in the stroma of developing kidneys.  The 
behaviour of the cells in the stromal compartment has not yet been determined, and for this 
reason it cannot be concluded if such cells remain undifferentiated or become embryonic kidney 
stroma. In any case, the high proportion of stem cells/progenitors not contributing to any renal 
structures can make efficient generation of de novo renal tissue difficult. For the future 
regenerative therapies it might be important to assess the prevalence of the cells in the stroma and 
their characteristics.  
Ultimately, it is possible that undifferentiated stem cells/progenitors which do not contribute to 
nephrons, collecting ducts or interstitium in the developing kidneys, could differentiate towards 
non-renal phenotypes within the kidney. MSCs were demonstrated to improve renal function in 
acute mesangioproliferative glomerulonephritis in rats, a model of acute renal failure; however, at 
the same time they were also shown to maldifferentiate into adipocytes. Administration of MSCs 
led as well to glomerular expression of smooth muscle actin which was accompanied by 
expression of collagen I, III and IV suggesting a fibrotic response in MSC-treated kidneys 
(Kunter et al. 2007). Recently, cells found in Wilms tumor, a childhood kidney cancer, were 
shown to resemble MSCs. Accordingly, Wilms tumor cells demonstrated a similar differentiation 
potential and expression profile as MSCs (Royer-Pokora et al. 2010). Finally, a recent report 
showing angiomyeloproliferative lesions in a patient receiving renal injection of hematopoietic 
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stem cells demonstrates possible risks associated with other stem cell (Thirabanjasak et al. 2010). 
In conclusion, integration of stem cells/progenitors could have harmful effects in the long term 
regenerative application. Further experiments are required to assess if MSCs and other cell types 
do not maldifferentiate when integrated into kidney structures. 
In this study the renogenic potential of MSCs, and thus their suitability for renal regeneration, 
was evaluated using the chimeric kidney assay. It was demonstrated that MSCs have low 
renogenic potential despite the fact that they expressed some genes involved in metanephric 
development. However, the integration potential of MSCs in the chimeric kidneys could be 
enhanced by pre-conditioning of the cells with medium derived from neonatal kidney cell culture. 
MSCs are possibly not the best candidates for de novo renal tissue generation due to their limited 
integration into nephrons, lack of contribution to UBs and negative indirect effect on kidney 
development. However, as no common standards exists to evaluate performance of the stem 
cells/progenitors in the metanephric environment it is difficult to assess if any of the stem 
cells/progenitors has sufficient renogenic potential to be used for de novo kidney formation. 
Above-mentioned issues should to be considered when evaluating renogenic potential of MSCs 
and other cells in the future.  
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